e10vk
UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
Form 10-K
|
|
|
(Mark One)
|
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the fiscal year ended
December 31, 2006
|
or
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the transition period
from to
|
Commission file number 1-12031
UNIVERSAL DISPLAY
CORPORATION
(Exact name of registrant as
specified in its charter)
|
|
|
Pennsylvania
|
|
23-2372688
|
(State or other jurisdiction
of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
375 Phillips Boulevard
Ewing, New Jersey
|
|
08618
(Zip Code)
|
(Address of principal executive
offices)
|
|
|
Registrants telephone number, including area code:
(609) 671-0980
Securities registered pursuant to Section 12(b) of the
Act:
None
Securities registered pursuant to Section 12(g) of the
Act:
Common
Stock (par value $0.01 per share)
(Title
of Class)
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act. Yes o No þ
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the
Act. Yes o No þ
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
is not contained herein, and will not be contained, to the best
of registrants knowledge, in definitive proxy or
information statements incorporated by reference in
Part III of this
Form 10-K
or any amendment to this
Form 10-K. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, or a non-accelerated
filer. See definition of accelerated filer and large
accelerated filer in
Rule 12b-2
of the Exchange Act. (Check one):
Large accelerated
filer o Accelerated
filer þ Non-accelerated
filer o
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the Exchange
Act). Yes o No þ
The aggregate market value of the voting and non-voting common
equity held by non-affiliates of the registrant computed by
reference to the closing sale price of the registrants
common stock on the NASDAQ Global Market as of June 30,
2006, was $344,611,872. Solely for purposes of this calculation,
all executive officers and directors of the registrant and all
beneficial owners of more than 10% of the registrants
common stock (and their affiliates) were considered affiliates.
As of March 8, 2007, the registrant had outstanding
31,535,616 shares of common stock.
DOCUMENTS
INCORPORATED BY REFERENCE
Portions of the registrants Proxy Statement for the 2007
Annual Meeting of Shareholders, which is to be filed with the
Securities and Exchange Commission no later than April 29,
2007, are incorporated by reference into Part III of this
report.
CAUTIONARY
STATEMENT
CONCERNING FORWARD-LOOKING STATEMENTS
This report and the documents incorporated by reference in this
report contain some forward-looking statements.
Forward-looking statements concern possible or assumed future
events, results and business outcomes. These statements often
include words such as believe, expect,
anticipate, intend, plan,
estimate, seek, will,
may or similar expressions. These statements are
based on assumptions that we have made in light of our
experience in the industry, as well as our perceptions of
historical trends, current conditions, expected future
developments and other factors we believe are appropriate under
the circumstances.
As you read and consider this report, you should not place undue
reliance on any forward-looking statements. You should
understand that these statements involve substantial risk and
uncertainty and are not guarantees of future performance or
results. They depend on many factors that are discussed further
under Item 1A below (Risk Factors), including:
|
|
|
|
|
the outcomes of our ongoing and future research and development
activities, and those of others, relating to organic light
emitting diode (OLED) technologies and materials;
|
|
|
|
our ability to access future OLED technology developments of our
academic and commercial research partners;
|
|
|
|
the potential commercial applications of and future demand for
our OLED technologies and materials, and of OLED products in
general;
|
|
|
|
our ability to form and continue strategic relationships with
manufacturers of OLED products;
|
|
|
|
successful commercialization of products incorporating our OLED
technologies and materials by OLED manufacturers, and their
continued willingness to utilize our OLED technologies and
materials;
|
|
|
|
the comparative advantages and disadvantages of our OLED
technologies and materials versus competing technologies and
materials currently on the market;
|
|
|
|
the nature and potential advantages of any competing
technologies that may be developed in the future;
|
|
|
|
our ability to compete against third parties with resources
greater than ours;
|
|
|
|
our ability to maintain and improve our competitive position
following the expiration of our fundamental OLED patents;
|
|
|
|
the adequacy of protections afforded to us by the patents that
we own or license and the cost to us of maintaining and
enforcing those patents;
|
|
|
|
our ability to obtain, expand and maintain patent protection in
the future, and to protect our unpatentable intellectual
property;
|
|
|
|
our exposure to and ability to withstand third-party claims and
challenges to our patents and other intellectual property rights;
|
|
|
|
the payments that we expect to receive under our existing
contracts with OLED manufacturers and the terms of contracts
that we expect to enter into with OLED manufacturers in the
future;
|
|
|
|
our future capital requirements and our ability to obtain
additional financing if and when needed; and
|
|
|
|
our future OLED technology licensing and OLED material sales
revenues and results of operations.
|
Changes or developments in any of these areas could affect our
financial results or results of operations, and could cause
actual results to differ materially from those contemplated by
any forward-looking statements.
All forward looking statements speak only as of the date of this
report or the documents incorporated by reference, as the case
may be. We do not undertake any duty to update any of these
forward-looking statements to reflect events or circumstances
after the date of this report, or to reflect the occurrence of
unanticipated events.
PART I
Our
Company
We are a leader in the research, development and
commercialization of organic light emitting diode, or OLED,
technologies and materials. OLEDs are thin, lightweight and
power-efficient solid-state devices, highly suitable for use in
full-color displays and as lighting products. We believe OLED
displays will capture a share of the growing flat panel display
market because they offer potential advantages over competing
display technologies with respect to brightness, power
efficiency, viewing angle, video response time and manufacturing
cost. We also believe that OLED lighting products have the
potential to replace many existing light sources in the future
because of their high efficiency, excellent color rendering
index, low heat generation and novel form factors. Our
technology leadership and intellectual property position should
enable us to share in the revenues from OLED displays and
lighting products as they enter mainstream consumer markets.
Our primary business strategy is to further develop and license
our proprietary OLED technologies to manufacturers of products
for display applications, such as cell phones, MP3 players,
laptop computers and televisions, and specialty and general
lighting products. In support of this objective, we also develop
new OLED materials and sell those materials to product
manufacturers. Through our internal research and development
efforts and our relationships with world-class partners such as
Princeton University, the University of Southern California, the
University of Michigan, Motorola, Inc. and PPG Industries, Inc.,
we have established a significant portfolio of proprietary OLED
technologies and materials. We currently own, exclusively
license or have the sole right to sublicense more than 750
patents issued and pending worldwide.
In 2006, three manufacturers purchased our proprietary OLED
materials for use in commercial OLED display products: Samsung
SDI Co., Ltd. of South Korea, AU Optronics Corporation of Taiwan
and Tohoku Pioneer Corporation of Japan. We also have entered
into a patent license agreement with Samsung SDI, under which we
expect to start receiving royalties in 2007 based on Samsung
SDIs commencement of sales of active matrix OLED display
products. In addition, we are working with many other companies
who are evaluating our OLED technologies and materials for
possible use in commercial OLED display and lighting products,
including Seiko Epson Corporation, Konica Minolta Technology
Center, Inc. and Sony Corporation.
Market
Overview
The
Flat Panel Display Market
Flat panel displays are essential for a wide variety of portable
consumer electronics products, such as cell phones, MP3 players,
digital cameras and laptop computers. Due to their narrow
profile and light weight, flat panel displays are also becoming
the display of choice for larger product applications, such as
desktop computer monitors and televisions.
Liquid crystal displays, or LCDs, currently dominate the flat
panel display market. However, we believe that OLED displays are
an attractive alternative to LCDs because they offer a number of
potential advantages, including:
|
|
|
|
|
a thinner profile and lighter weight;
|
|
|
|
higher brightness and contrast ratios, leading to sharper
picture images and graphics;
|
|
|
|
wider viewing angles;
|
|
|
|
faster response times for video;
|
|
|
|
higher operating efficiencies, thereby reducing energy
consumption; and
|
|
|
|
lower cost manufacturing methods and materials.
|
Based on these characteristics, product manufacturers are
starting to adopt small-area OLED displays for use in portable
electronic devices, such as cell phones and MP3 players. These
manufacturers are also working to
2
develop OLED displays for use in larger applications, such as
computer monitors and televisions. We believe that if these
efforts are successful, they could result in sizeable markets
for OLED displays.
In addition, due to the inherent transparency of organic
materials and through the use of transparent electrode
technology, OLEDs eventually may enable the production of
transparent displays for use in products such as automotive
windshields and windows with embedded displays. Organic
materials also make technically possible the development of
flexible displays for use in an entirely new set of product
applications, such as display devices that can be rolled up for
storage.
The
Solid-State Lighting Market
Traditional incandescent light bulbs are extremely inefficient
because they convert only about 5% of the energy they consume
into visible light, with the rest emerging as heat. Fluorescent
lamps use excited gases, or plasmas, to achieve a higher energy
conversion efficiency of about 20%. However, the color rendering
index, or CRI, of most fluorescent lamps how good
their color is compared to an ideal light source is
inferior to that of an incandescent bulb.
Solid-state lighting relies on the direct conversion of
electricity to visible white light using semiconductor
materials. By avoiding the heat and plasma-producing processes
of incandescent bulbs and fluorescent lamps, solid-state
lighting products can have substantially higher energy
conversion efficiencies, which in theory could approach 100%.
There are currently two basic types of solid-state lighting
devices: inorganic light emitting diodes, or LEDs, and OLEDs.
Current LEDs are very small in size (about one square
millimeter) and are extremely bright. Having been developed
about 25 years before OLEDs, they are already employed in
single-color specialty lighting products, such as traffic
lights, billboards, replacements for neon lighting and as border
or accent lighting. However, their intense brightness makes them
less desirable for general illumination and diffuse lighting
applications.
OLEDs, on the other hand, are larger in size and far more
moderate in brightness than LEDs. This allows them to be viewed
directly, without using diffusers that are required to temper
the intense brightness of LEDs. In principle, OLEDs can also be
manufactured inexpensively, and may be deposited on any suitable
flat surface including glass, plastic or metal foil. Given these
characteristics, product manufacturers are working to develop
OLEDs for diffuse lighting applications and eventually general
illumination. If these efforts are successful, we believe that
OLED lighting products could begin to be used for applications
currently addressed by incandescent bulbs and fluorescent lamps.
Our
Competitive Strengths
We believe our position as one of the leading technology
developers in the OLED industry is the direct result of our
technological innovation. We have built an extensive
intellectual property portfolio around our OLED technologies and
materials, and are working diligently to enable our
manufacturing partners to adopt our OLED technologies and
materials for commercial usage. Our key competitive strengths
include:
Technology Leadership. We are a recognized
technology leader in the OLED industry. We and our research
partners pioneered the development of our
PHOLEDtm
phosphorescent OLED technology, which can be used to produce
OLEDs that are up to four times as efficient as traditional
fluorescent OLEDs and significantly more efficient than current
backlit LCDs. We believe that our PHOLED technology is
well-suited for industry usage in the commercial production of
OLED displays and lighting products. Through our relationships
with companies such as PPG Industries and our academic partners,
we have also developed other important OLED technologies, as
well as novel OLED materials that we believe will facilitate the
adoption of our various OLED technologies by product
manufacturers.
Relationships with Leading Product
Manufacturers. We have established relationships
with well-known manufacturers that are using, or are evaluating,
our OLED technologies and materials for use in commercial
products. In 2006, Samsung SDI, AU Optronics and Tohoku Pioneer
purchased our proprietary OLED materials for use in commercial
OLED display products, and we licensed one of our ink jet
printing patents and certain related patent filings to Seiko
Epson. In 2005, we entered into a license agreement with Samsung
SDI for its manufacture of
3
active matrix OLED display products, and in 2002 we entered into
a cross-license agreement with DuPont Displays, Inc. for its
manufacture of solution-processed OLED display products. We also
continue to work with many product manufacturers who are
evaluating our OLED technologies and materials for use in
commercial OLED displays and lighting products, including
Samsung SDI, Seiko Epson, Konica Minolta and Sony.
Broad Portfolio of Intellectual Property. We
believe that our extensive portfolio of patents, trade secrets
and know-how provides us with a competitive advantage in the
OLED industry. Through our internal development efforts and our
relationships with Princeton University, the University of
Southern California, the University of Michigan and Motorola, we
own, exclusively license or have the sole right to sublicense
more than 750 patents issued and pending worldwide related to
our PHOLED and other OLED technologies and materials. We also
continue to accumulate valuable trade secret information and
technical know-how relating to our OLED technologies and
materials.
Business Model Focused on Technology
Licensing. We are focused on licensing our OLED
technologies to product manufacturers on a non-exclusive basis.
Our current business model does not involve the manufacture or
sale of OLED products. PPG Industries currently manufactures our
proprietary OLED materials for us, which we then qualify and
resell to OLED manufacturers. Our business model involves the
receipt of license fees and royalties from product manufacturers
based on their sales of licensed OLED products,
and/or
revenues based on our sales of OLED materials to them for use in
their OLED products. We believe this business model allows us to
concentrate on our core strengths of technology development and
innovation, while at the same time providing significant
operating leverage. We also believe that this approach may
reduce potential competitive conflicts between us and our
customers.
Established U.S. Government Contracts to
Fund Research and Development. In 2006, we
started or continued working under approximately 15 research and
development contracts with U.S. government agencies, such
as the U.S. Department of the Army, the U.S. Department of
the Navy and the U.S. Department of Energy. Under these
contracts, the U.S. government funds a portion of our
efforts to develop next-generation OLED technologies for
applications such as flexible displays and solid-state lighting.
This enables us to supplement our internal research and
development budget with additional funding.
Experienced Management and Scientific Advisory
Team. Our management team has significant
experience in developing business models focused on licensing
disruptive technologies in high growth industries, which serves
to differentiate us from our competitors. In addition, our
management team has assembled a Scientific Advisory Board that
includes some of the leading researchers in the OLED industry,
such as Professor Stephen R. Forrest of the University of
Michigan (formerly of Princeton University) and Professor Mark
E. Thompson of the University of Southern California.
Our
Business Strategy
Our current business strategy is to both promote and continue to
expand our portfolio of OLED technologies and materials for
widespread use in OLED displays and lighting products. We
presently are focused on the following steps to implement our
business strategy:
Target Leading Product Manufacturers. We are
targeting leading manufacturers of flat panel displays and
lighting products as potential commercial licensees of our OLED
technologies and purchasers of our OLED materials. For example,
in April 2005 we entered into a patent license agreement with
Samsung SDI for its manufacture and sale of active-matrix OLED
display products. In 2006, we also sold our proprietary
phosphorescent OLED materials to Samsung SDI, AU Optronics and
Tohoku Pioneer for use in commercial OLED display products. We
also provide technical assistance and support to several
manufacturers of displays and lighting products who are
evaluating our OLED technologies and materials, or utilizing
them in product development
and/or for
pre-commercial product manufacturing. We concentrate on working
closely with these manufacturers because we believe that the
successful incorporation of our technologies and materials into
commercial products is critical to their widespread adoption.
Enhance Our Existing Portfolio of PHOLED Technologies and
Materials. We believe that a strong portfolio of
proprietary OLED technologies and materials is critical to our
success. Consequently, we are continually seeking
4
to expand this portfolio through our internal development
efforts, our collaborative relationships with academic and other
research partners, and other strategic opportunities. One of our
primary goals is to develop new and improved PHOLED technologies
and materials with increased efficiencies, enhanced color gamut
and extended lifetimes, which are compatible with different
manufacturing methods, so that they can be used by various
manufacturers in a broad array of OLED products.
Develop Next-Generation Organic
Technologies. We continue to conduct research and
development activities relating to next-generation OLED
technologies. Our current research and development initiatives
involve flexible OLED displays, transparent or top-emitting OLED
displays and OLEDs for solid-state lighting. We also are funding
research by our academic partners on the use of organic
thin-film technology in applications such as lasers,
photodetectors and other related devices. Our focus on
next-generation technologies is designed to enable us to
continue our position as a leading provider of OLED and other
organic electronics technologies and materials as new markets
emerge.
Business
and Geographic Markets
We derive revenue from three business areas:
|
|
|
|
|
technology research and development, including internal R&D,
government contract work and collaborative R&D with third
parties;
|
|
|
|
intellectual property and technology licensing; and
|
|
|
|
sales of OLED materials for evaluation, development and
commercial manufacturing.
|
Most manufacturers of flat panel displays and lighting products
who are or might potentially be interested in our OLED
technologies and materials are currently located in foreign
countries, particularly the Asia-Pacific region. Consequently,
we receive a substantial portion of our revenues from external
customers that are domiciled outside of the United States, and
our business is heavily dependent on our relationships with
these customers. In particular, two customers located in the
Asia-Pacific region, Samsung SDI and AU Optronics, accounted for
14% and 24%, respectively, of our consolidated revenues for 2006.
For more information on our revenues, costs and expenses
associated with the various lines of our business, as well as a
breakdown of revenues from domestic and foreign sources, please
see our audited consolidated financial statements and the notes
thereto, as well as Managements Discussion and
Analysis of Financial Condition and Results of Operations,
included elsewhere in this report and incorporated herein by
reference.
Our
Phosphorescent OLED Technologies
Phosphorescent OLEDs, or PHOLEDs, our key proprietary
technology, utilize novel materials and device structures that
allow OLEDs to emit light through a process known as
phosphorescence. Conversely, traditional fluorescent OLEDs emit
light through an inherently less efficient process. Theory and
experiment show that PHOLEDs exhibit device efficiencies up to
four times higher than those exhibited by fluorescent OLEDs.
Phosphorescence substantially reduces the power requirements of
an OLED and is potentially useful for hand-held devices, such as
mobile phones, where battery power is often a limiting factor.
Phosphorescence also may be important for large-area displays
such as televisions, where higher device efficiency and lower
heat generation may enable longer product lifetimes and
increased energy efficiency.
We believe that we have a strong intellectual property portfolio
that covers our existing PHOLED technology and materials. We
also conduct extensive work to develop new and improved PHOLED
technologies and materials, and to enhance our intellectual
property position. In 2006, we announced several advances in the
development of our proprietary blue PHOLED materials and device
architectures. We also established collaborative relationships
with Idemitsu Kosan Co., Ltd. and Nippon Steel Chemical Company
to develop and evaluate new PHOLED materials for use in vacuum
thermal evaporation, or VTE, manufacturing systems. In addition,
we continued to work closely with our customers in their
evaluation and qualification of our proprietary PHOLED materials
for potential use in the production of commercial OLED displays
and lighting products.
5
Our
Additional Proprietary OLED Technologies
Our research, development and commercialization efforts also
encompass a number of other OLED device and manufacturing
technologies, including the following:
TOLEDtm
Transparent OLEDs. We have developed a technology
for the fabrication of OLEDs that have transparent cathodes.
Conventional OLEDs use a reflective metal cathode and a
transparent anode. In contrast, TOLEDs use a transparent cathode
and either a transparent, or reflective or opaque metal anode.
TOLEDs utilizing transparent cathodes and reflective metal
anodes are known as top-emission OLEDs. In a
top-emission active-matrix OLED, light is emitted
without having to travel through much of the device electronics
where a significant portion of the usable light is lost. This
results in OLED displays having image qualities and lifetimes
superior to those of conventional active-matrix OLEDs. TOLEDs
utilizing transparent cathodes and transparent anodes may also
be useful in novel flat panel display applications requiring
semi- transparency or transparency, such as graphical displays
in automotive windshields.
FOLEDtm
Flexible OLEDs. We are working on a number of
technologies required for the fabrication of OLEDs on flexible
substrates. Most OLED and other flat panel displays are built on
rigid substrates such as glass. In contrast, FOLEDs are OLEDs
built on non-rigid substrates such as plastic or metal foil.
FOLEDs are intended to be either conformable to specific shapes
or repeatedly bent or flexed. Eventually, FOLEDs may be capable
of being rolled into a cylinder, similar to a window shade.
These features create the possibility of new flat panel display
product applications that do not exist today, such as a
portable,
roll-up
Internet connectivity and communications device. Manufacturers
also may be able to produce FOLEDs using more efficient
continuous, or
roll-to-roll,
processing methods. We currently are conducting research and
development on FOLED technologies internally, under several of
our U.S. government programs and in connection with the
government-sponsored Flexible Display Center at Arizona State
University.
OVPDtm
Organic Vapor Phase Deposition. The standard
approach for manufacturing a small molecule OLED, including a
PHOLED, is based on a VTE process. With a VTE process, the thin
layers of organic material in an OLED are deposited in a
high-vacuum environment. An alternate approach for manufacturing
a small molecule OLED is based on OVPD. In contrast to the VTE
process, the OVPD process utilizes a carrier gas stream in a hot
walled reactor in a low pressure environment to deposit the
layers of organic material in an OLED. The OVPD process may
offer advantages over the VTE process through more efficient
materials utilization and enhanced deposition control. Over the
past several years, we have been working with Aixtron AG, a
leading manufacturer of metal-organic chemical vapor deposition
equipment, to develop and qualify equipment for the fabrication
of OLED displays utilizing the OVPD process.
P2OLEDtm
Printable Phosphorescent OLEDs. OLEDs can be
manufactured using other processes as well. Another method
involves preparing solutions of the various organic materials in
an OLED that can be solution-processed by techniques such as
spin coating or inkjet printing onto the substrate.
Solution-processing methods, and inkjet printing in particular,
have the potential to be lower cost approaches to OLED
manufacturing and scalable to large area displays. Others have
demonstrated that solution- processing methods can be used to
produce OLEDs containing polymer-based fluorescent emission
organic materials, and we are developing printable
P2OLEDs
to demonstrate that these methods can be used with our small
molecule-based phosphorescent emission technologies. We are
currently working on
P2OLEDs
under a Joint Development Agreement with Seiko Epson, and we are
collaborating with Mitsubishi Chemical Corporation to develop
and evaluate novel
P2OLED
materials. In December 2005, we completed work under a Joint
Development Agreement with DuPont Displays, Inc. for the
development of novel
P2OLED
materials and device structures.
Our
Strategic Relationships with Product Manufacturers
We have established evaluation, technology development,
licensing and material supply relationships with numerous
manufacturers of displays and lighting products. As of
December 31, 2006, we had entered into 29 such
relationships, three of which were newly established in 2006.
These relationships generally are directed towards tailoring our
proprietary OLED technologies and materials for use by each
individual manufacturer. Our ultimate objective is to license
our OLED technologies and sell our OLED materials to these
manufacturers for their
6
commercial production of OLED products. Our key relationships
with product manufacturers in 2006 included the following:
Samsung SDI. In April 2005, we entered into an
OLED Patent License Agreement with Samsung SDI. Under this
agreement, we granted Samsung SDI license rights to make and
sell active-matrix OLED displays. In the fourth quarter of 2006,
we began supplying one of our proprietary PHOLED materials to
Samsung SDI for use in the manufacture of these OLED displays.
We also continue to supply other of our proprietary PHOLED
materials to Samsung SDI for evaluation and development
activities under a separate agreement that has been in place
since July 2001.
Sony. We have been supporting Sony Corporation
in its development of active-matrix OLED display products under
various agreements since February 2001. We are currently
operating under an evaluation agreement with Sony that has been
in place since February 2005. That agreement enables us to sell
our proprietary PHOLED materials to Sony for evaluation.
Seiko Epson. In December 2004, we entered into
a joint development agreement with Seiko Epson Corporation.
Under this agreement, we are conducting development activities
with Seiko Epson relating to the application of our proprietary
PHOLED technology and materials to ink-jet printing processes
used by Seiko Epson. We also supply our proprietary PHOLED
materials to Seiko Epson for evaluation and for use under this
development program, and in July 2006 we licensed one of our
ink-jet printing patents and certain related patent filings to
Seiko Epson.
Tohoku Pioneer. In August 2003, we began
supplying our proprietary red PHOLED material to Tohoku Pioneer
Corporation, a subsidiary of Pioneer Corporation, for the
commercial production of a passive-matrix OLED display product.
Tohoku Pioneer continued purchasing this material from us in
2006.
Konica Minolta. In September 2005, we entered
into an agreement with Konica Minolta for the joint development
of high-efficiency white OLEDs for application as backlights. In
2006, the collaboration became more focused on incorporating our
proprietary PHOLED technology into Konica Minoltas white
OLED devices. Konica Minolta continues to purchase PHOLED
materials from us for evaluation under the agreement.
AU Optronics. In February 2006, we entered
into a Commercial Supply Agreement with AU Optronics
Corporation. Under this agreement, we supplied AU Optronics with
one of our proprietary PHOLED materials for use in a commercial
active-matrix OLED display product. That activity continued
until the third quarter of 2006 when AU Optronics discontinued
its display product.
DuPont Displays. In December 2005, we
completed work under a Joint Development Agreement with DuPont
Displays, Inc. for the development of novel phosphorescent
materials and device structures for solution-processed OLEDs. In
December 2002, we entered into a Cross-License Agreement with
DuPont Displays for its manufacture of solution-processed OLED
display products. As of December 31, 2006, we had not
received any royalties from DuPont under that agreement.
Our OLED
Materials Supply Business
In support of our primary objective of licensing our OLED
technologies, we supply our proprietary OLED materials to
display manufacturers and others. We device-qualify our
materials before shipment in order to ensure the materials meet
required specifications. We believe that our inventory-carrying
practices, along with the terms under which we sell our OLED
materials (including payment terms) are typical for the markets
in which we operate.
PPG Industries has manufactured OLED materials solely for us
since October 2000. In July 2005, we renewed our relationship
with PPG Industries by entering into an OLED Materials Supply
and Service Agreement. This agreement was effective as of
January 1, 2006, and extended the term of our relationship
with PPG Industries through December 31, 2008. Under the
new agreement, PPG Industries continues to supply us with OLED
materials for research and development, and for resale to our
customers, both for their evaluation and for use in commercial
OLED products. Through our collaboration with PPG Industries,
key raw materials are sourced from multiple suppliers to ensure
that we are able to meet the needs of our customers on a timely
basis.
7
In 2006, we continued supplying Tohoku Pioneer with one of our
proprietary PHOLED materials for use in a commercial
passive-matrix OLED display product. For the first seven months
of 2006, we also supplied one of our proprietary PHOLED
materials to AU Optronics for use in a commercial active-matrix
OLED display product. In the fourth quarter of 2006, we began
supplying one of our proprietary PHOLED materials to Samsung
SDI, also for use in a commercial active-matrix OLED display
product. Throughout the year, we supplied these and other of our
proprietary OLED materials to various other product
manufacturers for evaluation and for purposes of development,
manufacturing qualification and product testing.
During the past year, we also announced three separate
collaborative relationships with other manufacturers of OLED
materials, all of which are non-exclusive. These include
relationships with Nippon Steel Chemical Company (NSCC) and
Idemitsu Kosan Co., Ltd., both of which are focused on matching
our proprietary PHOLED emitters with the host and other OLED
materials of these companies, and a relationship with Mitsubishi
Chemical Company under which we collaborate to develop
solution-processible
P2OLED
materials. We believe that collaborative relationships such as
these are important for ensuring success of the OLED industry
and broader adoption of our PHOLED and other OLED technologies.
Research
and Development
Our research and development activities are focused on the
advancement of our OLED technologies and materials for displays,
lighting and other applications. We conduct this research and
development both internally and through various relationships
with our commercial business partners and academic institutions.
In the years 2006, 2005 and 2004, we spent approximately
$19,864,944, $19,183,390 and $16,651,335, respectively, on both
internal and third-party sponsored research and development
activities with respect to our various OLED technologies and
materials.
Internal
Development Efforts
We conduct a substantial portion of our OLED development
activities at our
state-of-the-art
development and testing facility in Ewing, New Jersey. We
purchased this 40,200 square foot facility in December
2004, and in early 2006 we completed a two-phase expansion
project at the facility.
At our Ewing facility, we perform technology development,
including device and process optimization, prototype
fabrication, manufacturing
scale-up
studies, process and product testing, characterization and
reliability studies, and technology transfer with our business
partners. The facility houses five OLED deposition systems,
including a system brought on line in 2005 that is designed to
process full-color, flexible OLED devices and a prototype
organic vapor phase deposition (OVPD) system that we are using
to study our proprietary OVPD technology. In addition, the
facility contains equipment for substrate patterning, organic
material deposition, display packaging, module assembly, and
extensive testing in Class 100 and 100,000 clean rooms and
opto-electronic test laboratories. These capabilities were
enhanced in 2005 as part of the first phase of our expansion
project.
As part of the second phase of our expansion project, we
constructed
state-of-the-art
synthetic chemistry laboratories at our Ewing facility. In these
laboratories, our scientists conduct OLED materials research and
make small quantities of new materials that we then test in OLED
devices. Through 2005, we conducted this materials research in
laboratory space that we leased in Princeton, New Jersey. This
activity was transferred to our Ewing facility in January 2006.
As of December 31, 2006, we employed a team of 40 research
scientists, engineers and laboratory assistants at our
facilities in Ewing, New Jersey. This team includes chemists,
physicists, engineers with electrical, chemical and mechanical
backgrounds, and highly-trained experimentalists. In 2006, this
team was expanded through the hiring of new researchers,
including several chemists from PPG Industries who had been
working on our OLED materials development program for a number
of years.
8
University
Sponsored Research
We have long-standing relationships with Princeton University
and the University of Southern California (USC), dating back to
1993, for the conduct of research relating to our OLED and other
organic thin-film technologies and materials for applications
such as displays and lighting. This research has been performed
at Princeton University under the direction of Dr. Stephen
R. Forrest and at USC under the direction of Dr. Mark E.
Thompson. In 2006, Dr. Forrest transferred to the
University of Michigan, where we continue to fund his research.
We have been funding research at Princeton University under a
Research Agreement we executed with the Trustees of Princeton
University in August 1997. In April 2002, we extended the term
of this Research Agreement through July 2007. We have exclusive
license rights to all OLED and other thin-film organic
electronic patents (other than for organic photovoltaic solar
cells) arising out of research conducted under this agreement.
In connection with Dr. Forrests transfer to the
University of Michigan, in May 2006 we entered into a new
Sponsored Research Agreement with USC under which we will
provide up to $4.6 million in continued funding for the
organic electronics research being conducted by
Drs. Forrest and Thompson. Work by Dr. Forrest is
being funded through a subcontract between USC and the
University of Michigan. The funding arrangement runs through
April 2009. As with the 1997 Research Agreement, we have
exclusive license rights to all OLED and thin-film organic
electronic patents (other than for organic photovoltaic solar
cells) arising out of this research.
In October 2005, we entered into a separate Sponsored Research
Agreement with Princeton University to fund research under the
direction of Dr. Sigurd Wagner on thin-film encapsulation
and fabrication of OLED devices. The term of this funding
relationship runs through September 2007, and we have exclusive
license rights to all patents arising out of the research.
In December 2004, we entered into a Sponsored Research Agreement
with the Yuen Tjing Ling Industrial Research Institute of
National Taiwan University (TLIRI). Under that agreement we
funded a research program under the direction of
Dr. Ken-Tsung Wong relating to new OLED materials. We
received exclusive rights to all intellectual property developed
under that program. In 2006, we extended the program through
February 2007. We are presently negotiating another extension to
sponsor further research at TLIRI under the direction of
Dr. Wong.
In April 2004, we entered into a Contract Research Agreement
with the Chitose Institute of Science and Technology of Japan
(CIST). Under that agreement, we funded a research program
headed by Dr. Chihaya Adachi relating to high-efficiency
OLED materials and devices. We were granted exclusive rights to
all intellectual property developed under this program. This
relationship with CIST ended in March 2006 when Dr. Adachi
transferred to Kyushu University. However, we have continued our
relationship with Dr. Adachi under a separate consulting
arrangement that currently runs through March 2007, and we are
in discussions with Dr. Adachi to extend the arrangement
beyond that date.
In July 2003, we entered into an agreement with Kyung Hee
University to conduct research as a subcontractor under one of
our government programs to develop prototypes of a transparent,
conformable PHOLED display. This research was under the
direction of Dr. Jin Jang. The program ended in April 2005;
however, in March 2006 we entered into an arrangement with Kyung
Hee University to sponsor additional research directed by
Dr. Jang on flexible, amorphous silicon TFT backplane
technology. That arrangement is scheduled to expire in March
2007, but we are in discussions with Dr. Jang to continue
our relationship with him beyond that date.
PPG
Industries
Our relationship with PPG Industries on the development of OLED
materials changed in 2006. We assumed sole responsibility over
OLED materials research and development, and we hired four
chemists from the PPG Industries OLED materials
development team to work for us in our newly constructed
synthetic chemistry laboratories. Under our OLED Materials
Supply and Service Agreement, PPG Industries remains
responsible, under our direction, for manufacturing scale up and
the supply of these OLED materials for use by us and for resale
to our customers.
9
Aixtron
In July 2000, we entered into a Development and License
Agreement with Aixtron AG of Aachen, Germany to jointly develop
and commercialize equipment for the manufacture of OLEDs using
the OVPD process. A pre-production OVPD manufacturing tool was
delivered to our Ewing, New Jersey facility in January 2002. We
continue to work with Aixtron to upgrade this tool for use in
research and development of our OVPD technology.
Under the Development and License Agreement, we granted Aixtron
an exclusive license to produce and sell equipment used to
manufacture OLEDs and other devices using our proprietary OVPD
process. Aixtron is required to pay us royalties on its sales of
this equipment. Purchasers of the equipment also must obtain
rights to use our proprietary OVPD process to manufacture OLEDs
and other devices using the equipment, which they may do through
us or Aixtron. If these rights are granted through Aixtron,
Aixtron is required to make additional payments to us under our
agreement.
Aixtron has reported to us the delivery of five OVPD systems
since July 2002, including a second-generation system that was
sold to RiTdisplay Corporation of Taiwan in April 2003. We
recorded our first royalty income from Aixtrons sale of
these systems in the fourth quarter of 2004.
U.S. Government-Funded
Research
We have entered into several U.S. government contracts and
subcontracts to fund a portion of our efforts to develop
next-generation OLED technologies and materials for applications
such as flexible displays and energy-efficient solid-state
lighting. These include, among others, Small Business Innovation
Research (SBIR) Phase I program contracts for the
demonstration of technical merit and feasibility and SBIR
Phase II program contracts for continued research and
development and the fabrication of prototypes. On contracts for
which we are the prime contractor, we subcontract portions of
the work to various entities and institutions, including
Princeton University, the University of Southern California, the
University of Michigan, Pennsylvania State University, Kyung Hee
University in South Korea, L-3 Communications
Corporation Display Systems (L-3DS), the Palo Alto
Research Center (PARC), a subsidiary of Xerox Corporation, and
Vitex Systems, Inc. All of our government contracts and
subcontracts are subject to termination at the election of the
contracting governmental agency. Our government contracts
include, among others, the following:
|
|
|
|
|
OLED Displays on Flexible Metal Foil
Substrates. In 2006, we continued our work to
develop and deliver next-generation prototype OLED displays on
flexible metal foil substrates for the U.S. Army Research
Laboratory (ARL), the U.S. Army Communications-Electronics
Research Development and Engineering Center (CERDEC), the Air
Force Research Laboratory and, more recently, the
U.S. Department of the Navy. These four government agencies
teamed to provide us with $1,610,168 in funding under this
program for 2006 through several government contracts and one
subcontract with L-3DS. In February 2006, we demonstrated a
full-color, active-matrix OLED display prototype on flexible
metal foil that was developed under the program. Our contractual
commitments to conduct further work under this program currently
run through November 2007.
|
|
|
|
Infrared OLED Displays for Night-Vision
Applications. In 2005, we started working on a
new program for CERDEC involving the development of a flexible
OLED display containing infrared-emitting OLED pixels that would
be visible through night vision goggles. In January 2006, we
entered into a SBIR Phase II contract for the continuation
of this work. The SBIR Phase II contract runs through
January 2008, at which time we will be expected to deliver to
CERDEC a prototype infrared-emitting OLED display. For 2006, we
received $251,338 in funding under this program.
|
|
|
|
Novel Encapsulation Technology for Flexible
OLEDs. In 2006, we were awarded SBIR Phase I
and Phase II contracts by ARL to develop innovative
encapsulation technology for flexible OLEDs. Using technology
pioneered at Princeton University, we demonstrated the
feasibility of a novel encapsulation process based on
plasma-enhanced chemical vapor deposition, or PECVD, which is an
important element on the development roadmap for flexible OLED
displays. We received $174,189 in funding from ARL during 2006
under this program, which is currently scheduled to run through
September 2008.
|
10
|
|
|
|
|
OLEDs for High-Efficiency White Lighting. Our
work on behalf of the U.S. Department of Energy (DOE) to
develop technical approaches for using our proprietary PHOLED
and other OLED technologies for high-efficiency white lighting
applications continued in 2006. During the year, the DOE
provided us with $975,818 in funding for this work under four
SBIR Phase II program contracts and two SBIR Phase I
program contracts. Two of these DOE programs were completed in
July 2006, and the others are currently scheduled for completion
between March 2007 and August 2008.
|
|
|
|
Novel Printing of Striped OLEDs for Lighting
Applications. In 2006, we continued our work on
behalf of the DOE to develop technology for the printing of
striped OLEDs for lighting applications using a novel deposition
process, called organic vapor jet printing (OVJP). Funding to us
under this DOE Solid State Lighting program totaled $692,204 for
2006. The program is currently funded through December 2007. At
the conclusion of the program, we will be expected to deliver to
the DOE various prototype OLED devices, wherein the OLED
materials are deposited in red, green and blue stripes using the
OVJP process and the resulting device generates white light.
|
The
Army Flexible Display Center
We have been a charter member of The Army Flexible Display
Center (FDC) since its establishment at Arizona State University
in December 2004. The FDC is being supported through a
$51.5 million Cooperative Agreement between Arizona State
University and the U.S. Army Research Laboratory. The goal
of the FDC is to develop flexible, low power, light-weight,
information displays for future usage by soldiers and for other
military and commercial applications. We believe our involvement
with the FDC enhances our flexible OLED display technology
development efforts.
The
United States Display Consortium
We are a member of the United States Display Consortium (USDC),
a cooperative industry and governmental effort aimed at
developing an infrastructure to support North American flat
panel display manufacturing. The USDCs role is to provide
a common platform for flat panel display manufacturers,
developers, users and the manufacturing equipment and supplier
base. It has more than 100 members, as well as support from ARL.
We are one of 12 members on the Governing Board of the USDC and
we actively participate on its Technical Council. In addition,
our President, Steven Abramson, served as Vice-Chairman of the
USDCs Governing Board during 2006.
Intellectual
Property
Along with our personnel, our primary and most fundamental
assets are patents and other intellectual property. This
includes numerous U.S. and foreign patents and patent
applications that we own, exclusively license or have the sole
right to sublicense. It also includes a substantial body of
trade secrets and technical know-how that we have accumulated
over time.
Our
Patents
Our research and development activities, conducted both
internally and through collaborative programs with our partners,
have resulted in the filing of a substantial number of patent
applications relating to our OLED technologies and materials. As
of December 31, 2006, we owned, through assignment to us
alone or jointly with others, 68 issued and pending patents in
the U.S., together with numerous counterparts filed in various
foreign countries. These patents will start expiring in 2020.
Patents
We License from Princeton University, the University of Southern
California and the University of Michigan
We exclusively license the bulk of our patent rights, including
our key PHOLED technology patents, under an Amended License
Agreement we executed with the Trustees of Princeton University
and the University of Southern California (USC) in October 1997.
Based on Dr. Stephen Forrests recent transfer to the
University of Michigan, in January 2006 the University of
Michigan was added as a party to this agreement. As of
December 31, 2006, the patent rights we license from these
universities included 206 issued and pending patents in the
U.S., together with
11
numerous counterparts filed in various foreign countries. These
patents will start expiring in 2014, but our key PHOLED
technology patents licensed from these universities will not
start expiring until 2017.
Under the Amended License Agreement, Princeton University, USC
and the University of Michigan granted us worldwide, exclusive
license rights to specified patents and patent applications
relating to OLED technologies and materials. Our license rights
also extend to any patent rights arising out of the research
conducted by Princeton University, USC or the University of
Michigan under our various research agreements with these
entities. We are free to sublicense to third parties all or any
portion of our patent rights under the Amended License
Agreement. The term of the Amended License Agreement is
perpetual, though it is subject to termination for an uncured
material breach or default by us, or if we become bankrupt or
insolvent.
Princeton University is primarily responsible for the filing,
prosecution and maintenance of all patent rights licensed to us
under the Amended License Agreement pursuant to an
Interinstitutional Agreement between Princeton University, USC
and the University of Michigan. However, we manage this process
and have the right to instruct patent counsel on specific
matters to be covered in any patent applications filed by
Princeton University. We are required to bear all costs
associated with the filing, prosecution and maintenance of these
patent rights.
We are required under the Amended License Agreement to pay
Princeton University royalties for licensed products sold by us
or our sublicensees. These royalties amount to 3% of the net
sales price for licensed products sold by us and 3% of the
revenues we receive for licensed products sold by our
sublicensees. These royalty rates are subject to renegotiation
for products not reasonably conceivable as arising out of the
research agreements if Princeton University reasonably
determines that the royalty rates payable with respect to these
products are not fair and competitive. Princeton University
shares portions of these royalties with USC and the University
of Michigan under their Interinstitutional Agreement.
We have a minimum royalty obligation of $100,000 per year
during the term of the Amended License Agreement. We paid
Princeton University royalties under the Amended License
Agreement in the amounts of $177,436 for 2006, $110,098 for
2005, and $100,000 for 2004. We also are required under the
Amended License Agreement to use commercially reasonable efforts
to bring the licensed OLED technology to market. However, this
requirement is deemed satisfied if we perform our obligations
under the research agreements and, when those agreements end, if
we invest a minimum of $800,000 per year in research,
development, commercialization or patenting efforts respecting
the patent rights licensed to us under the Amended License
Agreement.
Patents
We License from Motorola
In September 2000, we entered into a License Agreement with
Motorola whereby Motorola granted us perpetual license rights to
what are now 74 issued U.S. patents relating to
Motorolas OLED technologies, together with numerous
foreign counterparts in various countries. These patents will
start expiring in 2012. We have the right to freely sublicense
these patents to third parties and, with limited exceptions,
Motorola has agreed not to license these patents to others in
the OLED industry. Motorola remains responsible for the filing,
prosecution and maintenance of all patent rights licensed to us
under the License Agreement, including all associated costs.
Motorola is obligated to keep us informed as to the status of
these activities.
We are required under the License Agreement to pay Motorola
royalties on gross revenues received by us on account of our
sales of OLED products or components, or from our OLED
technology licensees, whether or not these revenues relate
specifically to inventions claimed in the patent rights licensed
from Motorola. We have the option to pay these royalties to
Motorola in either all cash or 50% cash and 50% shares of our
common stock. We also had minimum royalty obligations to
Motorola of $250,000 for the two-year period ended on
December 31, 2002, $500,000 for the two-year period ended
on December 31, 2004, and $1,000,000 for the two-year
period ended on December 31, 2006. Thereafter, we have no
minimum royalty obligations to Motorola.
In connection with our execution of the License Agreement, in
2000 we issued to Motorola 200,000 shares of our common
stock, 300,000 shares of our Series B Convertible
Preferred Stock, and seven-year warrants to purchase an
additional 150,000 shares of our common stock at an
exercise price of $21.60 per share. These warrants became
exercisable on September 29, 2001, and will remain
exercisable until September 29, 2008. On October 6,
12
2004, all 300,000 shares of the Series B Convertible
Preferred Stock were converted into 418,916 shares of our
common stock. The warrants issued to Motorola currently remain
outstanding.
Intellectual
Property Developed under Our Government Contracts
We and our subcontractors have developed and may continue to
develop patentable OLED technology inventions under our various
U.S. government contracts and subcontracts. Under these
arrangements, we or our subcontractors generally can elect to
take title to any patents on these inventions, and to control
the manner in which these patents are licensed to third parties.
However, the U.S. government reserves rights to these
inventions and associated technical data that could restrict our
ability to market them to the government for military and other
applications, or to third parties for commercial applications.
In addition, if the U.S. government determines that we or
our subcontractors have not taken effective steps to achieve
practical application of these inventions in any field of use in
a reasonable time, the government may require that we or our
subcontractors license these inventions to third parties in that
field of use.
Trade
Secrets and Technical Know-How
We have accumulated, and continue to accumulate, a substantial
amount of valuable trade secret information and technical
know-how relating to OLED technologies and materials. Where
practicable, we share portions of this information and know-how
with display manufacturers and other business partners on a
confidential basis. We also employ various methods to protect
this information and know-how from unauthorized use or
disclosure, although no such methods can afford complete
protection. Moreover, because we derive some of this information
and know-how from academic institutions such as Princeton
University, USC and the University of Michigan, there is an
increased potential for public disclosure.
Competition
The industry in which we operate is highly competitive. We
compete against alternative flat panel display technologies, in
particular LCDs, as well as other OLED technologies. We also
compete against other lighting technologies, in particular
inorganic LEDs.
Flat
Panel Display Industry Competitors
Numerous domestic and foreign companies have developed or are
developing LCD, plasma and other flat panel display technologies
that compete with our OLED display technologies. We believe that
OLED display technologies ultimately can compete with LCDs and
other display technologies for many product applications on the
basis of lower power consumption, better contrast ratios, faster
video rates and lower manufacturing cost. However, other
companies may succeed in continuing to improve these competing
display technologies, or in developing new display technologies,
that are superior to OLED display technologies in various
respects. We cannot predict the timing or extent to which such
improvements or developments may occur.
Lighting
Industry Competitors
Traditional incandescent bulbs and fluorescent lamps are
well-entrenched products in the lighting industry. In addition,
compact fluorescent lamps and solid-state LEDs have recently
been introduced into the market and would compete with OLED
lighting products. Having attributes different than fluorescent
lamps and LEDs, OLEDs might not compete directly with these
products for all lighting applications. However, manufacturers
of LEDs and compact fluorescent lamps may succeed in more
broadly adapting their products to various lighting
applications, or others may develop competing solid-state
lighting technologies that are superior to OLEDs. Again, we
cannot predict whether or when this might occur.
OLED
Technology and Materials Competitors
Eastman Kodak Company has licensed its competing fluorescent
OLED technology and other patents to a number of display
manufacturers, several of whom are presently manufacturing OLED
products. Another OLED industry participant, Cambridge Display
Technology, Ltd., licenses its competing polymer OLED technology
and
13
recently entered into a joint venture with Sumitomo Chemical
Company to develop polymer OLED materials. Many display
manufacturers themselves are engaged in research, development
and commercialization activities with respect to OLED
technologies and materials. In addition, other manufacturers of
OLED materials, such as Idemitsu Kosan Co., Ltd., are selling
products that compete with our proprietary PHOLED materials.
Our existing business relationships with Samsung SDI and other
product manufacturers suggest that our OLED technologies and
materials, particularly our PHOLED technologies and materials,
may achieve some level of market penetration in the flat panel
display and lighting industries. However, our competitors may
succeed in improving their competing OLED technologies and
materials so as to render them superior to ours. We cannot be
sure of the extent to which product manufacturers ultimately
will adopt our OLED technologies and materials for the
production of commercial flat panel displays and lighting
products.
Employees
As of December 31, 2006, we had 62 full-time employees
and two part-time employees, none of whom are unionized. We
believe that relations with our employees are good.
Our
Company History
Our corporation was organized under the laws of the Commonwealth
of Pennsylvania in April 1985. Our business was commenced in
June 1994 by a company then known as Universal Display
Corporation, which had been incorporated under the laws of the
State of New Jersey. On June 22, 1995, a wholly-owned
subsidiary of ours merged into this New Jersey corporation. The
surviving corporation in this merger became a wholly-owned
subsidiary of ours and changed its name to UDC, Inc.
Simultaneously with the consummation of this merger, we changed
our name to Universal Display Corporation. UDC, Inc. now
functions as an operating subsidiary of ours and has overlapping
officers and directors.
Our
Compliance with Environmental Protection Laws
We are not aware of any material effects that compliance with
Federal, State or local environmental protection laws or
regulations will have on our business. We have not expended
material amounts to comply with any environmental protection
laws or regulations and do not anticipate having to do so in the
foreseeable future.
Our
Internet Site
Our Internet website can be found at
www.universaldisplay.com. Through our website, free of
charge, you can access our Annual Report on
Form 10-K,
our Quarterly Reports on
Form 10-Q,
our Current Reports on
Form 8-K
and any amendments to those reports that we may file with or
furnish to the SEC. These materials are made available through
our website as soon as reasonably practicable after we
electronically file the material with the SEC.
The following factors, as well as other factors affecting our
operating results and financial condition, could cause our
actual future results and financial condition to differ
materially from those projected.
If our
OLED technologies and materials are not feasible for broad-based
product applications, we may never generate revenues sufficient
to support ongoing operations.
Our main business strategy is to license our OLED technologies
and sell our OLED materials to manufacturers for incorporation
into the flat panel display and lighting products that they
sell. Consequently, our success depends on the ability and
willingness of these manufacturers to develop, manufacture and
sell commercial products integrating our technologies and
materials.
Before product manufacturers will agree to utilize our OLED
technologies and materials for wide-scale commercial production,
they will likely require us to demonstrate to their satisfaction
that our OLED technologies and materials are feasible for
broad-based product applications. This, in turn, may require
additional advances in
14
our technologies and materials, as well as those of others, for
applications in a number of areas, including, without
limitation, advances with respect to the development of:
|
|
|
|
|
OLED materials with sufficient lifetimes, brightness and color
coordinates for full-color OLED displays and general lighting
products;
|
|
|
|
more robust OLED materials for use in large-scale, more
demanding manufacturing environments; and
|
|
|
|
scalable and cost-effective methods and technologies for the
fabrication of OLED products.
|
We cannot be certain that these advances will ever occur, and
hence our OLED technologies and materials may never be feasible
for broad-based product applications.
Even
if our OLED technologies are technically feasible, they may not
be adopted by product manufacturers.
The potential size, timing and viability of market opportunities
targeted by us are uncertain at this time. Market acceptance of
our OLED technologies will depend, in part, upon these
technologies providing benefits comparable or superior to
current display and lighting technologies at an advantageous
cost to manufacturers, and the adoption of products
incorporating these technologies by consumers. Many potential
licensees of our OLED technologies manufacture flat panel
displays and lighting products utilizing competing technologies,
and may, therefore, be reluctant to redesign their products or
manufacturing processes to incorporate our OLED technologies.
During the entire product development process for a new product,
we face the risk that our technology will fail to meet the
manufacturers technical, performance or cost requirements
or will be replaced by a competing product or alternative
technology. For example, we are aware that some of our licensees
and prospective licensees have entered into arrangements with
our competitors regarding the development of competing
technologies. Even if we offer technologies that are
satisfactory to a product manufacturer, the manufacturer may
choose to delay or terminate its product development efforts for
reasons unrelated to our technologies.
Mass production of OLED products will require the availability
of suitable manufacturing equipment, components and materials,
many of which are available only from a limited number of
suppliers. In addition, there may be a number of other
technologies that manufacturers need to utilize to be used in
conjunction with our OLED technologies in order to bring OLED
products containing them to the market. Thus, even if our OLED
technologies are a viable alternative to competing approaches,
if product manufacturers are unable to obtain access to this
equipment and these components, materials and other
technologies, they may not utilize our OLED technologies.
There
are numerous potential alternatives to OLEDs, which may limit
our ability to commercialize our OLED technologies and
materials.
The flat panel display market is currently, and will likely
continue to be for some time, dominated by displays based on LCD
technology. Numerous companies are making substantial
investments in, and conducting research to improve
characteristics of, LCDs. Plasma and other competing flat panel
display technologies have been, or are being, developed. A
similar situation exists in the solid-state lighting market,
which is currently dominated by LED products. Advances in any of
these various technologies may overcome their current
limitations and permit them to become the leading technologies
in their field, either of which could limit the potential market
for products utilizing our OLED technologies and materials.
This, in turn, would cause product manufacturers to avoid
entering into commercial relationships with us, or to terminate
or not renew their existing relationships with us.
Other
OLED technologies may be more successful or cost-effective than
ours, which may limit the commercial adoption of our OLED
technologies and materials.
Our competitors have developed OLED technologies that differ
from or compete with our OLED technologies. In particular,
competing fluorescent OLED technology, which entered the
marketplace prior to ours, may become entrenched in the industry
before our OLED technologies have a chance to become widely
utilized. Moreover, our competitors may succeed in developing
new OLED technologies that are more cost-effective or have fewer
15
limitations than our OLED technologies. If our OLED
technologies, and particularly our phosphorescent OLED
technology, are unable to capture a substantial portion of the
OLED product market, our business strategy may fail.
If we
fail to make advances in our OLED research and development
activities, we might not succeed in commercializing our OLED
technologies and materials.
Further advances in our OLED technologies and materials depend,
in part, on the success of the research and development work we
conduct, both alone and with our research partners. We cannot be
certain that this work will yield additional advances in the
research and development of these technologies and materials.
Our research and development efforts remain subject to all of
the risks associated with the development of new products based
on emerging and innovative technologies, including, without
limitation, unanticipated technical or other problems and the
possible insufficiency of funds for completing development of
these products. Technical problems may result in delays and
cause us to incur additional expenses that would increase our
losses. If we cannot complete research and development of our
OLED technologies and materials successfully, or if we
experience delays in completing research and development of our
OLED technologies and materials for use in potential commercial
applications, particularly after incurring significant
expenditures, our business may fail.
If we
cannot form and maintain lasting business relationships with
OLED product manufacturers, our business strategy will
fail.
Our business strategy ultimately depends upon our development
and maintenance of commercial licensing and material supply
relationships with high-volume manufacturers of OLED products.
We have entered into only a limited number of such
relationships. All of our other relationships with product
manufacturers currently are limited to technology development
and the evaluation of our OLED technologies and materials for
possible use in commercial products. Some or all of these
relationships may not succeed or, even if they are successful,
may not result in the product manufacturers entering into
commercial licensing and material supply relationships with us.
Under our existing technology development and evaluation
agreements, we are working with manufacturers to incorporate our
technologies into their commercial products. However, these
technology development and evaluation agreements typically last
for limited periods of time, such that our relationships with
the product manufacturers will expire unless they continually
are renewed. These manufacturers may not agree to renew their
relationships with us on a continuing basis. In addition, we
regularly continue working with manufacturers evaluating our
OLED technologies and materials after our existing agreements
with them have expired while we are attempting to negotiate
contract extensions or new agreements with them. Should our
relationships with the various product manufacturers not
continue or be renewed, our business would suffer.
Our ability to enter into additional commercial licensing and
material supply relationships, or to maintain our existing
technology development and evaluation relationships, may require
us to make financial or other commitments. We might not be able,
for financial or other reasons, to enter into or continue these
relationships on commercially acceptable terms, or at all.
Failure to do so may cause our business strategy to fail.
Conflicts
may arise with our licensees or joint development partners,
resulting in renegotiation or termination of, or litigation
related to, our agreements with them. This would adversely
affect our revenues.
Conflicts could arise between us and our licensees or joint
development partners as to royalty rates, milestone payments or
other commercial terms. Similarly, we may disagree with our
licensees or joint development partners as to which party owns
or has the right to commercialize intellectual property that is
developed during the course of the relationship or as to other
non-commercial terms. If such a conflict were to arise, a
licensee or joint development partner might attempt to compel
renegotiation of certain terms of their agreement or terminate
their agreement entirely, and we might lose the royalty revenues
and other benefits of the agreement. Either we or the licensee
or joint development partner might initiate litigation to
determine commercial obligations, establish intellectual
property rights or resolve other disputes under the agreement.
Such litigation could be costly to us and require substantial
attention of management. If we were unsuccessful in such
litigation, we could lose the commercial
16
benefits of the agreement, be liable for other financial damages
and suffer losses of intellectual property or other rights that
are the subject of dispute. Any of these adverse outcomes could
cause our business strategy to fail.
If we
cannot obtain and maintain appropriate patent and other
intellectual property rights protection for our OLED
technologies and materials, our business will
suffer.
The value of our OLED technologies and materials is dependent on
our ability to secure and maintain appropriate patent and other
intellectual property rights protection. Although we own or
license many patents respecting our OLED technologies and
materials that have already been issued, there can be no
assurance that additional patents applied for will be obtained,
or that any of these patents, once issued, will afford
commercially significant protection for our OLED technologies
and materials, or will be found valid if challenged. Moreover,
we have not obtained patent protection for some of our OLED
technologies and materials in all foreign countries in which
OLED products or materials might be manufactured or sold. In any
event, the patent laws of other countries may differ from those
of the United States as to the patentability of our OLED
technologies and materials and the degree of protection afforded.
The strength of our current intellectual property position
results primarily from the essential nature of our fundamental
patents covering phosphorescent OLED devices and certain
materials utilized in these devices. Our existing fundamental
phosphorescent OLED patents expire in 2017 and 2019. While we
hold a wide range of additional patents and patent applications
whose expiration dates extend (and in the case of patent
applications, will extend) beyond 2019, many of which are also
of key importance in the OLED industry, none are of an equally
essential nature as our fundamental patents, and therefore our
competitive position after 2019 may be less certain.
We may become engaged in litigation to protect or enforce our
patent and other intellectual property rights, or in
International Trade Commission proceedings to abate the
importation of goods that would compete unfairly with those of
our licensees. In addition, we are currently participating in,
and will likely have to participate in the future in,
interference or reexamination proceedings before the
U.S. Patent and Trademark Office, and opposition, nullity
or other proceedings before foreign patent offices, with respect
to our patents or patent applications. All of these actions
place our patents and other intellectual property rights at risk
and may result in substantial costs to us as well as a diversion
of management attention. Moreover, if successful, these actions
could result in the loss of patent or other intellectual
property rights protection for the key OLED technologies and
materials on which our business depends.
In addition, we rely in part on unpatented proprietary
technologies, and others may independently develop the same or
similar technologies or otherwise obtain access to our
unpatented technologies. To protect our trade secrets, know-how
and other proprietary information, we require employees,
consultants, financial advisors and strategic partners to enter
into confidentiality agreements. These agreements may not
ultimately provide meaningful protection for our trade secrets,
know-how or other proprietary information. In particular, we may
not be able to fully or adequately protect our proprietary
information as we conduct discussions with potential strategic
partners. If we are unable to protect the proprietary nature of
our technologies, it will harm our business.
We or
our licensees may incur substantial costs or lose important
rights as a result of litigation or other proceedings relating
to our patent and other intellectual property
rights.
There are a number of other companies and organizations that
have been issued patents and are filing patent applications
relating to OLED technologies and materials, including, without
limitation, Eastman Kodak Company, Cambridge Display Technology,
Fuji Film Co., Ltd., Canon, Inc., Pioneer Corporation,
Semiconductor Energy Laboratories Co. and Mitsubishi Chemical
Corporation. As a result, there may be issued patents or pending
patent applications of third parties that would be infringed by
the use of our OLED technologies or materials, thus subjecting
our licensees to possible suits for patent infringement in the
future. Such lawsuits could result in our licensees being liable
for damages or require our licensees to obtain additional
licenses that could increase the cost of their products, which
might have an adverse affect on their sales and thus our
royalties or cause them to seek to renegotiate our royalty rates.
In addition, we may be required from
time-to-time
to assert our intellectual property rights by instituting legal
proceedings against others. We cannot assure you that we will be
successful in enforcing our patents in any lawsuits
17
we may commence. Defendants in any litigation we may commence to
enforce our patents may attempt to establish that our patents
are invalid or are unenforceable. Thus, any patent litigation we
commence could lead to a determination that one or more of our
patents are invalid or unenforceable. If a third party succeeds
in invalidating one or more of our patents, that party and
others could compete more effectively against us. Our ability to
derive licensing revenues from products or technologies covered
by these patents could also be adversely affected.
Whether our licensees are defending the assertion of third-party
intellectual property rights against their businesses arising as
a result of the use of our technology, or we are asserting our
own intellectual property rights against others, such litigation
can be complex, costly, protracted and highly disruptive to our
or our licensees business operations by diverting the
attention and energies of management and key technical
personnel. As a result, the pendency or adverse outcome of any
intellectual property litigation to which we or our licensees
are subject could disrupt business operations, require the
incurrence of substantial costs and subject us or our licensees
to significant liabilities, each of which could severely harm
our business.
Plaintiffs in intellectual property cases often seek injunctive
relief in addition to money damages. Any intellectual property
litigation commenced against our licensees could force them to
take actions that could be harmful to their business and thus to
our royalties, including the following:
|
|
|
|
|
stop selling their products that incorporate or otherwise use
technology that contains our allegedly infringing intellectual
property;
|
|
|
|
attempt to obtain a license to the relevant third-party
intellectual property, which may not be available on reasonable
terms or at all; or
|
|
|
|
attempt to redesign their products to remove our allegedly
infringing intellectual property to avoid infringement of the
third-party intellectual property.
|
If our licensees are forced to take any of the foregoing
actions, they may be unable to manufacture and sell their
products that incorporate our technology at a profit or at all.
Furthermore, the measure of damages in intellectual property
litigation can be complex, and is often subjective or uncertain.
If our licensees were to be found liable for infringement of
proprietary rights of a third party, the amount of damages they
might have to pay could be substantial and is difficult to
predict. Decreased sales of our licensees products
incorporating our technology would have an adverse effect on our
royalty revenues under existing licenses. Any necessity to
procure rights to the third-party technology might cause our
existing licensees to renegotiate the royalty terms of their
license with us to compensate for this increase in their cost of
production or, in certain cases, to terminate their license with
us entirely. Were this renegotiation to occur, it would likely
harm our ability to compete for new licensees and have an
adverse effect on the terms of the royalty arrangements we could
enter into with any new licensees.
As is commonplace in technology companies, we employ individuals
who were previously employed at other technology companies. To
the extent our employees are involved in research areas that are
similar to those areas in which they were involved at their
former employers, we may be subject to claims that such
employees or we have, inadvertently or otherwise, used or
disclosed the alleged trade secrets or other proprietary
information of the former employers. Litigation may be necessary
to defend against such claims. The costs associated with these
actions or the loss of rights critical to our or our
licensees business could negatively impact our revenues or
cause our business to fail.
We
have a history of losses and may never be
profitable.
Since inception, we have incurred significant losses and we
expect to incur losses until such time, if ever, as we are able
to achieve sufficient levels of revenue from the commercial
exploitation of our OLED technologies and materials to support
our operations. This may never occur because:
|
|
|
|
|
OLED technologies might not be adopted for broad commercial
usage;
|
|
|
|
markets for flat panel displays and solid-state lighting
products utilizing OLED technologies may be limited; and
|
18
|
|
|
|
|
amounts we can charge for access to our OLED technologies and
materials may not be sufficient for us to make a profit.
|
We may
require additional funding in the future in order to continue
our business.
Our capital requirements have been and will continue to be
significant. We may require additional funding in the future for
the research, development and commercialization of our OLED
technologies and materials, to obtain and maintain patents and
other intellectual property rights in these technologies and
materials, and for working capital and other purposes, the
timing and amount of which are difficult to ascertain. Our cash
on hand may not be sufficient to meet all of our future needs.
When we need additional funds, such funds may not be available
on commercially reasonable terms or at all. If we cannot obtain
more money when needed, our business might fail. Additionally,
if we attempt to raise money in an offering of shares of our
common stock, preferred stock, warrants or depositary shares, or
if we engage in acquisitions involving the issuance of such
securities, the issuance of these shares will dilute our
then-existing shareholders.
Many
of our competitors have greater resources, which may make it
difficult for us to compete successfully against
them.
The flat panel display and solid-state lighting industries are
characterized by intense competition. Many of our competitors
have better name recognition and greater financial, technical,
marketing, personnel and research capabilities than us. Because
of these differences, we may never be able to compete
successfully in these markets.
The
consumer electronics industry has historically experienced
significant downturns, which may adversely affect the demand for
and pricing of our OLED technologies and
materials.
Because we do not sell any products to consumers, our success
depends upon the ability and continuing willingness of our
licensees to manufacture and sell products utilizing our
technologies and materials, and the widespread acceptance of
those products. Any slowdown in the demand for our
licensees products would adversely affect our royalty
revenues and thus our business. The markets for flat panel
displays and lighting products are highly competitive. Success
in the market for end-user products that may integrate our OLED
technologies and materials also depends on factors beyond the
control of our licensees and us, including the cyclical and
seasonal nature of the end-user markets that our licensees
serve, as well as industry and general economic conditions.
The markets that we hope to penetrate have experienced
significant periodic downturns, often in connection with, or in
anticipation of, declines in general economic conditions. These
downturns have been characterized by lower product demand,
production overcapacity and erosion of average selling prices.
Our business strategy is dependent on manufacturers building and
selling products that incorporate our OLED technologies and
materials. Industry-wide fluctuations and downturns in the
demand for flat panel displays and solid-state lighting products
could cause significant harm to our business.
We
rely solely on PPG Industries to manufacture the OLED materials
we use and sell to product manufacturers.
Our business prospects depend significantly on our ability to
obtain proprietary OLED materials for our own use and for sale
to product manufacturers. Our agreement with PPG Industries,
Inc. provides us with a source for these materials for
development and evaluation purposes, as well as for commercial
purposes. This agreement, however, is currently scheduled to
expire on December 31, 2008. Our inability to continue
obtaining these OLED materials from PPG Industries or another
source would have a material adverse effect on our revenues from
sales of these materials, as well as on our ability to perform
development work and to support those product manufacturers
currently evaluating our OLED technologies and materials for
possible commercial use.
The
U.S. government has rights to our OLED technologies that
might prevent us from realizing the benefits of these
technologies.
The U.S. government, through various government agencies,
has provided and continues to provide funding to us, Princeton
University, the University of Southern California and the
University of Michigan for research
19
activities related to certain aspects of our OLED technologies.
Because we have been provided with this funding, the government
has rights to these OLED technologies that could restrict our
ability to market them to the government for military and other
applications, or to third parties for commercial applications.
Moreover, if the government determines that we have not taken
effective steps to achieve practical application of these OLED
technologies in any field of use in a reasonable time, the
government could require us to grant licenses to other parties
in that field of use. Any of these occurrences would limit our
ability to obtain the full benefits of our OLED technologies.
If we
cannot keep our key employees or hire other talented persons as
we grow, our business might not succeed.
Our performance is substantially dependent on the continued
services of senior management and other key personnel, and on
our ability to offer competitive salaries and benefits to our
employees. We do not have employment agreements with any of our
management or other key personnel. Additionally, competition for
highly skilled technical, managerial and other personnel is
intense. We might not be able to attract, hire, train, retain
and motivate the highly skilled managers and employees we need
to be successful. If we fail to attract and retain the necessary
technical and managerial personnel, our business will suffer and
might fail.
We can
issue shares of preferred stock that may adversely affect the
rights of shareholders of our common stock.
Our Articles of Incorporation authorize us to issue up to
5,000,000 shares of preferred stock with designations,
rights and preferences determined from
time-to-time
by our Board of Directors. Accordingly, our Board of Directors
is empowered, without shareholder approval, to issue preferred
stock with dividend, liquidation, conversion, voting or other
rights superior to those of shareholders of our common stock.
For example, an issuance of shares of preferred stock could:
|
|
|
|
|
adversely affect the voting power of the shareholders of our
common stock;
|
|
|
|
make it more difficult for a third party to gain control of us;
|
|
|
|
discourage bids for our common stock at a premium; or
|
|
|
|
otherwise adversely affect the market price of our common stock.
|
As of March 8, 2007, we have issued and outstanding
200,000 shares of Series A Nonconvertible Preferred
Stock, all of which are held by an entity controlled by members
of the family of Sherwin I. Seligsohn, our Chairman of the Board
and Chief Executive Officer. Our Board of Directors has
authorized and issued other shares of preferred stock in the
past, none of which are currently outstanding, and may do so
again at any time in the future.
If the
price of our common stock goes down, we may have to issue more
shares than are presently anticipated to be issued under our
agreement with PPG Industries.
Under our agreement with PPG Industries, we are required to
issue to PPG Industries shares of our common stock as partial
payment for services rendered by it, though under limited
circumstances we are required to compensate PPG Industries fully
in cash in lieu of common stock. The number of shares of common
stock that we are required to deliver to PPG Industries is based
on a specified formula. Under this formula, the lower the price
of our common stock at and around the time of issuance, the
greater the number of shares that we are required to issue to
PPG Industries. Lower than anticipated market prices for our
common stock, and correspondingly greater numbers of shares
issuable to PPG Industries, with a resulting increase in the
number of shares available for public sale, could cause people
to sell our common stock, including in short sales, which could
drive down the price of our common stock, thus reducing its
value and perhaps hindering our ability to raise additional
funds in the future. In addition, such an increase in the number
of outstanding shares of our common stock would further dilute
existing holders of this stock.
20
Our
executive officers and directors own a large percentage of our
common stock and could exert significant influence over matters
requiring shareholder approval, including takeover
attempts.
Our executive officers and directors, their respective
affiliates and the adult children of Sherwin Seligsohn, our
Chairman of the Board and Chief Executive Officer, beneficially
own, as of March 8, 2007, approximately 16.2% of the
outstanding shares of our common stock. Accordingly, these
individuals may, as a practical matter, be able to exert
significant influence over matters requiring approval by our
shareholders, including the election of directors and the
approval of mergers or other business combinations. This
concentration also could have the effect of delaying or
preventing a change in control of us.
Because
the vast majority of OLED product manufacturers are located in
the Asia-Pacific region, we are subject to international
operational, financial, legal and political risks which may
negatively impact our operations.
Many of our licensees and prospective licensees have a majority
of their operations in countries other than the United States,
particularly in the Asia-Pacific region. Risks associated with
our doing business outside of the United States include, without
limitation:
|
|
|
|
|
compliance with a wide variety of foreign laws and regulations;
|
|
|
|
legal uncertainties regarding taxes, tariffs, quotas, export
controls, export licenses and other trade barriers;
|
|
|
|
economic instability in the countries of our licensees, causing
delays or reductions in orders for their products and therefore
our royalties;
|
|
|
|
political instability in the countries in which our licensees
operate, particularly in South Korea relating to its disputes
with North Korea and in Taiwan relating to its disputes with
China;
|
|
|
|
difficulties in collecting accounts receivable and longer
accounts receivable payment cycles; and
|
|
|
|
potentially adverse tax consequences.
|
Any of these factors could impair our ability to license our
OLED technologies and sell our OLED materials, thereby harming
our business.
The
market price of our common stock might be highly
volatile.
The market price of our common stock might be highly volatile,
as has been the case with our common stock in the past as well
as the securities of many companies, particularly other small
and emerging-growth companies. We have included in the section
of this report entitled Market for Registrants
Common Equity, Related Stockholder Matters and Issuer Purchases
of Equity Securities, a table indicating the high and low
closing prices of our common stock as reported on the Nasdaq
National Market for the past two years. Factors such as the
following may have a significant impact on the market price of
our common stock in the future:
|
|
|
|
|
our expenses and operating results;
|
|
|
|
announcements by us or our competitors of technological
developments, new product applications or license
arrangements; and
|
|
|
|
other factors affecting the flat panel display and solid-state
lighting industries in general.
|
Our
operating results may have significant
period-to-period
fluctuations, which would make it difficult to predict our
future performance.
Due to the current stage of commercialization of our OLED
technologies and the significant development and manufacturing
objectives that we and our licensees must achieve to be
successful, our quarterly operating results will be difficult to
predict and may vary significantly from quarter to quarter.
We believe that
period-to-period
comparisons of our operating results are not a reliable
indicator of our future performance at this time. Among other
factors affecting our
period-to-period
results, our license and technology
21
development fees often consist of large one-time or annual
payments, resulting in significant fluctuations in our revenues.
If, in some future period, our operating results or business
outlook fall below the expectations of securities analysts or
investors, our stock price would be likely to decline and
investors in our common stock may not be able to resell their
shares at or above their purchase price. Broad market, industry
and global economic factors may also materially reduce the
market price of our common stock, regardless of our operating
performance.
The
issuance of additional shares of our common stock could drive
down the price of our stock.
The price of our common stock can be expected to decrease if:
|
|
|
|
|
other shares of our common stock that are currently subject to
restriction on sale become freely salable, whether through an
effective registration statement or based on Rule 144 under
the Securities Act of 1933, as amended; or
|
|
|
|
we issue additional shares of our common stock that might be or
become freely salable, including shares that would be issued
upon conversion of our preferred stock or the exercise of
outstanding warrants and options.
|
Because
we do not intend to pay dividends, shareholders will benefit
from an investment in our common stock only if it appreciates in
value.
We have never declared or paid any cash dividends on our common
stock. We currently intend to retain our future earnings, if
any, to finance further research and development and do not
expect to pay any cash dividends in the foreseeable future. As a
result, the success of an investment in our common stock will
depend upon any future appreciation in its value. There is no
guarantee that our common stock will appreciate in value or even
maintain the price at which shareholders have purchased their
shares.
|
|
ITEM 1B.
|
UNRESOLVED
STAFF COMMENTS
|
None.
Our corporate offices and research and development laboratories
are located at 375 Phillips Boulevard in Ewing, New Jersey. On
December 1, 2004, we acquired the building and property at
which this facility is located. During 2005, we conducted a
two-stage expansion of our laboratory and office space in the
building. We currently occupy the entire 40,200 square feet
facility, with the exception of a small portion of office space
that we lease to Global Photonic Energy Corporation.
We also lease approximately 850 square feet of office space
in Coeur dAlene, Idaho. We have two employees who work in
this office. This office space is shared with Global Photonic
Energy Corporation.
|
|
ITEM 3.
|
LEGAL
PROCEEDINGS
|
Patent
Interference with Semiconductor Energy Laboratory Co.,
Ltd.
In June 2006, Patent Interference No. 104,461 was declared
by the United States Patent and Trademark Office (the
USPTO) between Semiconductor Energy Laboratory Co.,
Ltd. (SEL), and Princeton University and the
University of Southern California (the
Universities). The dispute concerns a
U.S. patent issued to SEL that we believe claims aspects of
our phosphorescent OLED technology covered under several
U.S. patents and patent applications which we exclusively
license from the Universities. The Universities are seeking a
ruling by the USPTO that they should be granted a patent to the
claimed invention and that the SEL patent is invalid because the
Universities invention was prior to that of SEL.
We believe that the substantial and uncontested factual evidence
of record in this patent interference strongly supports the
Universities position of priority to the invention in
question, and thus that the Universities should prevail in this
action. However, we cannot predict a favorable outcome with
certainty, and an adverse ruling by the USPTO against the
Universities might be referenced in separate proceedings to
challenge related U.S. patents and patent applications that
we exclusively license from them. Even if this were to occur,
however, we exclusively
22
license other patent rights from the Universities that
substantially cover our phosphorescent OLED technology in the
form(s) that we believe it will have commercial value for the
foreseeable future.
Various cross-motions have been filed and briefed in this
proceeding, and they are currently under consideration by the
USPTO. Under our agreement with the Universities, we are
required to pay all legal costs and fees associated with the
proceeding.
Patent
Opposition Initiated by Cambridge Display Technology,
Ltd.
On December 8, 2006, Cambridge Display Technology, Ltd.
(CDT) filed a Notice of Opposition to European
Patent No. 0946958 (the EP 958 patent).
The EP 958 patent, which was issued on March 8, 2006,
is the European counterpart patent to U.S. patents
5,844,363, 6,602,540 and 6,888,306, and to pending
U.S. patent application
10/966,417,
filed on October 15, 2004. These patents and patent
applications relate to our flexible OLED, or FOLED, technology.
They are exclusively licensed to us by Princeton University, and
under the license agreement we are required to pay all legal
costs and fees associated with this proceeding.
We are in the process of reviewing the Notice of Opposition and
preparing our response. We believe that the Princeton University
patent being challenged by CDT is valid, and thus that Princeton
University should prevail in this action. However, we cannot
predict a favorable outcome with certainty.
|
|
ITEM 4.
|
SUBMISSION
OF MATTERS TO A VOTE OF SECURITY HOLDERS
|
None.
EXECUTIVE
OFFICERS OF THE REGISTRANT
The following table sets forth certain information with respect
to our executive officers as of March 8, 2007:
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
|
Sherwin I. Seligsohn
|
|
|
71
|
|
|
Chairman of the Board and Chief
Executive Officer
|
Steven V. Abramson
|
|
|
55
|
|
|
President, Chief Operating Officer
and Director
|
Sidney D. Rosenblatt
|
|
|
59
|
|
|
Executive Vice President, Chief
Financial Officer, Treasurer, Secretary and Director
|
Julia J. Brown
|
|
|
45
|
|
|
Vice President and Chief Technical
Officer
|
Our Board of Directors has appointed these executive officers to
hold office until their successors are duly appointed.
Sherwin I. Seligsohn has been our Chief Executive Officer
and Chairman of the Board since June 1995. He also served as our
President from June 1995 through May 1996. Mr. Seligsohn
founded and since has served as the sole Director, President and
Secretary of American Biomimetics Corporation, International
Multi-Media Corporation, and Wireless Unified Network Systems
Corporation. He is also Chairman of the Board, Chief Executive
Officer and President of Global Photonic Energy Corporation.
From June 1990 to October 1991, Mr. Seligsohn was Chairman
Emeritus of InterDigital Communications, Inc.
(InterDigital), formerly International Mobile
Machines Corporation. He founded InterDigital and from August
1972 to June 1990 served as its Chairman of the Board.
Mr. Seligsohn is a member of the Industrial Advisory Board
of the Princeton Institute for the Science and Technology of
Materials (PRISM) at Princeton University.
Steven V. Abramson has been our President and Chief
Operating Officer and a member of our Board of Directors since
May 1996. From March 1992 to May 1996, he was Vice President,
General Counsel, Secretary and Treasurer of Roy F. Weston, Inc.,
a worldwide environmental consulting and engineering firm. From
December 1982 to December 1991, Mr. Abramson held various
positions at InterDigital, including General Counsel, Executive
Vice President and General Manager of the Technology Licensing
Division. Mr. Abramson is a member of the Executive
Committee of PRISM, and he was also Vice-Chairman of the Board
of Governors of the United States Display Consortium during 2006.
23
Sidney D. Rosenblatt has been our Executive Vice
President, Chief Financial Officer, Treasurer and Secretary
since June 1995, and has been a member of our Board of Directors
since May 1996. Mr. Rosenblatt is the owner of and served
as the President of S. Zitner Company from August 1990 through
December 1998. From May 1982 to August 1990, Mr. Rosenblatt
served as the Senior Vice President, Chief Financial Officer and
Treasurer of InterDigital.
Julia J. Brown, Ph.D. has been our Vice President
and Chief Technical Officer since June 2002. She joined us in
June 1998 as our Vice President of Technology Development. From
November 1991 to June 1998, Dr. Brown was a Research
Department Manager at Hughes Research Laboratories where she
directed the pilot line production of high-speed Indium
Phosphide-based integrated circuits for insertion into advanced
airborne radar and satellite communication systems.
Dr. Brown received an M.S. and Ph.D. in Electrical
Engineering/Electrophysics at the University of Southern
California under the advisement of Professor Stephen R. Forrest.
Dr. Brown has served as an Associate Editor of the Journal
of Electronic Materials and as an elected member of the Electron
Device Society Technical Board. She co-founded an international
engineering mentoring program sponsored by the Institute of
Electrical and Electronics Engineers (IEEE) and is a
Fellow of the IEEE. Dr. Brown has served on numerous
technical conference committees and is presently a member of the
Society of Information Display.
PART II
|
|
ITEM 5.
|
MARKET
FOR REGISTRANTS COMMON EQUITY, RELATED STOCKHOLDER MATTERS
AND ISSUER PURCHASES OF EQUITY SECURITIES
|
Our
Common Stock
Our common stock is quoted on the NASDAQ Global Market under the
symbol PANL. The following table sets forth, for the
periods indicated, the high and low closing prices of our common
stock as reported on the NASDAQ Global Market.
|
|
|
|
|
|
|
|
|
|
|
High
|
|
|
Low
|
|
|
|
Close
|
|
|
Close
|
|
|
2006
|
|
|
|
|
|
|
|
|
Fourth Quarter
|
|
$
|
15.15
|
|
|
$
|
10.59
|
|
Third Quarter
|
|
|
13.66
|
|
|
|
10.02
|
|
Second Quarter
|
|
|
16.08
|
|
|
|
12.25
|
|
First Quarter
|
|
|
15.25
|
|
|
|
10.94
|
|
2005
|
|
|
|
|
|
|
|
|
Fourth Quarter
|
|
$
|
12.79
|
|
|
$
|
9.71
|
|
Third Quarter
|
|
|
13.60
|
|
|
|
11.15
|
|
Second Quarter
|
|
|
10.37
|
|
|
|
5.83
|
|
First Quarter
|
|
|
9.01
|
|
|
|
6.83
|
|
As of March 8, 2007, there were approximately 17,000
holders of record of our common stock.
We have never declared or paid cash dividends on our common
stock. We currently intend to retain any future earnings for the
operation and expansion of our business. We do not anticipate
declaring or paying cash dividends on our common stock in the
foreseeable future. Any future payment of cash dividends on our
common stock will be at the discretion of our Board of Directors
and will depend upon our results of operations, earnings,
capital requirements, contractual restrictions and other factors
deemed relevant by our Board of Directors.
Issuance
of Securities to PPG Industries
Pursuant to our agreements with PPG Industries, Inc. we are
required to issue shares of our common stock to PPG Industries
on a periodic basis in return for services performed by PPG
Industries under those agreements. During the quarter ended
December 31, 2006, we issued an aggregate of
91,055 shares of our common stock to PPG
24
Industries for services provided to us under this agreement. The
shares were issued in reliance on the exemption from
registration contained in Section 4(2) of the Securities
Act of 1933, as amended.
Issuance
of Securities Upon the Exercise of Outstanding
Warrants
During the quarter ended December 31, 2006, we issued an
aggregate of 22,588 shares of our common stock upon the
exercise of outstanding warrants. The warrants had an exercise
price of $6.38 per share. The shares were issued in
reliance on the exemption from registration contained in
Section 4(2) of the Securities Act of 1933, as amended.
25
Performance
Graph
The performance graph below compares the change in the
cumulative shareholder return of our common stock from
December 31, 2001 to December 31, 2006, with the
percentage change in the cumulative total return over the same
period on (i) the Russell 2000 Index, and (ii) the
Nasdaq Electronics Components Index. This performance graph
assumes an initial investment of $100 on December 31, 2001
in each of our common stock, the Russell 2000 Index and the
Nasdaq Electronics Components Index.
COMPARISON
OF 5 YEAR CUMULATIVE TOTAL RETURN*
Among Universal Display Corp., The Russell 2000 Index
And The NASDAQ Electronic Components Index
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative Total Return
|
|
|
|
12/01
|
|
|
12/02
|
|
|
12/03
|
|
|
12/04
|
|
|
12/05
|
|
|
12/06
|
|
UNIVERSAL DISPLAY CORP.
|
|
|
100.00
|
|
|
|
86.70
|
|
|
|
150.77
|
|
|
|
98.90
|
|
|
|
115.49
|
|
|
|
164.95
|
|
RUSSELL 2000
|
|
|
100.00
|
|
|
|
79.52
|
|
|
|
117.09
|
|
|
|
138.55
|
|
|
|
144.86
|
|
|
|
171.47
|
|
NASDAQ ELECTRONIC COMPONENTS
|
|
|
100.00
|
|
|
|
64.40
|
|
|
|
92.31
|
|
|
|
100.78
|
|
|
|
113.36
|
|
|
|
115.84
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
$100 invested on 12/31/01 in stock or index-including
reinvestment of dividends. Fiscal year ending December 31.
|
26
|
|
ITEM 6.
|
SELECTED
FINANCIAL DATA
|
The following selected condensed consolidated financial data has
been derived from, and should be read in conjunction with, our
audited consolidated financial statements and the notes thereto,
and with Managements Discussion and Analysis of
Financial Condition and Results of Operations, included
elsewhere in this report and incorporated herein by reference.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
2002
|
|
|
Operating Results:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue
|
|
$
|
11,921,292
|
|
|
$
|
10,147,995
|
|
|
$
|
7,006,913
|
|
|
$
|
6,593,193
|
|
|
$
|
2,484,948
|
|
Research and development expense
|
|
|
19,864,944
|
|
|
|
19,183,390
|
|
|
|
16,651,335
|
|
|
|
17,897,522
|
|
|
|
15,804,267
|
|
General and administrative expense
|
|
|
8,902,462
|
|
|
|
7,704,931
|
|
|
|
7,052,047
|
|
|
|
5,766,761
|
|
|
|
4,754,850
|
|
Interest income
|
|
|
2,168,933
|
|
|
|
1,419,858
|
|
|
|
795,620
|
|
|
|
162,356
|
|
|
|
429,356
|
|
Income tax benefit
|
|
|
544,567
|
|
|
|
424,207
|
|
|
|
612,966
|
|
|
|
|
|
|
|
225,657
|
|
Net loss
|
|
|
(15,186,804
|
)
|
|
|
(15,801,612
|
)
|
|
|
(15,776,574
|
)
|
|
|
(17,353,205
|
)
|
|
|
(31,019,201
|
)
|
Net loss attributable to common
shareholders
|
|
|
(15,186,804
|
)
|
|
|
(15,801,612
|
)
|
|
|
(15,906,198
|
)
|
|
|
(18,387,507
|
)
|
|
|
(32,972,680
|
)
|
Net loss per share, basic and
diluted
|
|
|
(0.49
|
)
|
|
|
(0.56
|
)
|
|
|
(0.59
|
)
|
|
|
(0.82
|
)
|
|
|
(1.71
|
)
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
72,331,536
|
|
|
$
|
73,819,417
|
|
|
$
|
73,892,163
|
|
|
$
|
46,201,646
|
|
|
$
|
39,639,216
|
|
Current liabilities
|
|
|
14,382,673
|
|
|
|
11,974,854
|
|
|
|
7,404,278
|
|
|
|
4,194,776
|
|
|
|
2,866,759
|
|
Capital lease obligations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,886
|
|
|
|
8,599
|
|
Long-term debt
|
|
|
|
|
|
|
|
|
|
|
4,200,000
|
|
|
|
|
|
|
|
|
|
Shareholders equity
|
|
|
54,382,363
|
|
|
|
57,616,463
|
|
|
|
59,187,885
|
|
|
|
38,906,870
|
|
|
|
33,668,571
|
|
Other Financial Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Working capital
|
|
$
|
37,422,740
|
|
|
$
|
38,347,913
|
|
|
$
|
40,630,913
|
|
|
$
|
23,679,705
|
|
|
$
|
18,541,596
|
|
Capital expenditures
|
|
|
2,349,033
|
|
|
|
5,656,905
|
|
|
|
7,418,053
|
|
|
|
957,328
|
|
|
|
1,169,945
|
|
Weighted average shares of common
stock, basic and diluted
|
|
|
30,855,297
|
|
|
|
28,462,925
|
|
|
|
26,791,158
|
|
|
|
22,428,219
|
|
|
|
19,227,697
|
|
Shares of common stock
outstanding, end of period
|
|
|
31,385,408
|
|
|
|
29,545,471
|
|
|
|
27,903,385
|
|
|
|
24,196,765
|
|
|
|
21,525,412
|
|
|
|
ITEM 7.
|
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
|
The following discussion and analysis of our financial
condition and results of operations should be read in
conjunction with the section entitled Selected Financial
Data in this report and our consolidated financial
statements and related notes to this report. This discussion and
analysis contains forward-looking statements based on our
current expectations, assumptions, estimates and projections.
These forward-looking statements involve risks and
uncertainties. Our actual results could differ materially from
those indicated in these forward-looking statements as a result
of certain factors, as more fully discussed in Section 1A
of this report, entitled Risk Factors.
Overview
We are a leader in the research, development and
commercialization of organic light emitting diode, or OLED,
technologies for use in flat panel display, solid-state lighting
and other applications. Since 1994, we have been
27
exclusively engaged, and expect to continue to be exclusively
engaged, in funding and performing research and development
activities relating to OLED technologies and materials, and in
attempting to commercialize these technologies and materials.
Our revenues are generated through contract research, sales of
development and commercial chemicals, technology development and
evaluation agreements and license fees and royalties. In the
future, we anticipate that the revenues from licensing our
intellectual property will become a more significant part of our
revenue stream.
While we have made significant progress over the past few years
developing and commercializing our family of OLED technologies
(PHOLED, TOLED, FOLED, etc.) and materials, we have incurred
significant losses and will likely continue to do so until our
OLED technologies and materials become more widely adopted by
product manufacturers. We have incurred significant losses since
our inception, resulting in an accumulated deficit of
$145,356,626 as of December 31, 2006.
We anticipate fluctuations in our annual and quarterly results
of operations due to uncertainty regarding:
|
|
|
|
|
the timing of our receipt of license fees and royalties, as well
as fees for future technology development and evaluation;
|
|
|
|
the timing and volume of sales of our OLED materials for both
commercial usage and evaluation purposes;
|
|
|
|
the timing and magnitude of expenditures we may incur in
connection with our ongoing research and development
activities; and
|
|
|
|
the timing and financial consequences of our formation of new
business relationships and alliances.
|
Critical
Accounting Policies and Estimates
The discussion and analysis of our financial condition and
results of operations is based on our consolidated financial
statements, which have been prepared in accordance with
U.S. generally accepted accounting principles. The
preparation of these financial statements requires us to make
estimates and judgments that affect our reported assets and
liabilities, revenues and expenses, and other financial
information. Actual results may differ significantly from our
estimates under other assumptions and conditions.
We believe that our accounting policies related to revenue
recognition and deferred license fees, valuation of acquired
technology and stock-based compensation, as described below, are
our critical accounting policies as contemplated by
the SEC. These policies, which have been reviewed with our Audit
Committee, are discussed in greater detail below.
Revenue
Recognition and Deferred License Fees
Contract research revenue represents reimbursements by the
U.S. government for all or a portion of the research and
development expenses we incur related to our government
contracts. Revenue is recognized proportionally as research and
development expenses are incurred or as defined milestones are
achieved. In order to ascertain the revenue associated with
these contracts for a period, we estimate the proportion of
related research and development expenses incurred and whether
defined milestones have been achieved. Different estimates would
result in different revenues for the period.
We also receive non-refundable advance license and royalty
payments under certain of our development and technology
evaluation agreements. These payments are classified as deferred
revenue and deferred license fees, which represents the cash
received and recorded as a liability until such time revenue can
be recognized. Payments that are not creditable to a license are
recognized as revenue over the life of the agreement. Payments
that are creditable to a license are deferred until a license
agreement is executed or negotiations have ceased and there is
no appreciable likelihood of executing a license agreement with
the other party. If a license agreement is executed, these
payments would be recorded as revenues over the expected life of
the licensed technology; otherwise, they will be recorded as
revenues at the time negotiations with the other party show that
there is no appreciable likelihood of entering into a license
agreement. If we used different estimates for the expected life
of this licensed technology, reported revenue during the
relevant period would differ. As of December 31, 2006,
$10,894,768 was recorded as deferred revenue and deferred
license fees.
28
A portion of our license and royalty revenue for 2004 was
received from Aixtron AG based on OVPD equipment sold by Aixtron
under our development and license agreement with them. This
revenue was recognized upon our receipt of notification that the
equipment was sold and an acknowledgement from Aixtron that
royalties were due.
Valuation
of Acquired Technology
We regularly review our acquired OLED technologies for events or
changes in circumstances that might indicate the carrying value
of these technologies may not be recoverable. Factors considered
important that could cause impairment include, among others,
significant changes in our anticipated future use of these
technologies and our overall business strategy as it pertains to
these technologies, particularly in light of patents owned by
others in the same field of use. As of December 31, 2006,
we believe that no revision of the remaining useful lives or
write-down of our acquired technology was required for 2006, nor
was such a revision needed in 2005 or 2004. If such a write-down
is required in the future, it could be for up to
$6,319,488 the net book value of our acquired
technology as of December 31, 2006.
Valuation
of Stock-Based Compensation
We account for our stock-based compensation (see Notes 2
and 10 of the Notes to Consolidated Financial Statements) under
Statement of Financial Accounting Standards (SFAS)
No. 123R, Share-Based Payment, which addresses all
forms of share-based payment awards, including shares issued
under employee stock purchase plans, stock options, restricted
stock and stock appreciation rights. It requires companies to
recognize in the statement of operations the grant-date fair
value of stock options and other equity-based compensation
issued to employees. The statement eliminates the intrinsic
value-based method prescribed by Accounting Principles Board
(APB) Opinion No. 25, Accounting for Stock Issued to
Employees, and related interpretations, that we used prior
to 2006. We account for our stock option and warrant grants to
non-employees in exchange for goods or services in accordance
with SFAS No. 123R and Emerging Issues Task Force
No. 96-18
(EITF 96-18).
SFAS No. 123R and
EITF 96-18
require that we record an expense for our option and warrant
grants to non-employees based on the fair value of the options
and warrants granted.
We use the Black-Scholes option-pricing model to estimate the
fair value of options we have granted for purposes of making the
disclosure required by SFAS No. 123R. In order to
calculate the fair value of the options, assumptions are made
for certain components of the model, including risk-free
interest rate, volatility, expected dividend yield rate and
expected option life. Although we use available resources and
information when setting these assumptions, changes to the
assumptions could cause significant adjustments to the valuation.
Results
of Operations
Year
Ended December 31, 2006 Compared to Year Ended
December 31, 2005
We had a net loss attributable to holders of our common stock of
$15,186,804 (or $0.49 per diluted share) for the year ended
December 31, 2006, compared to a net loss attributable to
holders of our common stock of $15,801,612 (or $0.56 per
diluted share) for the year ended December 31, 2005. The
decrease in net loss was primarily due to:
|
|
|
|
|
increased revenues of $1,773,297; and
|
|
|
|
an increase in interest income of $749,075.
|
The decrease in net loss was offset to some extent by an
increase of $2,203,209 in operating expenses.
Our revenues were $11,921,292 for the year ended
December 31, 2006, compared to $10,147,995 for the year
ended December 31, 2005. The increase in revenues was
mainly due to:
|
|
|
|
|
an increase in commercial chemical revenue of $1,844,676;
|
|
|
|
an increase in royalty and license revenue of
$2,166,624; and
|
|
|
|
an increase in technology development revenue of $440,909.
|
29
The increase was offset by the following:
|
|
|
|
|
a decrease in contract research revenue of $832,078; and
|
|
|
|
a decrease in development chemical revenue of $1,846,834.
|
We earned $3,821,903 in contract research revenue from the
U.S. government in 2006, compared to $4,653,981 in 2005.
The decrease was mainly attributable to the timing of revenue
recognition under our government contracts. The number of
government contracts we worked under and the level of effort
performed under these contracts remained essentially constant
from 2005 to 2006.
We earned $1,656,851 from our sales of OLED materials for
evaluation purposes in 2006, compared to $3,503,685 for
corresponding sales in 2005. The decrease was mainly due to a
customer that formerly purchased evaluation materials commencing
the purchase of commercial materials instead. We cannot
accurately predict the amount and timing of such purchases from
customers due to the early stage of the OLED industry.
For 2006, our commercial chemical revenues and our royalty and
license revenues were $1,876,071 and $2,400,179, respectively,
compared to $31,395 and $233,555, respectively, for the
corresponding period in 2005. The increase was due to purchases
of our proprietary PHOLED materials for use in commercial OLED
products by two new customers. In the fourth quarter of 2006, we
began supplying one of our proprietary PHOLED materials to
Samsung SDI for use in a commercial active-matrix OLED display
product. We cannot accurately predict how long these material
sales will continue, as Samsung SDI is purchasing material from
us on a purchase order basis. Continued sales of our PHOLED
materials to Samsung SDI will depend on several factors,
including, pricing, availability, continued technical
improvement and competitive product offerings.
For the first seven months of 2006, we also supplied one of our
proprietary PHOLED materials to AU Optronics Corporation
for use in a commercial active-matrix OLED display product.
Under this arrangement, we recognized both commercial chemical
revenues and royalty and license revenue of $2,660,000 on
account of our sales of these materials to AU Optronics.
However, those sales ended when AU Optronics discontinued its
manufacture of this display product, and we do not expect
material sales to AU Optronics to resume in the foreseeable
future. Commercial chemical revenues and royalty and license
revenue from our sales of these materials to AU Optronics
represented a substantial component of our revenues for 2006.
Our royalty and license revenue for 2006 also included fees
received under a patent license agreement executed with Samsung
SDI in April 2005, and a cross-license agreement executed with
DuPont Displays, Inc. in December 2002. In connection with each
of these agreements, we received upfront payments of license
fees and of royalties, both of which have been classified as
deferred revenue and deferred license fees. The deferred license
fees are being recognized as license fee revenue over the life
of the agreement for Samsung SDI, and over 10 years for
DuPont Displays. The deferred royalties in connection with the
Samsung SDI agreement will be recognized as Samsung SDI
commences sales of commercial OLED products and reports to us
the royalties due on account of those sales. We expect to start
receiving royalties based on Samsung SDIs sales of active
matrix OLED display products in 2007.
We recognized $2,166,288 in technology development revenue in
2006 in connection with technology development and evaluation
agreements, compared to $1,725,379 for the same period in 2005.
Although the number of contracts did not change, revenues
increased due mainly to the timing of revenue recognition under
a contract that commenced in the third quarter of 2005. The
amount and timing of our receipt of fees for technology
development and evaluation services is difficult to predict due
to the early stage of the OLED industry.
We incurred research and development expenses of $19,864,944 for
the year ended December 31, 2006, compared to $19,183,390
for the year ended December 31, 2005. The increase was
mainly due to:
|
|
|
|
|
an increase of $1,661,326 in personnel costs; and
|
|
|
|
an increase of $1,464,059 attributable to increased operating
costs associated with recent expansion of our New Jersey
facility.
|
30
The increase was offset to some extent by the following:
|
|
|
|
|
a refund by Princeton University for unspent research and
development funds of $1,011,358;
|
|
|
|
a decrease of $611,392 in amounts payable to PPG Industries due
to the hiring of certain PPG employees as employees of
ours; and
|
|
|
|
a decrease of $563,203 in expenses related to the timing of
recognition of the expense for stock issuances to non-employee
members of our Scientific Advisory Board.
|
Included within research and development expenses are patent
defense costs of $513,487 and $97,353 for each of 2006 and 2005,
respectively. These costs are associated with the Semiconductor
Energy Laboratory (SEL) patent interference matter described in
response to Item 3 of this report (Legal Proceedings). We
anticipate that our patent defense costs may increase as active
matrix OLED products using our PHOLED and other OLED
technologies and materials enter the consumer marketplace.
General and administrative expenses were $8,902,462 for the year
ended December 31, 2006, compared to $7,704,931 for the
same period in 2005. The increase was due mainly to:
|
|
|
|
|
an increase of $559,359 in costs relating to personnel due to
salary increases and the recognition of stock based compensation
under SFAS No. 123R; and
|
|
|
|
an increase of $631,422 attributable to increased operating
costs associated with our expanded facility.
|
Royalty and license expenses were $687,436 for the year ended
December 31, 2006, compared to $610,098 for the same period
in 2005. The increase was due to an increase accrual in
royalties due to Princeton University of $67,338.
Interest income increased to $2,168,933 for the year ended
December 31, 2006, compared to $1,419,858 for the year
ended December 31, 2005. This was the result of higher
rates of return on investments during 2006.
During 2006, we sold approximately $7 million of our
state-related income tax net operating losses (NOLs) to New
Jersey under the Technology Tax Certificate Transfer Program. In
2006, we received proceeds of $544,567 from the sale of these
NOLs and recorded these proceeds as an income tax benefit.
During 2005, we sold approximately $5 million of our
state-related income tax NOLs and received proceeds from these
sales of $424,207. We expect to sell a similar quantity of NOLs
in 2007.
Year
Ended December 31, 2005 Compared to Year Ended
December 31, 2004
We had a net loss attributable to holders of our common stock of
$15,801,612 (or $0.56 per diluted share) for the year ended
December 31, 2005, compared to a net loss attributable to
holders of our common stock of $15,906,198 (or $0.59 per
diluted share) for the year ended December 31, 2004. The
decrease in net loss was primarily due to:
|
|
|
|
|
increased revenues of $3,141,082; and
|
|
|
|
an increase in interest income of $624,238.
|
The decrease in net loss was offset to some extent by an
increase of $3,399,535 in operating expenses.
Our revenues were $10,147,995 for the year ended
December 31, 2005, compared to $7,006,913 for the year
ended December 31, 2004. The increase in revenues was
mainly due to:
|
|
|
|
|
an increase in contract research revenue of $2,032,345;
|
|
|
|
an increase in development chemical revenue of
$1,019,615; and
|
|
|
|
an increase in technology development revenue of $374,842.
|
The increase was offset by the following:
|
|
|
|
|
a decrease in commercial chemical revenue of $116,205; and
|
|
|
|
a decrease in royalty and license revenue of $169,515.
|
31
We earned $4,653,981 in contract research revenue from the
U.S. government in 2005, compared to $2,621,636 in 2004.
The increase resulted mainly from our entering into several new
government contracts during 2005. These contracts also involved
additional prototyping work as compared to the more basic
research we conducted under our government contracts in 2004.
We earned $3,503,685 from our sales of OLED materials for
evaluation purposes in 2005, compared to $2,484,070 for
corresponding sales in 2004. The increase was mainly due to an
increased volume of OLED materials purchased for evaluation by
potential OLED display manufacturers, including our technology
development and evaluation partners.
For 2005, our commercial chemical revenues and our royalty and
license revenues were $31,395 and $233,555, respectively,
compared to $147,600 and $403,070, respectively, for the
corresponding period in 2004. The decrease was due mainly to the
timing of purchases of our proprietary PHOLED materials for use
in a commercial OLED product by Tohoku Pioneer Corporation. All
commercial chemical revenues in 2005 and 2004 were from this
customer.
Our royalty and license revenue for 2005 included fees received
under our patent license agreement with Samsung SDI and our
cross-license agreement with DuPont Displays. Royalty and
license revenue for 2004 also included $58,670 of royalty
revenue from the sale of OVPD equipment by Aixtron AG, one of
our licensees. Aixtron sold no such equipment in 2005.
We recognized $1,725,379 in technology development revenue in
2005 in connection with technology development and evaluation
agreements, compared to $1,350,537 for the same period in 2004.
The increase was primarily due to new technology development and
evaluation agreements entered into in 2005.
We incurred research and development expenses of $19,183,390 for
the year ended December 31, 2005, compared to $16,651,335
for the year ended December 31, 2004. The increase was
mainly attributable to:
|
|
|
|
|
an increase of $904,524 in our operating costs, associated in
large part with the expansion of our New Jersey facility;
|
|
|
|
an increase of $702,396 in charges in connection with our
Development and License Agreement with PPG Industries (see
Note 7 of the Notes to Consolidated Financial Statements);
|
|
|
|
an increase of $518,283 in expenses related to the timing of
recognition of the expense for stock and option issuances to
non-employee members of our Scientific Advisory Board; and
|
|
|
|
increased patent legal costs of $318,015.
|
Included within research and development expenses are patent
defense costs of $97,353 and $24,206 for each of 2005 and 2004,
respectively. These costs are associated with the SEL patent
interference matter described in response to Item 3 of this
report (Legal Proceedings).
General and administrative expenses were $7,704,931 for the year
ended December 31, 2005, compared to $7,052,047 for the
same period in 2004. The increase was due mainly to:
|
|
|
|
|
an increase of $282,068 in personnel costs due to salary
increases and increased healthcare costs; and
|
|
|
|
an increase of $139,300 in expenses related to the timing of
stock issuances to non-employee members of our Board of
Directors.
|
Royalty expenses were $610,098 for the year ended
December 31, 2005, compared to $350,000 for the same period
in 2004. The increase was mainly due to the minimum royalty
requirement under our agreement with Motorola (Notes 5 and
12 in the Notes to Consolidated Financial Statements). Under
this agreement, we are required to make a minimum royalty
payment at the end of the two-year period ended
December 31, 2006 of $1,000,000, as compared to a payment
of $500,000 for the two-year period ended December 31, 2004.
Interest income increased to $1,419,858 for the year ended
December 31, 2005, compared to $795,620 for the prior year.
This was mainly the result of increased cash balances throughout
2005, due to our March 2004 registered offering of common stock,
together with higher rates of return on investments during 2005.
32
During 2005, we sold approximately $5 million of our
state-related income tax NOLs to New Jersey under the Technology
Tax Certificate Transfer Program. In 2005, we received proceeds
of $424,207 from the sale of these NOLs and recorded these
proceeds as an income tax benefit. During 2004, we sold
approximately $8 million of our state-related income tax
NOLs and received proceeds from these sales of $612,966.
We recorded no deemed dividends for the year ended
December 31, 2005, compared to $129,624 in deemed dividends
recorded for the prior year. In 2004, we issued a warrant to
purchase shares of our common stock and completed a registered
offering of our common stock. These actions were deemed dilutive
under the terms of a stock-purchase warrant we had previously
issued and resulted in the reduction of the exercise price of
that warrant and an increase in the number of shares issuable
under the warrant. We treated this occurrence as a deemed
dividend of $46,176. In 2005, there were no actions deemed
dilutive under the terms of this warrant.
In 2004, the conversion price of the Series B Convertible
Preferred Stock we issued to Motorola, Inc. in September 2000
was adjusted in accordance with the Certificate of Designations
for that stock. We accounted for this adjustment as a contingent
beneficial conversion feature (CBCF). As a result, we recorded
the CBCF as a deemed dividend in the amount of $83,448. There
were no such deemed dividends in 2005.
Liquidity
and Capital Resources
As of December 31, 2006, we had cash and cash equivalents
of $31,097,533, short-term investments of $17,957,752 and
investments in certificates of deposit and other liquid
instruments with an original maturity of more than one year of
$42,770, for a total of $49,098,055. This compares to cash and
cash equivalents of $30,654,249, short-term investments of
$17,190,242 and investments in certificates of deposit and other
liquid instruments with an original maturity of more than one
year of $1,828,708, for a total of $49,673,199, as of
December 31, 2005. The small decrease in cash and cash
equivalents and short-term and long-term investments of $575,144
was primarily due to cash used in operating activities and
purchases of equipment, offset to some extent by proceeds
received from stock-purchase warrant and stock option exercises.
Cash used in operating activities was $4,703,792 for 2006, as
compared to $345,059 for 2005. The increase was primarily due to
changes in the following:
|
|
|
|
|
increased recognition of deferred revenue and deferred license
fees received in previous years; and
|
|
|
|
the timing of billings to our customers and payments to our
vendors during 2006 as compared to 2005.
|
Cash used in investing activities was $1,134,692 for 2006, as
compared to cash provided by investing activities of $3,945,069
for 2005. The increase in cash used was due mainly to the
partial use of proceeds from the sale of our investments for
operating activities.
Cash provided by financing activities was $6,281,769 for 2006,
as compared to $8,123,658 for 2005. The cash provided by
financing activities for both 2006 and 2005 consisted of
proceeds from the exercise of stock-purchase warrants and stock
options.
Working capital decreased to $37,422,740 as of December 31,
2006, from working capital of $38,347,913 as of
December 31, 2005. The reduction was primarily due to an
increase in current liabilities relating to the classification
of deferred license fees as current liabilities. In 2006, we
received $3,700,000 in non-refundable payments under our
development and technology evaluation agreements that are
creditable against license fees under a license agreement, if
executed. Therefore, we classify these advanced payments as
current deferred license fees until a license agreement is
executed or until there is no appreciable likelihood of entering
into a license agreement.
We anticipate, based on our internal forecasts and assumptions
relating to our operations (including, among others, assumptions
regarding our working capital requirements, the progress of our
research and development efforts, the availability of sources of
funding for our research and development work, and the timing
and costs associated with the preparation, filing, prosecution,
maintenance and defense of our patents and patent applications),
that we have sufficient cash, cash equivalents and short-term
investments to meet our obligations through at least 2008.
33
We believe that potential additional financing sources for us
include long-term and short-term borrowings, public and private
sales of our equity and debt securities and the receipt of cash
upon the exercise of warrants and options. We have an effective
shelf registration statement that would enable us to offer, from
time to time, up to $44,725,524 of our common stock, preferred
stock, debt securities and other securities, subject to market
conditions and other factors. It should be noted, however, that
additional funding may be required in the future for research,
development and commercialization of our OLED technologies and
materials, to obtain and maintain patents respecting these
technologies and materials, and for working capital and other
purposes, the timing and amount of which are difficult to
ascertain. There can be no assurance that this additional
funding will be available to us when needed, on commercially
reasonable terms or at all.
Contractual
Obligations
As of December 31, 2006, we had the following contractual
commitments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Period
|
|
|
|
|
|
|
Less Than
|
|
|
1-3
|
|
|
3-5
|
|
|
More Than
|
|
Contractual Obligations
|
|
Total
|
|
|
1 Year
|
|
|
Years
|
|
|
Years
|
|
|
5 Years
|
|
|
Long-term debt
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Operating lease obligations
|
|
|
4,000
|
|
|
|
4,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital lease obligations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase obligations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other long-term liabilities
reflected on the balance sheet under GAAP
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Obligations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sponsored research obligation
|
|
|
4,504,439
|
|
|
|
2,398,260
|
|
|
|
2,106,179
|
|
|
|
|
|
|
|
|
|
Minimum royalty obligation
|
|
|
600,000
|
|
|
|
100,000
|
|
|
|
300,000
|
|
|
|
200,000
|
|
|
$
|
100,000/year(1
|
)
|
Total(2)
|
|
$
|
5,108,439
|
|
|
$
|
2,502,260
|
|
|
$
|
2,406,179
|
|
|
$
|
200,000
|
|
|
$
|
100,000/year(1
|
)
|
|
|
|
(1) |
|
Under our Amended License Agreement with Princeton University,
the University of Southern California and the University of
Michigan, we are obligated to pay minimum royalties of
$100,000 per year until such time as the agreement is no
longer in effect. |
|
(2) |
|
See Note 12 to the Consolidated Financial Statements for
discussion of obligations upon termination of employment of
executive officers as a result of a change in control of the
Company. |
Off-Balance
Sheet Arrangements
As of December 31, 2006, we had no off-balance sheet
arrangements in the nature of guarantee contracts, retained or
contingent interests in assets transferred to unconsolidated
entities (or similar arrangements serving as credit, liquidity
or market risk support to unconsolidated entities for any such
assets), or obligations (including contingent obligations)
arising out of variable interests in unconsolidated entities
providing financing, liquidity, market risk or credit risk
support to us, or that engage in leasing, hedging or research
and development services with us.
Recently
Issued Accounting Pronouncements
Recently issued accounting pronouncements are addressed in
Note 2 in the Notes to Consolidated Financial Statements.
We do not expect that the adoption of these recently accounting
pronouncements will have a material impact on our financial
statements or results of operations.
|
|
ITEM 7A.
|
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
We do not utilize financial instruments for trading purposes and
hold no derivative financial instruments, other financial
instruments or derivative commodity instruments that could
expose us to significant market risk. Our
34
primary market risk exposure with regard to financial
instruments is to changes in interest rates, which would impact
interest income earned on investments.
|
|
ITEM 8.
|
FINANCIAL
STATEMENTS AND SUPPLEMENTARY DATA
|
Our Consolidated Financial Statements and the relevant notes to
those statements are attached to this report beginning on
page F-1.
|
|
ITEM 9.
|
CHANGES
IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
|
None.
|
|
ITEM 9A.
|
CONTROLS
AND PROCEDURES
|
Evaluation
of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive
Officer and Chief Financial Officer, evaluated the effectiveness
of our disclosure controls and procedures as of the end of the
period covered by this report. Based on that evaluation, the
Chief Executive Officer and Chief Financial Officer concluded
that our disclosure controls and procedures, as of
December 31, 2006, are functioning effectively to provide
reasonable assurance that the information required to be
disclosed by us in reports filed or submitted under the
Securities Exchange Act of 1934, as amended, is
(i) recorded, processed, summarized and reported within the
time periods specified in the SECs rules and forms, and
(ii) accumulated and communicated to our management,
including the Chief Executive Officer and Chief Financial
Officer, as appropriate to allow timely decisions regarding
disclosure. However, a controls system, no matter how well
designed and operated, cannot provide absolute assurance that
the objectives of the controls system are met, and no evaluation
of controls can provide absolute assurance that all control
issues and instances of fraud, if any, within a company have
been detected.
Managements
Report on Internal Control over Financial Reporting and
Attestation Report of Public Accounting Firm
The report of management on our internal control over financial
reporting and the associated attestation report of our
independent registered public accounting firm are set forth in
Item 8 of this report and are incorporated herein by
reference.
Changes
in Internal Control over Financial Reporting
There were no changes in our internal control over financial
reporting during the quarter ended December 31, 2006 that
have materially affected, or is reasonably likely to materially
affect, our internal control over financial reporting.
|
|
ITEM 9B.
|
OTHER
INFORMATION
|
None.
PART III
|
|
ITEM 10.
|
DIRECTORS,
EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
|
Information with respect to this item is set forth in our
definitive Proxy Statement for the 2007 Annual Meeting of
Shareholders, which is to be filed with the Securities and
Exchange Commission no later than April 29, 2007, (our
Proxy Statement), and which is incorporated herein
by reference. Information regarding our executive officers is
included at the end of Part I of this report.
35
|
|
ITEM 11.
|
EXECUTIVE
COMPENSATION
|
Information with respect to this item is set forth in our Proxy
Statement, and is incorporated herein by reference.
|
|
ITEM 12.
|
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND
RELATED STOCKHOLDER MATTERS
|
Information with respect to this item is set forth in our Proxy
Statement, and is incorporated herein by reference.
|
|
ITEM 13.
|
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE
|
Information with respect to this item is set forth in our Proxy
Statement, and is incorporated herein by reference.
|
|
ITEM 14.
|
PRINCIPAL
ACCOUNTANT FEES AND SERVICES
|
Information with respect to this item is set forth in our Proxy
Statement, and is incorporated herein by reference.
PART IV
|
|
ITEM 15.
|
EXHIBITS AND
FINANCIAL STATEMENT SCHEDULES
|
(a) The following documents are filed as part of this
report:
(1) Financial Statements:
|
|
|
|
|
Managements Report on
Internal Control Over Financial Reporting
|
|
|
F-2
|
|
Reports of Independent Registered
Public Accounting Firm
|
|
|
F-3
|
|
Consolidated Balance Sheets
|
|
|
F-5
|
|
Consolidated Statements of
Operations
|
|
|
F-6
|
|
Consolidated Statements of
Shareholders Equity
|
|
|
F-7
|
|
Consolidated Statements of Cash
Flows
|
|
|
F-10
|
|
Notes to Consolidated Financial
Statements
|
|
|
F-11
|
|
(2) Financial Statement Schedules:
None.
(3) Exhibits:
The following is a list of the exhibits filed as part of this
report. Where so indicated by footnote, exhibits that were
previously filed are incorporated by reference. For exhibits
incorporated by reference, the location of the exhibit in the
previous filing is indicated parenthetically, together with a
reference to the filing indicated by footnote.
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
3
|
.1
|
|
Amended and Restated Articles of
Incorporation of the registrant(1)
|
|
3
|
.2
|
|
Bylaws of the registrant(1)
|
|
10
|
.1#
|
|
Warrant Agreement between the
registrant and Steven V. Abramson, dated as of April 2,
1998(2)
|
|
10
|
.2#
|
|
Warrant Agreement between the
registrant and Sidney D. Rosenblatt, dated as of April 2,
1998(2)
|
|
10
|
.3#
|
|
Warrant Agreement between the
registrant and Julia J. Brown, dated as of April 18,
2000(3)
|
36
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
10
|
.4#
|
|
Amendment No. 1 to Warrant
Agreement between the registrant and Julia J. Brown, dated as of
April 18, 2000(1)
|
|
10
|
.5#
|
|
Change in Control Agreement
between the registrant and Sherwin I. Seligsohn, dated as of
April 28, 2003(4)
|
|
10
|
.6#
|
|
Change in Control Agreement
between the registrant and Steven V. Abramson, dated as of
April 28, 2003(4)
|
|
10
|
.7#
|
|
Change in Control Agreement
between the registrant and Sidney D. Rosenblatt, dated as of
April 28, 2003(4)
|
|
10
|
.8#
|
|
Change in Control Agreement
between the registrant and Julia J. Brown, dated as of
April 28, 2003(4)
|
|
10
|
.9#*
|
|
Non-Competition and
Non-Solicitation Agreement between the registrant and Sherwin I.
Seligsohn, dated as of February 23, 2007
|
|
10
|
.10#*
|
|
Non-Competition and
Non-Solicitation Agreement between the registrant and Steven V.
Abramson, dated as of January 26, 2007
|
|
10
|
.11#*
|
|
Non-Competition and
Non-Solicitation Agreement between the registrant and Sidney D.
Rosenblatt, dated as of February 7, 2007
|
|
10
|
.12#*
|
|
Non-Competition and
Non-Solicitation Agreement between the registrant and Julia J.
Brown, dated as of February 5, 2007
|
|
10
|
.13#
|
|
Executive Performance Compensation
Program, dated as of April 20, 2004(2)
|
|
10
|
.14
|
|
Equity Compensation Plan, dated as
of June 29, 2006(5)
|
|
10
|
.15
|
|
1997 Research Agreement between
the registrant and The Trustees of Princeton University, dated
as of August 1, 1997(6)
|
|
10
|
.16
|
|
Amendment #1 to the 1997
Research Agreement between the registrant and the Trustees of
Princeton University, dated as of November 14, 2000(7)
|
|
10
|
.17
|
|
Amendment #2 to the 1997
Research Agreement between the registrant and the Trustees of
Princeton University, dated as of April 11, 2002(7)
|
|
10
|
.18
|
|
Sponsored Research Agreement
between the registrant and the University of Southern
California, dated as of May 1, 2006(8)
|
|
10
|
.19
|
|
1997 Amended License Agreement
among the registrant, The Trustees of Princeton University and
the University of Southern California, dated as of
October 9, 1997(6)
|
|
10
|
.20
|
|
Amendment #1 to the Amended
License Agreement among the registrant, the Trustees of
Princeton University and the University of Southern California,
dated as of August 7, 2003(7)
|
|
10
|
.21
|
|
Amendment #2 to the Amended
License Agreement among the registrant, the Trustees of
Princeton University, the University of Southern California and
the Regents of the University of Michigan, dated as of
January 1, 2006(8)
|
|
10
|
.22
|
|
Termination, Amendment and License
Agreement by and among the registrant, PD-LD, Inc.,
Dr. Vladimir S. Ban, and The Trustees of Princeton
University, dated as of July 19, 2000(9)
|
|
10
|
.23*
|
|
Letter of Clarification of
UDC/GPEC Research and License Arrangements between the
registrant and Global Photonic Energy Corporation, dated as of
June 4, 2004
|
|
10
|
.24+
|
|
License Agreement between the
registrant and Motorola, Inc., dated as of September 29,
2000(9)
|
|
10
|
.25+
|
|
OLED Materials Supply and Service
Agreement between the registrant and PPG Industries, Inc., dated
as of July 29, 2005(10)
|
|
10
|
.26+
|
|
OLED Patent License Agreement
between the registrant and Samsung SDI Co., Ltd., dated as of
April 19, 2005(11)
|
|
10
|
.27+
|
|
OLED Supplemental License
Agreement between the registrant and Samsung SDI Co., Ltd.,
dated as of April 19, 2005(11)
|
|
10
|
.28+
|
|
Commercial Supply Agreement
between the registrant and AU Optronics Corporation, dated as of
January 1, 2006(12)
|
37
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
10
|
.29+
|
|
Settlement and License Agreement
between the registrant and Seiko Epson Corporation, dated as of
July 31, 2006(13)
|
|
21
|
*
|
|
Subsidiaries of the registrant
|
|
23
|
.1*
|
|
Consent of KPMG LLP
|
|
31
|
.1*
|
|
Certifications of Sherwin I.
Seligsohn, Chief Executive Officer, as required by
Rule 13a-14(a)
or
Rule 15d-14(a)
|
|
31
|
.2*
|
|
Certifications of Sidney D.
Rosenblatt, Chief Financial Officer, as required by
Rule 13a-14(a)
or
Rule 15d-14(a)
|
|
32
|
.1**
|
|
Certifications of Sherwin I.
Seligsohn, Chief Executive Officer, as required by
Rule 13a-14(b)
or
Rule 15d-14(b),
and by 18 U.S.C. Section 1350. (This exhibit shall not
be deemed filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as
amended, or otherwise subject to the liability of that section.
Further, this exhibit shall not be deemed to be incorporated by
reference into any filing under the Securities Act of 1933, as
amended, or the Securities Exchange Act of 1934, as amended.)
|
|
32
|
.2**
|
|
Certifications of Sidney D.
Rosenblatt, Chief Financial Officer, as required by
Rule 13a-14(b)
or
Rule 15d-14(b),
and by 18 U.S.C. Section 1350. (This exhibit shall not
be deemed filed for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liability of that section. Further, this exhibit
shall not be deemed to be incorporated by reference into any
filing under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended.)
|
Explanation of footnotes to listing of exhibits:
|
|
|
* |
|
Filed herewith. |
|
** |
|
Furnished herewith. |
|
# |
|
Management contract or compensatory plan or arrangement. |
|
+ |
|
Confidential treatment has been accorded to certain portions of
this exhibit pursuant to Rule 406 under the Securities Act
of 1933, as amended, or
Rule 24b-2
under the Securities Exchange Act of 1934, as amended. |
|
(1) |
|
Filed as an Exhibit to the Annual Report on
Form 10-K
for the year ended December 31, 2003, filed with the SEC on
March 1, 2004. |
|
(2) |
|
Filed as an Exhibit to the Annual Report on
Form 10-K
for the year ended December 31, 2004, filed with the SEC on
March 14, 2001. |
|
(3) |
|
Filed as an Exhibit to the Annual Report on
Form 10-K
for the year ended December 31, 2000, filed with the SEC on
March 29, 2001. |
|
(4) |
|
Filed as an Exhibit to the Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2003, filed with the SEC on
May 13, 2003. |
|
(5) |
|
Filed as an Exhibit to the Definitive Proxy Statement for the
2006 Annual Meeting of Shareholders, filed with the SEC on
April 27, 2006. |
|
(6) |
|
Filed as an Exhibit to the Annual Report on
Form 10K-SB
for the year ended December 31, 1997, filed with the SEC on
March 31, 1998. |
|
(7) |
|
Filed as an Exhibit to the Quarterly Report on
Form 10-Q
for the quarter ended September 30, 2003, filed with the
SEC on November 10, 2003. |
|
(8) |
|
Filed as an Exhibit to the Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2006, filed with the SEC on
August 9, 2006. |
|
(9) |
|
Filed as an Exhibit to the amended Quarterly Report on
Form 10-Q
for the quarter ended September 30, 2000, filed with the
SEC on November 20, 2001. |
|
(10) |
|
Filed as an Exhibit to the Quarterly Report on
Form 10-Q
for the quarter ended September 30, 2005, filed with the
SEC on November 7, 2005. |
38
|
|
|
(11) |
|
Filed as an Exhibit to the Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2005, filed with the SEC on
August 9, 2005. |
|
(12) |
|
Filed as an Exhibit to the Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2006, filed with the SEC on
May 10, 2006. |
|
(13) |
|
Filed as an Exhibit to the Quarterly Report on
Form 10-Q
for the quarter ended September 30, 2006, filed with the
SEC on November 6, 2006. |
Note: Any of the exhibits listed in the foregoing index not
included with this report may be obtained, without charge, by
writing to Mr. Sidney D. Rosenblatt, Corporate Secretary,
Universal Display Corporation, 375 Phillips Boulevard,
Ewing, New Jersey 08618.
(b) The exhibits required to be filed by us with this
report are listed above.
(c) The consolidated financial statement schedules required
to be filed by us with this report are listed above.
39
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized:
UNIVERSAL DISPLAY CORPORATION
|
|
|
|
By:
|
/s/ Sidney
D. Rosenblatt
|
Sidney D. Rosenblatt
Executive Vice President, Chief Financial Officer,
Treasurer and Secretary
Date: March 15, 2007
Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed below by the following persons
on behalf of the registrant and in the capacities and on the
dates indicated.
|
|
|
|
|
|
|
Name
|
|
Title
|
|
Date
|
|
/s/ Sherwin
I. Seligsohn
Sherwin
I. Seligsohn
|
|
Chairman of Board and Chief
Executive Officer
|
|
March 15, 2007
|
|
|
|
|
|
/s/ Steven
V. Abramson
Steven
V. Abramson
|
|
President, Chief Operating Officer
and Director
|
|
March 15, 2007
|
|
|
|
|
|
/s/ Sidney
D. Rosenblatt
Sidney
D. Rosenblatt
|
|
Executive Vice President, Chief
Financial Officer, Treasurer, Secretary and Director
|
|
March 15, 2007
|
|
|
|
|
|
/s/ Leonard
Becker
Leonard
Becker
|
|
Director
|
|
March 15, 2007
|
|
|
|
|
|
/s/ Elizabeth
H. Gemmill
Elizabeth
H. Gemmill
|
|
Director
|
|
March 15, 2007
|
|
|
|
|
|
/s/ C.
Keith Hartley
C.
Keith Hartley
|
|
Director
|
|
March 15, 2007
|
|
|
|
|
|
/s/ Lawrence
Lacerte
Lawrence
Lacerte
|
|
Director
|
|
March 15, 2007
|
40
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
INDEX TO
CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
Consolidated Financial
Statements:
|
|
|
|
|
|
|
|
F-2
|
|
|
|
|
F-3
|
|
|
|
|
F-4
|
|
|
|
|
F-5
|
|
|
|
|
F-6
|
|
|
|
|
F-7
|
|
|
|
|
F-10
|
|
|
|
|
F-11
|
|
F-1
MANAGEMENTS
REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Our management is responsible for establishing and maintaining
adequate internal control over financial reporting for the
company. Internal control over financial reporting is a process
designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. Our system of internal
control over financial reporting includes those policies and
procedures that (i) pertain to the maintenance of records
that, in reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of the company;
(ii) provide reasonable assurance that transactions are
recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (iii) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use or disposition of the
companys assets that could have a material effect on the
financial statements.
Management performed an assessment of the effectiveness of our
internal control over financial reporting as of
December 31, 2006 based upon criteria in Internal
Control Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway
Commission (COSO). Based on this assessment,
management determined that the companys internal control
over financial reporting was effective as of December 31,
2006, based on the criteria in Internal Control-Integrated
Framework issued by COSO.
Managements assessment of the effectiveness of our
internal control over financial reporting as of
December 31, 2006, has been audited by KPMG LLP, an
independent registered public accounting firm, as stated in its
report which appears on the following page.
|
|
|
Sherwin I. Seligsohn
Chairman of the Board and Chief Executive Officer
|
|
Sidney D. Rosenblatt
Executive Vice President and Chief Financial Officer
|
Dated: March 14, 2007
F-2
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Shareholders
Universal Display Corporation:
We have audited managements assessment, included in the
accompanying Managements Report on Internal Control Over
Financial Reporting, that Universal Display Corporation (the
Company) maintained effective internal control over financial
reporting as of December 31, 2006, based on criteria
established in Internal Control Integrated
Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO). The
Companys management is responsible for maintaining
effective internal control over financial reporting and for its
assessment of the effectiveness of internal control over
financial reporting. Our responsibility is to express an opinion
on managements assessment and an opinion on the
effectiveness of the Companys internal control over
financial reporting based on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control
over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of
internal control over financial reporting, evaluating
managements assessment, testing and evaluating the design
and operating effectiveness of internal control, and performing
such other procedures as we considered necessary in the
circumstances. We believe that our audit provides a reasonable
basis for our opinion.
A companys internal control over financial reporting is a
process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
In our opinion, managements assessment that Universal
Display Corporation maintained effective internal control over
financial reporting as of December 31, 2006, is fairly
stated, in all material respects, based on criteria established
in Internal Control Integrated Framework
issued by COSO. Also, in our opinion, Universal Display
Corporation maintained, in all material respects, effective
internal control over financial reporting as of
December 31, 2006, based on criteria established in
Internal Control Integrated Framework issued
by COSO.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
consolidated balance sheets of Universal Display Corporation and
subsidiary as of December 31, 2006 and 2005, and the
related consolidated statements of operations,
shareholders equity and comprehensive loss and cash flows
for each of the years in the three-year period ended
December 31, 2006, and our report dated March 14, 2007
expressed an unqualified opinion on those consolidated financial
statements.
Philadelphia, Pennsylvania
March 14, 2007
F-3
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Shareholders
Universal Display Corporation:
We have audited the accompanying consolidated balance sheets of
Universal Display Corporation and subsidiary (the Company) as of
December 31, 2006 and 2005, and the related consolidated
statements of operations, shareholders equity and
comprehensive loss and cash flows for each of the years in the
three-year period ended December 31, 2006. These
consolidated financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these consolidated financial statements based on our
audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the consolidated financial
statements are free of material misstatement. An audit includes
examining, on a test basis, evidence supporting the amounts and
disclosures in the consolidated financial statements. An audit
also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating
the overall financial statement presentation. We believe that
our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred
to above present fairly, in all material respects, the financial
position of Universal Display Corporation and subsidiary as of
December 31, 2006 and 2005, and the results of their
operations and their cash flows for each of the years in the
three-year period ended December 31, 2006, in conformity
with U.S. generally accepted accounting principles.
As discussed in Notes 2 and 10 to the consolidated
financial statements, effective January 1, 2006, the
Company adopted the fair value method of accounting for
stock-based compensation as required by Statement of Financial
Accounting Standards No. 123R, Share-Based Payment.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
effectiveness of Universal Display Corporations internal
control over financial reporting as of December 31, 2006,
based on criteria established in Internal Control
Integrated Framework issued by the Committee of
Sponsoring Organizations of the Treadway Commission (COSO),
and our report dated March 14, 2007, expressed an
unqualified opinion on managements assessment of, and the
effective operation of, internal control over financial
reporting.
Philadelphia, Pennsylvania
March 14, 2007
F-4
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
CONSOLIDATED
BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
ASSETS
|
CURRENT ASSETS:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
31,097,533
|
|
|
$
|
30,654,249
|
|
Short-term investments
|
|
|
17,957,752
|
|
|
|
17,190,242
|
|
Accounts receivable
|
|
|
2,113,263
|
|
|
|
1,944,099
|
|
Inventory
|
|
|
30,598
|
|
|
|
36,431
|
|
Other current assets
|
|
|
606,267
|
|
|
|
497,746
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
51,805,413
|
|
|
|
50,322,767
|
|
PROPERTY AND EQUIPMENT, net
|
|
|
14,074,093
|
|
|
|
13,553,611
|
|
ACQUIRED TECHNOLOGY, net
|
|
|
6,319,488
|
|
|
|
8,014,559
|
|
INVESTMENTS
|
|
|
42,770
|
|
|
|
1,828,708
|
|
OTHER ASSETS
|
|
|
89,772
|
|
|
|
99,772
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
72,331,536
|
|
|
$
|
73,819,417
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
SHAREHOLDERS EQUITY
|
CURRENT LIABILITIES:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
|
1,808,869
|
|
|
|
1,249,576
|
|
Accrued expenses
|
|
|
5,245,536
|
|
|
|
5,168,223
|
|
Deferred license fees
|
|
|
7,178,268
|
|
|
|
3,478,267
|
|
Deferred revenue
|
|
|
150,000
|
|
|
|
2,078,788
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
14,382,673
|
|
|
|
11,974,854
|
|
DEFERRED LICENSE FEES
|
|
|
2,966,500
|
|
|
|
3,478,100
|
|
DEFERRED REVENUE
|
|
|
600,000
|
|
|
|
750,000
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
17,949,173
|
|
|
|
16,202,954
|
|
|
|
|
|
|
|
|
|
|
COMMITMENTS AND CONTINGENCIES
(Note 12)
|
|
|
|
|
|
|
|
|
SHAREHOLDERS EQUITY:
|
|
|
|
|
|
|
|
|
Preferred Stock, par value
$0.01 per share, 5,000,000 shares authorized,
200,000 shares of Series A Nonconvertible Preferred
Stock issued and outstanding (liquidation value of
$7.50 per share or $1,500,000), 300,000 shares of
Series B Convertible Preferred Stock authorized and none
outstanding, 5,000 shares of
Series C-1
Convertible Preferred Stock authorized and none outstanding,
5,000 shares of Series D Convertible Preferred Stock
authorized and none outstanding
|
|
|
2,000
|
|
|
|
2,000
|
|
Common Stock, par value
$0.01 per share, 50,000,000 shares authorized,
31,385,408 and 29,545,471 shares issued and outstanding at
December 31, 2006 and 2005, respectively
|
|
|
313,854
|
|
|
|
295,455
|
|
Additional
paid-in-capital
|
|
|
199,505,981
|
|
|
|
187,609,407
|
|
Unrealized loss on available for
sale securities
|
|
|
(82,846
|
)
|
|
|
(120,577
|
)
|
Accumulated deficit
|
|
|
(145,356,626
|
)
|
|
|
(130,169,822
|
)
|
|
|
|
|
|
|
|
|
|
Total shareholders equity
|
|
|
54,382,363
|
|
|
|
57,616,463
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
72,331,536
|
|
|
$
|
73,819,417
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
F-5
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
CONSOLIDATED
STATEMENTS OF OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
REVENUE:
|
|
|
|
|
|
|
|
|
|
|
|
|
Contract research revenue
|
|
$
|
3,821,903
|
|
|
$
|
4,653,981
|
|
|
$
|
2,621,636
|
|
Development chemical revenue
|
|
|
1,656,851
|
|
|
|
3,503,685
|
|
|
|
2,484,070
|
|
Commercial chemical revenue
|
|
|
1,876,071
|
|
|
|
31,395
|
|
|
|
147,600
|
|
Royalty and license revenue
|
|
|
2,400,179
|
|
|
|
233,555
|
|
|
|
403,070
|
|
Technology development revenue
|
|
|
2,166,288
|
|
|
|
1,725,379
|
|
|
|
1,350,537
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue
|
|
|
11,921,292
|
|
|
|
10,147,995
|
|
|
|
7,006,913
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of chemicals sold
|
|
|
356,567
|
|
|
|
109,781
|
|
|
|
155,283
|
|
Research and development
|
|
|
19,864,944
|
|
|
|
19,183,390
|
|
|
|
16,651,335
|
|
General and administrative
|
|
|
8,902,462
|
|
|
|
7,704,931
|
|
|
|
7,052,047
|
|
Royalty and license expense
|
|
|
687,436
|
|
|
|
610,098
|
|
|
|
350,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
29,811,409
|
|
|
|
27,608,200
|
|
|
|
24,208,665
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss
|
|
|
(17,890,117
|
)
|
|
|
(17,460,205
|
)
|
|
|
(17,201,752
|
)
|
INTEREST INCOME
|
|
|
2,168,933
|
|
|
|
1,419,858
|
|
|
|
795,620
|
|
INTEREST EXPENSE
|
|
|
(10,187
|
)
|
|
|
(185,472
|
)
|
|
|
(14,120
|
)
|
OTHER REVENUE
|
|
|
|
|
|
|
|
|
|
|
30,712
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LOSS BEFORE INCOME TAX BENEFIT
|
|
|
(15,731,371
|
)
|
|
|
(16,225,819
|
)
|
|
|
(16,389,540
|
)
|
INCOME TAX BENEFIT
|
|
|
544,567
|
|
|
|
424,207
|
|
|
|
612,966
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET LOSS
|
|
|
(15,186,804
|
)
|
|
|
(15,801,612
|
)
|
|
|
(15,776,574
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DEEMED DIVIDENDS (Notes 8 and
9)
|
|
|
|
|
|
|
|
|
|
|
(129,624
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET LOSS ATTRIBUTABLE TO COMMON
SHAREHOLDERS
|
|
$
|
(15,186,804
|
)
|
|
$
|
(15,801,612
|
)
|
|
$
|
(15,906,198
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BASIC AND DILUTED NET LOSS PER
COMMON SHARE
|
|
$
|
(0.49
|
)
|
|
$
|
(0.56
|
)
|
|
$
|
(0.59
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WEIGHTED AVERAGE SHARES USED
IN COMPUTING BASIC AND DILUTED NET LOSS PER COMMON SHARE
|
|
|
30,855,297
|
|
|
|
28,462,925
|
|
|
|
26,791,158
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
F-6
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
CONSOLIDATED
STATEMENTS OF SHAREHOLDERS EQUITY AND COMPREHENSIVE
LOSS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A
|
|
|
Series B
|
|
|
|
Nonconvertible
|
|
|
Convertible
|
|
|
|
Preferred Stock
|
|
|
Preferred Stock
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
BALANCE, DECEMBER 31, 2003
|
|
|
200,000
|
|
|
$
|
2,000
|
|
|
|
300,000
|
|
|
$
|
3,000
|
|
Exercise of common stock options
and warrants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock through
direct offerings, net of expenses of $2,077,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deemed dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based employee compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based non-employee
compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock to Board
of Directors and Scientific Advisory Board
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock, options
and warrants in connection with the Development Agreements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock upon
conversion of Series B Preferred Stock
|
|
|
|
|
|
|
|
|
|
|
(300,000
|
)
|
|
|
(3,000
|
)
|
Amortization of deferred
compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized loss on
available-for-sale
securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE, DECEMBER 31, 2004
|
|
|
200,000
|
|
|
|
2,000
|
|
|
|
|
|
|
|
|
|
Exercise of common stock options
and warrants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based employee compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based non-employee
compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock to Board
of Directors and Scientific Advisory Board
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock, options
and warrants in connection with the Development Agreements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of deferred
compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized loss on
available-for-sale
securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE, DECEMBER 31, 2005
|
|
|
200,000
|
|
|
|
2,000
|
|
|
|
|
|
|
|
|
|
Exercise of common stock options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of common stock warrants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based employee compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based non-employee
compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock to Board
of Directors and Scientific Advisory Board
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock, options
and warrants in connection with the Development Agreement
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gains on
available-for-sale
securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE, DECEMBER 31, 2006
|
|
|
200,000
|
|
|
$
|
2,000
|
|
|
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
F-7
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
CONSOLIDATED
STATEMENTS OF SHAREHOLDERS EQUITY AND
COMPREHENSIVE
LOSS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
|
Common Stock
|
|
|
Paid-in
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
BALANCE, DECEMBER 31, 2003
|
|
|
24,196,765
|
|
|
$
|
241,968
|
|
|
$
|
137,160,751
|
|
Exercise of common stock options
and warrants
|
|
|
467,599
|
|
|
|
4,676
|
|
|
|
2,918,964
|
|
Issuance of common stock through
direct offerings, net of expenses of $2,077,750
|
|
|
2,550,000
|
|
|
|
25,500
|
|
|
|
28,496,749
|
|
Deemed dividends
|
|
|
|
|
|
|
|
|
|
|
46,176
|
|
Stock-based employee compensation
|
|
|
64,750
|
|
|
|
647
|
|
|
|
870,332
|
|
Stock-based non-employee
compensation
|
|
|
|
|
|
|
|
|
|
|
(5,485
|
)
|
Issuance of common stock to Board
of Directors and Scientific Advisory Board
|
|
|
38,000
|
|
|
|
380
|
|
|
|
643,340
|
|
Issuance of common stock, options
and warrants in connection with the Development Agreements
|
|
|
167,355
|
|
|
|
1,674
|
|
|
|
3,242,706
|
|
Issuance of common stock upon
conversion of Series B Preferred Stock
|
|
|
418,916
|
|
|
|
4,189
|
|
|
|
(1,189
|
)
|
Amortization of deferred
compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized loss on
available-for-sale
securities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE, DECEMBER 31, 2004
|
|
|
27,903,385
|
|
|
|
279,034
|
|
|
|
173,372,344
|
|
Exercise of common stock options
and warrants
|
|
|
1,029,710
|
|
|
|
10,297
|
|
|
|
8,413,361
|
|
Stock-based employee compensation
|
|
|
88,270
|
|
|
|
883
|
|
|
|
725,532
|
|
Stock-based non-employee
compensation
|
|
|
|
|
|
|
|
|
|
|
(4,225
|
)
|
Issuance of common stock to Board
of Directors and Scientific Advisory Board
|
|
|
48,000
|
|
|
|
480
|
|
|
|
725,524
|
|
Issuance of common stock, options
and warrants in connection with the Development Agreements
|
|
|
476,106
|
|
|
|
4,761
|
|
|
|
4,376,871
|
|
Amortization of deferred
compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized loss on
available-for-sale
securities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE, DECEMBER 31, 2005
|
|
|
29,545,471
|
|
|
|
295,455
|
|
|
|
187,609,407
|
|
Exercise of common stock options
|
|
|
351,032
|
|
|
|
3,510
|
|
|
|
2,559,854
|
|
Exercise of common stock warrants
|
|
|
1,081,623
|
|
|
|
10,816
|
|
|
|
3,707,588
|
|
Stock-based employee compensation
|
|
|
123,922
|
|
|
|
1,239
|
|
|
|
1,720,481
|
|
Stock-based non-employee
compensation
|
|
|
|
|
|
|
|
|
|
|
105,011
|
|
Issuance of common stock to Board
of Directors and Scientific Advisory Board
|
|
|
73,766
|
|
|
|
738
|
|
|
|
837,062
|
|
Issuance of common stock, options
and warrants in connection with the Development Agreement
|
|
|
209,594
|
|
|
|
2,096
|
|
|
|
2,966,578
|
|
Unrealized gains on
available-for-sale
securities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE, DECEMBER 31, 2006
|
|
|
31,385,408
|
|
|
$
|
313,854
|
|
|
$
|
199,505,981
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
F-8
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
CONSOLIDATED
STATEMENTS OF SHAREHOLDERS EQUITY AND
COMPREHENSIVE LOSS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized Losses
|
|
|
|
|
|
|
|
|
|
Deferred
|
|
|
on Available -for-
|
|
|
Accumulated
|
|
|
|
|
|
|
Compensation
|
|
|
Sale Securities
|
|
|
Deficit
|
|
|
Total Equity
|
|
|
BALANCE, DECEMBER 31, 2003
|
|
$
|
|
|
|
$
|
(38,837
|
)
|
|
$
|
(98,462,012
|
)
|
|
$
|
38,906,870
|
|
Exercise of common stock options
and warrants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,923,640
|
|
Issuance of common stock through
direct offerings, net of expenses of $2,077,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28,522,249
|
|
Deemed dividends
|
|
|
|
|
|
|
|
|
|
|
(129,624
|
)
|
|
|
(83,448
|
)
|
Stock-based employee compensation
|
|
|
(353,513
|
)
|
|
|
|
|
|
|
|
|
|
|
517,466
|
|
Stock-based non-employee
compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5,485
|
)
|
Issuance of common stock to Board
of Directors and Scientific Advisory Board
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
643,720
|
|
Issuance of common stock, options
and warrants in connection with the Development Agreements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,244,380
|
|
Issuance of common stock upon
conversion of Series B Preferred Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of deferred
compensation
|
|
|
336,067
|
|
|
|
|
|
|
|
|
|
|
|
336,067
|
|
Unrealized loss on
available-for-sale
securities
|
|
|
|
|
|
|
(41,000
|
)
|
|
|
|
|
|
|
(41,000
|
)
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
(15,776,574
|
)
|
|
|
(15,776,574
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15,817,574
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE, DECEMBER 31, 2004
|
|
|
(17,446
|
)
|
|
|
(79,837
|
)
|
|
|
(114,368,210
|
)
|
|
|
59,187,885
|
|
Exercise of common stock options
and warrants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,423,658
|
|
Stock-based employee compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
726,415
|
|
Stock-based non-employee
compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,225
|
)
|
Issuance of common stock to Board
of Directors and Scientific Advisory Board
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
726,004
|
|
Issuance of common stock, options
and warrants in connection with the Development Agreements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,381,632
|
|
Amortization of deferred
compensation
|
|
|
17,446
|
|
|
|
|
|
|
|
|
|
|
|
17,446
|
|
Unrealized loss on
available-for-sale
securities
|
|
|
|
|
|
|
(40,740
|
)
|
|
|
|
|
|
|
(40,740
|
)
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
(15,801,612
|
)
|
|
|
(15,801,612
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15,842,352
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE, DECEMBER 31, 2005
|
|
|
|
|
|
|
(120,577
|
)
|
|
|
(130,169,822
|
)
|
|
|
57,616,463
|
|
Exercise of common stock options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,563,364
|
|
Exercise of common stock warrants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,718,404
|
|
Stock-based employee compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,721,720
|
|
Stock-based non-employee
compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
105,011
|
|
Issuance of common stock to Board
of Directors and Scientific Advisory Board
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
837,800
|
|
Issuance of common stock, options
and warrants in connection with the Development Agreement
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,968,674
|
|
Unrealized gains on
available-for-sale
securities
|
|
|
|
|
|
|
37,731
|
|
|
|
|
|
|
|
37,731
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
(15,186,804
|
)
|
|
|
(15,186,804
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15,149,073
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE, DECEMBER 31, 2006
|
|
$
|
|
|
|
$
|
(82,846
|
)
|
|
$
|
(145,356,626
|
)
|
|
$
|
54,382,363
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
F-9
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
CONSOLIDATED
STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
CASH FLOWS USED IN OPERATING
ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(15,186,804
|
)
|
|
$
|
(15,801,612
|
)
|
|
$
|
(15,776,574
|
)
|
Non-cash charges to statement of
operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation
|
|
|
1,828,551
|
|
|
|
1,654,826
|
|
|
|
1,398,636
|
|
Amortization of intangibles
|
|
|
1,695,072
|
|
|
|
1,695,072
|
|
|
|
1,695,072
|
|
Amortization of premium and
discount on investments
|
|
|
(158,182
|
)
|
|
|
(112,747
|
)
|
|
|
(24,143
|
)
|
Stock-based employee compensation
|
|
|
2,442,149
|
|
|
|
1,373,196
|
|
|
|
1,738,549
|
|
Stock-based non-employee
compensation
|
|
|
105,011
|
|
|
|
(4,225
|
)
|
|
|
(5,484
|
)
|
Non-cash expense under a
Development Agreement
|
|
|
2,968,074
|
|
|
|
3,908,666
|
|
|
|
3,356,146
|
|
Stock-based compensation to Board
of Directors and Scientific Advisory Board
|
|
|
509,600
|
|
|
|
1,314,202
|
|
|
|
643,720
|
|
(Increase) decrease in assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(169,164
|
)
|
|
|
644,180
|
|
|
|
(1,782,677
|
)
|
Inventory
|
|
|
5,833
|
|
|
|
(16,490
|
)
|
|
|
13,103
|
|
Other current assets
|
|
|
(108,521
|
)
|
|
|
(259,819
|
)
|
|
|
(84,003
|
)
|
Other assets
|
|
|
10,000
|
|
|
|
5,586
|
|
|
|
29,415
|
|
Increase (decrease) in liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable and accrued
expenses
|
|
|
244,976
|
|
|
|
1,252,285
|
|
|
|
883,694
|
|
Deferred license fees
|
|
|
3,188,401
|
|
|
|
2,089,700
|
|
|
|
500,000
|
|
Deferred revenue
|
|
|
(2,078,788
|
)
|
|
|
1,912,121
|
|
|
|
449,463
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in operating
activities
|
|
|
(4,703,792
|
)
|
|
|
(345,059
|
)
|
|
|
(6,965,083
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS (USED IN) PROVIDED BY
INVESTING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of property and equipment
|
|
|
(2,349,033
|
)
|
|
|
(5,656,905
|
)
|
|
|
(7,418,053
|
)
|
Purchases of investments
|
|
|
(24,374,659
|
)
|
|
|
(22,791,027
|
)
|
|
|
(48,653,858
|
)
|
Proceeds from sale of investments
|
|
|
25,589,000
|
|
|
|
32,393,001
|
|
|
|
36,155,365
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by
investing activities
|
|
|
(1,134,692
|
)
|
|
|
3,945,069
|
|
|
|
(19,916,546
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS PROVIDED BY FINANCING
ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds from issuance of
common stock
|
|
|
|
|
|
|
|
|
|
|
28,522,249
|
|
Proceeds from loan
|
|
|
|
|
|
|
|
|
|
|
4,500,000
|
|
Repayment of loan
|
|
|
|
|
|
|
(4,500,000
|
)
|
|
|
|
|
Restricted cash
|
|
|
|
|
|
|
4,200,000
|
|
|
|
(4,200,000
|
)
|
Proceeds from the exercise of
common stock options and warrants
|
|
|
6,281,768
|
|
|
|
8,423,658
|
|
|
|
2,923,640
|
|
Principal payments on capital lease
|
|
|
|
|
|
|
|
|
|
|
(3,886
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing
activities
|
|
|
6,281,768
|
|
|
|
8,123,658
|
|
|
|
31,742,003
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INCREASE IN CASH AND CASH
EQUIVALENTS
|
|
|
443,284
|
|
|
|
11,723,668
|
|
|
|
4,860,374
|
|
CASH AND CASH EQUIVALENTS,
BEGINNING OF YEAR
|
|
|
30,654,249
|
|
|
|
18,930,581
|
|
|
|
14,070,207
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS, END OF
YEAR
|
|
$
|
31,097,533
|
|
|
$
|
30,654,249
|
|
|
$
|
18,930,581
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL DISCLOSURE OF CASH
FLOW INFORMATION
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for interest
|
|
$
|
|
|
|
$
|
181,686
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
F-10
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
1. BUSINESS:
Universal Display Corporation (the Company) is
engaged in the research, development and commercialization of
organic light emitting diode (OLED) technologies and
materials for use in flat panel display, solid-state lighting
and other product applications. The Companys primary
business strategy is to develop and license its proprietary OLED
technologies to product manufacturers for use in these
applications. In support of this objective, the Company also
develops new OLED materials and sells those materials to product
manufacturers. Through internal research and development efforts
and relationships with entities such as Princeton University,
the University of Southern California (USC), the
University of Michigan, Motorola, Inc. and PPG Industries, Inc.,
the Company has established a significant portfolio of
proprietary OLED technologies and materials (Note 3).
The Company conducts a substantial portion of its OLED
technology and material development activities at its technology
development and transfer facility in Ewing, New Jersey. In
December 2004, the Company acquired the entire
40,200 square foot building at which the facility is
located. During 2005, the Company conducted a two-stage
expansion of its laboratory and office space in the building.
The Company also leases approximately 850 square feet of
office space in Coeur dAlene, Idaho.
2. SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES:
Principles
of Consolidation
The consolidated financial statements include the accounts of
Universal Display Corporation and its wholly owned subsidiary,
UDC, Inc. All intercompany transactions and accounts have been
eliminated.
Managements
Use of Estimates
The preparation of financial statements in conformity with
U.S. generally accepted accounting principles requires
management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from
those estimates.
Cash,
Cash Equivalents, Short-Term Investments and Long-Term
Investments
The Company considers all highly liquid debt instruments
purchased with an original maturity of three months or less to
be cash equivalents. The Company classifies its existing
marketable securities as
available-for-sale.
These securities are carried at fair market value, with
unrealized gains and losses reported in the consolidated
statement of shareholders equity and comprehensive loss.
Gains or losses on securities sold are based on the specific
identification method.
F-11
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Investments at December 31, 2006 and 2005 consist of the
following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Market Value
|
|
Investment Classification
|
|
Cost
|
|
|
Gains
|
|
|
(Losses)
|
|
|
Aggregate Fair
|
|
|
December 31, 2006-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Certificates of deposit
|
|
$
|
11,243,000
|
|
|
$
|
|
|
|
$
|
(79,070
|
)
|
|
$
|
11,163,930
|
|
US Government bonds
|
|
|
6,840,368
|
|
|
|
668
|
|
|
|
(4,444
|
)
|
|
|
6,836,592
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
18,083,368
|
|
|
$
|
668
|
|
|
$
|
(83,514
|
)
|
|
$
|
18,000,522
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2005-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Certificates of deposit
|
|
$
|
11,525,000
|
|
|
$
|
|
|
|
$
|
(51,149
|
)
|
|
$
|
11,473,851
|
|
Corporate bonds
|
|
|
1,505,477
|
|
|
|
|
|
|
|
(50,000
|
)
|
|
|
1,455,477
|
|
US Government bonds
|
|
|
6,109,050
|
|
|
|
|
|
|
|
(19,428
|
)
|
|
|
6,089,622
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
19,139,527
|
|
|
$
|
|
|
|
$
|
(120,577
|
)
|
|
$
|
19,018,950
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair
Value of Financial Instruments
Cash and cash equivalents, accounts receivable, other current
assets, and accounts payable are reflected in the accompanying
financial statements at fair value due to the short-term nature
of those instruments. Short-term and long-term investments are
recorded at fair market value.
Property
and Equipment
Property and equipment are stated at cost and depreciated
generally on a straight-line basis over their estimated useful
life of 30 years for building, 15 years for building
improvements, and three to seven years for office and lab
equipment, furniture and fixtures. Repair and maintenance costs
are charged to expense as incurred. Additions and betterments
are capitalized.
Inventory
Inventory consists of chemicals held at the Companys Ewing
location and is valued at the lower of cost or market, with cost
determined using the specific identification method.
Acquired
Technology
Acquired technology consists of license rights and know-how
obtained from PD-LD Inc. and Motorola, Inc (Note 5).
Acquired technology is amortized on a straight-line basis over
its estimated useful life of 10 years.
Impairment
of Long-Lived Assets
Company management continually evaluates whether events or
changes in circumstances might indicate that the remaining
estimated useful life of long-lived assets may warrant revision,
or that the remaining balance may not be recoverable. When
factors indicate that long-lived assets should be evaluated for
possible impairment, the Company uses an estimate of the related
undiscounted cash flows in measuring whether the long-lived
asset should be written down to fair value. Measurement of the
amount of impairment would be based on generally accepted
valuation methodologies, as deemed appropriate. As of
December 31, 2006, Company management believed that no
revision to the remaining useful lives or write-down of the
Companys long-lived assets was required. No such revisions
were required in 2005 or 2004.
F-12
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Net
Loss Per Common Share
Basic net loss per common share is computed by dividing the net
loss attributable to common shareholders by the weighted-average
number of shares of common stock outstanding for the period.
Diluted net loss per common share reflects the potential
dilution from the exercise or conversion of securities into
common stock. For the years ended December 31, 2006, 2005
and 2004, the effects of the combined outstanding stock options
and warrants of 6,812,601, 8,395,297 and 8,422,197,
respectively, were excluded from the calculation of diluted EPS
as the impact would have been antidilutive.
Revenue
Recognition and Deferred License Fees
Contract research revenue represents reimbursements by
government entities for all or a portion of the research and
development costs the Company incurs in relation to its
government contracts. Revenues are recognized proportionally as
research and development costs are incurred, or as defined
milestones are achieved.
Development chemical revenue represents revenues from sales of
OLED materials to product manufacturers for evaluation and
development purposes. Revenue is recognized at the time of
shipment and passage of title. The customer does not have the
right to return the materials.
Commercial chemical revenue represents sales of OLED materials
to manufacturers for the production of commercial products. This
revenue is recognized at the time of shipment, or at time of
delivery and passage of title, depending upon the contractual
agreement between the parties.
The Company receives non-refundable advance license and royalty
payments under certain development and technology evaluation
agreements. Certain of these payments are creditable against
future amounts payable under commercial license agreements that
the parties may subsequently enter into and, as such, are
deferred until such license agreements are executed or
negotiations have ceased and Company management determines that
there is no appreciable likelihood of executing a license
agreement. Revenue would then be recorded over the expected life
of the relevant licensed technology, if there is an effective
license agreement, or at the time Company management determines
that there is no appreciable likelihood of an executable license
agreement. Advanced payments received under technology
development and evaluation agreements that are not creditable
against license fees are deferred and recognized as technology
development revenue over the term of the agreement.
Royalty revenue was received in 2004 from OVPD equipment sold
under a development and license agreement with Aixtron AG. This
revenue was recognized upon the Companys receipt of
notification that equipment was sold and that royalties were due
from Aixtron. No royalty revenue was earned in 2006 and 2005.
F-13
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Research
and Development
Expenditures for research and development are charged to
operations as incurred. Research and development expenses
consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Development and operations in the
Companys facility
|
|
$
|
12,092,669
|
|
|
$
|
8,967,285
|
|
|
$
|
7,892,810
|
|
Patent application and prosecution
expenses
|
|
|
1,799,819
|
|
|
|
2,158,598
|
|
|
|
1,950,576
|
|
Patent maintenance and defense
expenses
|
|
|
611,512
|
|
|
|
171,135
|
|
|
|
61,142
|
|
Refunded amounts from Princeton
University, net of costs incurred to Princeton University and
USC under the 1997 Research Agreement (Note 3)
|
|
|
(752,037
|
)
|
|
|
598,796
|
|
|
|
679,910
|
|
PPG Development and License
Agreement (Note 7)
|
|
|
4,157,909
|
|
|
|
4,769,301
|
|
|
|
4,066,905
|
|
Amortization of intangibles
|
|
|
1,695,072
|
|
|
|
1,695,072
|
|
|
|
1,695,072
|
|
Scientific Advisory Board
compensation
|
|
|
260,000
|
|
|
|
823,203
|
|
|
|
304,920
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
19,864,944
|
|
|
$
|
19,183,390
|
|
|
$
|
16,651,335
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patent
Costs
Patent applications, maintenance, prosecution and defense costs
are charged to expense as incurred. Costs to successfully defend
a challenge to a patent are capitalized to the extent of an
evident increase in the value of the patent. Legal costs which
relate to an unsuccessful outcome are charged to expense.
Statement
of Cash Flow Information
The following non-cash activities occurred:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Unrealized gain (loss) on
available-for-sale
securities
|
|
$
|
37,731
|
|
|
$
|
(40,740
|
)
|
|
$
|
(41,000
|
)
|
Deemed dividends (Notes 8 and
9)
|
|
|
|
|
|
|
|
|
|
|
129,624
|
|
Common stock issued to Board of
Directors and Scientific Advisory Board that were earned in a
previous period
|
|
|
588,200
|
|
|
|
390,720
|
|
|
|
643,720
|
|
Common stock issued to employees
that were earned in a previous period
|
|
|
838,854
|
|
|
|
726,414
|
|
|
|
517,466
|
|
Income
Taxes
Deferred tax assets and liabilities are determined based on the
difference between the financial statement and tax bases of
assets and liabilities. Deferred tax assets or liabilities at
the end of each period are determined using the tax rate
expected to be in effect when taxes are actually paid or
recovered. The Company accounts for the sale of its net state
operating losses on a cash basis; therefore, it does not record
an income tax benefit until the cash is received.
Share
Based Payment Awards
Statement of Financial Accounting Standards (SFAS)
No. 123R, Share-Based Payment, addresses all forms
of share-based payment awards including shares issued under
employee stock purchase plans, stock options, restricted stock
and stock appreciation rights. It requires companies to
recognize in the statement of operations the grant-date
F-14
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
fair value of stock options and other equity based
compensation issued to employees and directors. The statement
eliminates the intrinsic value-based method prescribed by
Accounting Principles Board (APB) Opinion No. 25,
Accounting for Stock Issued to Employees, and related
interpretations, that the Company used prior to 2006.
Effective January 1, 2006, the Company adopted
SFAS No. 123R using the modified prospective method
(Note 10). Under this method, share-based compensation
recognized in 2006 included: (1) compensation expense for
all share-based payments granted prior to, but not yet vested as
of, January 1, 2006, based on the grant date fair value
estimated in accordance with the original provisions of
SFAS 123, and (2) compensation expense for all share-based
payments granted, modified or settled subsequent to
January 1, 2006, based on the grant date fair value. The
Companys net loss and basic and diluted net loss per share
for the year ended December 31, 2006 was $850,552 and $0.02
higher than if the Company had continued to account for
share-based compensation under APB Opinion No. 25.
The grant-date fair value of stock options are determined using
the Black-Scholes valuation model, which is the same model the
Company used previously for valuing stock options for footnote
disclosure purposes. The fair value of share-based awards is
recognized as compensation expense over the requisite service
period, net of estimated forfeitures. The Company relies
primarily upon historical experience to estimate expected
forfeitures and recognizes compensation expense on a
straight-line basis from the date of the grant. The Company
issues new shares upon exercise or vesting of share-based awards.
Prior to the adoption of SFAS No. 123R, the Company
used the intrinsic value method of accounting for stock-based
employee compensation in accordance with APB Opinion
No. 25. Under the intrinsic value method, no compensation
expense was recognized for the Companys stock options as
the exercise price was equal to the market price of the common
stock on the date of grant. The following table illustrates the
effect on net loss and net loss per share if the Company had
applied SFAS No. 123 for the years ended
December 31, 2005 and 2004:
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2005
|
|
|
2004
|
|
|
Net loss attributable to common
shareholders:
|
|
|
|
|
|
|
|
|
As reported
|
|
$
|
(15,801,612
|
)
|
|
$
|
(15,906,198
|
)
|
Add stock-based employee
compensation expense included in reported net loss
|
|
|
1,851,296
|
|
|
|
2,077,349
|
|
Deduct total stock-based employee
compensation expense determined under fair-value-based method
for all awards
|
|
|
(8,459,041
|
)
|
|
|
(6,883,549
|
)
|
|
|
|
|
|
|
|
|
|
Pro forma net loss
|
|
$
|
(22,409,357
|
)
|
|
$
|
(20,712,398
|
)
|
|
|
|
|
|
|
|
|
|
Basic and diluted net loss per
share:
|
|
|
|
|
|
|
|
|
As reported
|
|
$
|
(0.56
|
)
|
|
$
|
(0.59
|
)
|
Pro forma
|
|
$
|
(0.79
|
)
|
|
$
|
(0.77
|
)
|
Recent
Accounting Pronouncements
In June 2006, the FASB issued FASB Interpretation No. 48,
Accounting for Uncertainty in Income Taxes
an Interpretation of FASB Statement No. 109
(FIN 48). FIN 48 clarifies the accounting
for uncertainty in income taxes by prescribing a minimum
recognition threshold for a tax position taken, or expected to
be taken, in a tax return that is required to be met before
being recognized in the financial statements. FIN 48 also
provides guidance on derecognition, measurement, classification,
interest and penalties, accounting in interim periods,
disclosure and transition. The requirements of FIN 48 are
effective for fiscal years beginning after December 15,
2006. The Company does not believe the adoption of FIN 48
will have an effect on the consolidated financial position or
results of operations.
F-15
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
In June 2006, the FASB ratified the Emerging Issues Task Force
(EITF) Issue
No. 06-3,
How Taxes Collected from Customers and Remitted to
Government Authorities Should Be Presented in the Income
Statement (That Is, Gross Versus Net Presentation).
This standard allows companies to present in their statements of
operations any taxes assessed by a governmental authority that
are directly imposed on revenue- producing transactions between
a seller and a customer, such as sales, use, value-added and
some excise taxes, on either a gross (included in revenue and
costs) or a net (excluded from revenue) basis. This standard
will be effective for financial statements issued in interim
periods and fiscal years beginning after December 15, 2006.
The Company presents these transactions on a gross basis, and
therefore the adoption of this standard will have no impact on
the Companys consolidated financial position and results
of operations.
In September 2006, the FASB issued SFAS No. 157,
Fair Value Measurements (SFAS 157), to
increase consistency and comparability in fair value
measurements by defining fair value, establishing a framework
for measuring fair value in generally accepted accounting
principles, and expanding disclosures about fair value
measurements. SFAS 157 emphasizes that fair value is a
market-based measurement, not an entity-specific measurement. It
clarifies the extent to which fair value is used to measure
recognized assets and liabilities, the inputs used to develop
the measurements, and the effect of certain of the measurements
on earnings of the period. SFAS 157 is effective for
financial statements issued for fiscal years beginning after
November 15, 2007, and will be applied on a prospective
basis. Company management does not expect the adoption of
SFAS 157 to have a material impact on the consolidated
financial position, results of operations and cash flows.
Reclassifications
Certain prior year amounts have been reclassified to conform to
the current year presentation.
|
|
3.
|
RESEARCH
AND LICENSE AGREEMENTS WITH PRINCETON UNIVERSITY, USC AND THE
UNIVERSITY OF MICHIGAN:
|
The Company has been funding OLED technology research at
Princeton University and, on a subcontractor basis, at USC,
under a Research Agreement executed with the Trustees of
Princeton University in August 1997 (as amended, the 1997
Research Agreement). In April 2002, the 1997 Research
Agreement was amended to provide for, among other things, an
additional five-year term. Under the terms of this amendment,
the Company was obligated to pay Princeton University up to
$7,477,993 for the period from July 31, 2002 through
July 31, 2007. Payments to Princeton University under this
agreement were charged to research and development expenses when
they became due. Through the period ended December 31,
2006, the Company paid $3,480,361 to Princeton University under
the 1997 Research Agreement. Although the payments were charged
to expense when they became due, the actual work performed by
Princeton University and USC did not always equate to the fixed
amounts actually paid for each period. In the third quarter of
2006, Princeton University refunded $1,011,358 to the Company
for cumulative amounts overpaid under the 1997 Research
Agreement. The Company recorded the refund as an offset to
research and development expenses.
On October 9, 1997, the Company, Princeton University and
USC entered into an Amended License Agreement under which
Princeton University and USC granted the Company worldwide,
exclusive license rights, with rights to sublicense, to make,
have made, use, lease
and/or sell
products and to practice processes based on patent applications
and issued patents arising out of work performed by Princeton
University and USC under the 1997 Research Agreement (as
amended, the 1997 Amended License Agreement). Under
this agreement, the Company is required to pay Princeton
University royalties for licensed products sold by the Company
or its sublicensees. For licensed products sold by the Company,
the Company is required to pay Princeton University 3% of the
net sales price of these products. For licensed products sold by
the Companys sublicensees, the Company is required to pay
Princeton University 3% of the revenues received by the Company
from these sublicensees. These royalty rates are subject to
renegotiation for products not reasonably conceivable as arising
out of the 1997 Research Agreement if Princeton University
reasonably determines that the royalty rates payable with
respect to these
F-16
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
products are not fair and competitive. The Company is obligated
under the 1997 Amended License Agreement to pay to Princeton
University minimum annual royalties. The minimum royalty payment
is $100,000 per year. The Company accrued $177,436 of
royalty expense in connection with the agreement for the year
ended December 31, 2006.
The Company also is required under the 1997 Amended License
Agreement to use commercially reasonable efforts to bring the
licensed OLED technology to market. However, this requirement is
deemed satisfied provided the Company performs its obligations
under the 1997 Research Agreement and, when that agreement ends,
the Company invests a minimum of $800,000 per year in
research, development, commercialization or patenting efforts
respecting the patent rights licensed to the Company.
In January 2006, the Principal Investigator conducting research
at Princeton University under the 1997 Research Agreement
transferred to the University of Michigan
(Michigan). As a result of this transfer, the
Company has entered into a new Sponsored Research Agreement with
USC to sponsor OLED technology research at USC and, on a
subcontractor basis, Michigan. This new Research Agreement (the
2006 Research Agreement) was effective as of
May 1, 2006, and has a term of three years. Under the 2006
Research Agreement, the Company is obligated to pay USC up to
$4,636,296 for work actually performed during the period from
May 1, 2006 through April 30, 2009. Amounts paid to
Princeton University under the 1997 Research Agreement offset
any amounts the Company is obligated to pay USC under the 2006
Research Agreement. Payments under the 2006 Research Agreement
are made to USC on a quarterly basis as actual expenses are
incurred. For the year ended December 31, 2006, the Company
paid $131,856 under the 2006 Research Agreement.
In connection with entering into the 2006 Research Agreement,
the Company amended the 1997 Amended License Agreement to
include Michigan as a party to that agreement effective as of
January 1, 2006. Under this amendment, Princeton
University, USC and Michigan have granted the Company a
worldwide exclusive license, with rights to sublicense, to make,
have made, use, lease
and/or sell
products and to practice processes based on patent applications
and issued patents arising out of work performed under the 2006
Research Agreement. The financial terms of the 1997 Amended
License Agreement were not impacted by this amendment.
|
|
4.
|
PROPERTY
AND EQUIPMENT:
|
Property and equipment consist of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
Land
|
|
$
|
820,000
|
|
|
$
|
820,000
|
|
Building and improvements
|
|
|
11,087,331
|
|
|
|
6,795,900
|
|
Office and lab equipment
|
|
|
11,286,548
|
|
|
|
9,866,078
|
|
Furniture and fixtures
|
|
|
285,573
|
|
|
|
285,573
|
|
Construction-in-progress
|
|
|
827,123
|
|
|
|
4,374,512
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,306,575
|
|
|
|
22,142,063
|
|
Less: Accumulated depreciation
|
|
|
(10,232,482
|
)
|
|
|
(8,588,452
|
)
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
$
|
14,074,093
|
|
|
$
|
13,553,611
|
|
|
|
|
|
|
|
|
|
|
Construction-in-progress
consists of costs incurred for the acquisition of laboratory
equipment for the Companys facility. Upon commencement of
operation of the lab equipment, the cost associated with such
assets will be depreciated over their estimated useful lives.
Depreciation expense was $1,828,551, $1,654,826 and $1,398,636
for the years ended December 31, 2006, 2005 and 2004,
respectively.
F-17
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Acquired technology consists of acquired license rights for
patents and know-how obtained from PD-LD, Inc. and Motorola,
Inc. These intangible assets consist of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
PD-LD, Inc.
|
|
$
|
1,481,250
|
|
|
$
|
1,481,250
|
|
Motorola, Inc.
|
|
|
15,469,468
|
|
|
|
15,469,468
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,950,718
|
|
|
|
16,950,718
|
|
Less: Accumulated amortization
|
|
|
(10,631,230
|
)
|
|
|
(8,936,159
|
)
|
|
|
|
|
|
|
|
|
|
Acquired technology, net
|
|
$
|
6,319,488
|
|
|
$
|
8,014,559
|
|
|
|
|
|
|
|
|
|
|
On July 19, 2000, the Company, PD-LD, Inc.
(PD-LD), its president Dr. Vladimir Ban and the
Trustees of Princeton University entered into a Termination,
Amendment and License Agreement whereby the Company acquired all
PD-LDs rights to certain issued and pending OLED
technology patents in exchange for 50,000 shares of the
Companys common stock. Pursuant to this transaction, these
patents were included in the patent rights exclusively licensed
to the Company under the 1997 Amended License Agreement. The
acquisition of these patents had a fair value of $1,481,250.
On September 29, 2000, the Company entered into a License
Agreement with Motorola, Inc. (Motorola). Pursuant
to this agreement, the Company licensed from Motorola what are
now 74 issued U.S. patents and corresponding foreign
patents relating to OLED technologies. These patents expire
between 2012 and 2018. The Company has the sole right to
sublicense these patents to OLED product manufacturers. As
consideration for this license, the Company issued to Motorola
200,000 shares of the Companys common stock (valued
at $4,412,500), 300,000 shares of the Companys
Series B Convertible Preferred Stock (valued at
$6,618,750), and a warrant to purchase 150,000 shares of the
Companys common stock at $21.60 per share. This
warrant became exercisable on September 29, 2001, and will
remain exercisable until September 29, 2008. The warrant
was recorded at a fair market value of $2,206,234 based on the
Black-Scholes option-pricing model, and was recorded as a
component of the cost of the acquired technology.
The Company also issued a warrant to an unaffiliated third party
to acquire 150,000 shares of common stock as a
finders fee in connection with the Motorola transaction.
This warrant was granted with an exercise price of $21.60 per
share, was exercisable immediately and will remain exercisable
until September 29, 2007. This warrant was accounted for at
its fair value based on the Black-Scholes option pricing model
and $2,206,234 was recorded as a component of the cost of the
acquired technology. The Company used the following assumptions
in the Black-Scholes option pricing model for the 300,000
warrants issued in connection with this transaction:
(1) 6.3% risk-free interest rate, (2) expected life of
7 years, (3) 60% volatility, and (4) zero
expected dividend yield. In addition, the Company incurred
$25,750 of direct cash transaction costs that have been included
in the cost of the acquired technology. In total, the Company
recorded an intangible asset of $15,469,468 for the technology
acquired from Motorola.
Amortization expense was $1,695,072 for each of the years ended
December 31, 2006, 2005 and 2004. For each of the three
succeeding fiscal years, amortization expense will be $1,695,072
and for the fourth year it will be $1,234,272.
The Company is required under the License Agreement to pay
Motorola royalties on gross revenues earned by the Company from
its sales of OLED products or components, or from its OLED
technology licensees, whether or not these revenues relate
specifically to inventions claimed in the patent rights licensed
from Motorola (Note 12). Moreover, the Company was required
to pay Motorola minimum royalties of $150,000 for the two-year
period ended on December 31, 2002, $500,000 for the
two-year period ended on December 31, 2004, and $1,000,000
for
F-18
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
the two-year period ended on December 31, 2006. All royalty
payments were made, at the Companys discretion, in 50%
cash and 50% in shares of the Companys common stock. The
number of shares of common stock used to pay the stock portion
of the royalty was equal to 50% of the royalty due divided by
the average daily closing price per share of the Companys
common stock over the 10 trading days ending two business days
prior to the date the common stock is issued.
For the two-year period ended on December 31, 2004, the
Company issued to Motorola 35,516 shares of the
Companys common stock, valued at $249,997, and paid
Motorola $250,003 in cash to satisfy the minimum royalty
obligation of $500,000. Since the minimum royalty obligation
exceeded actual royalties for the two years ended
December 31, 2006, the Company accrued $1,000,000 in
royalty expense. In March 2007, the Company issued to Motorola
37,075 shares of the Companys common stock, valued at
$499,993, and paid Motorola $500,007 in cash to satisfy the
minimum royalty obligation of $1,000,000.
6. ACCRUED
EXPENSES:
Accrued expenses consist of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
Compensation
|
|
$
|
2,876,897
|
|
|
$
|
2,409,593
|
|
Minimum royalties
|
|
|
1,177,436
|
|
|
|
610,098
|
|
Consulting
|
|
|
260,000
|
|
|
|
260,000
|
|
Professional fees
|
|
|
324,288
|
|
|
|
455,511
|
|
Subcontracts
|
|
|
153,104
|
|
|
|
410,547
|
|
Research and development agreements
|
|
|
200,658
|
|
|
|
199,248
|
|
Other
|
|
|
253,153
|
|
|
|
823,226
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
5,245,536
|
|
|
$
|
5,168,223
|
|
|
|
|
|
|
|
|
|
|
|
|
7.
|
EQUITY
AND CASH COMPENSATION UNDER THE PPG AGREEMENTS:
|
On October 1, 2000, the Company entered into a five-year
Development and License Agreement (Development
Agreement) and a seven-year Supply Agreement (Supply
Agreement) with PPG Industries, Inc. (PPG).
Under the Development Agreement, a team of PPG scientists and
engineers assisted the Company in developing its proprietary
OLED materials and supplied the Company with these materials for
evaluation purposes. Under the Supply Agreement, PPG supplied
the Company with its proprietary OLED materials that were
intended for resale to customers for commercial purposes.
For the period from inception of the Development Agreement
through December 2004, the Company issued shares of its common
stock and warrants to acquire its common stock to PPG on an
annual basis in consideration of the services provided under the
agreement. The consideration to PPG for these services was
determined by reference to an
agreed-upon
annual budget and was subject to adjustment based on costs
actually incurred for work performed during the budget period.
The specific number of shares of common stock and warrants
issued to PPG was determined based on the average closing price
of the Companys common stock during a specified period
prior to the start of the budget period. In January 2003, the
Company and PPG amended the Development Agreement, providing for
additional consideration to PPG for additional services to be
provided under that agreement, which services were paid for in
cash. All materials provided by PPG under the Supply Agreement
were also paid for in cash.
In December 2004 and again in March 2005, the Company and PPG
amended both the Development Agreement and the Supply Agreement
to alter the charges and method of payment for services and
materials provided by PPG under both agreements during 2005.
Under the amended Development Agreement, the Company
F-19
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
compensated PPG on a cost-plus basis for the services provided
during each calendar quarter. The Company was required to pay
for some of these services in cash and for other of the services
in common stock. Payment for up to 50% of the remaining services
was able to be paid, at the Companys sole discretion, in
cash or shares of common stock, with the balance payable in all
cash. The actual number of shares of common stock issuable to
PPG was determined based on the average closing price for the
Companys common stock during a specified period prior to
the end of that quarter. If, however, this average closing price
was less than $6.00, the Company was required to compensate PPG
in all cash. The Company recorded these expenses to research and
development as they were incurred.
Under the amended Supply Agreement, the Company also compensated
PPG on a cost-plus basis for services and materials provided
during each calendar quarter of 2005. The Company was required
to pay for all materials and for some of these services in cash.
Payment for up to 50% of the remaining services was able to be
paid, at the Companys sole discretion, in cash or shares
of common stock, with the balance payable in all cash. Again,
the specific number of shares of common stock issuable to PPG
was determined based on the average closing price for the
Companys common stock during a specified period prior to
the end of the quarter. If, however, this average closing price
was less than $6.00, the Company was required to compensate PPG
in cash.
On July 29, 2005, the Company entered into an OLED
Materials Supply and Service Agreement with PPG. This Agreement
superseded and replaced in their entireties the amended
Development and Supply Agreements effective as of
January 1, 2006, and extended the term of the
Companys existing relationship with PPG through
December 31, 2008. Under the new agreement, PPG Industries
has continued to assist the Company in developing its
proprietary OLED materials and supplying the Company with those
materials for evaluation purposes and for resale to its
customers. The financial terms of the new agreement are
substantially similar to those of the amended Development and
Supply Agreements, and include a requirement that the Company
pay PPG in a combination of cash and the Companys common
stock.
On April 19, 2006 and February 15, 2005, the Company
issued 1,957 and 27,276 shares of common stock to PPG based
on a final accounting for actual costs incurred by PPG under the
Development Agreement for the year ended December 31, 2005
and 2004, respectively. Accordingly, the Company accrued $22,515
and $245,484 of additional research and development expense as
of December 31, 2005 and 2004, based on the fair value of
these additional shares as of the end of 2005 and 2004,
respectively.
In 2006, 2005 and 2004, the Company issued to PPG 207,637,
413,314 and 157,609 shares of the Companys common
stock, respectively, as consideration for services provided by
PPG under the applicable agreement(s) during 2006 and 2005. For
these shares, the Company recorded charges of $2,619,439,
$3,610,229 and $1,626,003 to research and development expense
for 2006, 2005 and 2004, respectively. The charges were
determined based on the fair value of the Companys common
stock as of the end of each period. The Company also recorded
$952,633 and $606,926 to research and development expense for
the cash portion of the work performed by PPG during 2006 and
2005, respectively. There was no cash paid to PPG in 2004 for
these services.
Also, in accordance with the agreements with PPG, the Company is
required to reimburse PPG for its raw materials and conversion
costs for all development chemicals produced on behalf of the
Company. The Company recorded $237,202, $253,709 and $710,759 in
research and development expenses related to these costs during
2006, 2005 and 2004, respectively.
For work performed through the end of 2006, the Company was
required under its agreements with PPG to grant options to
purchase shares of the Companys common stock to PPG
employees performing certain development services for the
Company, in a manner consistent with that for issuing options to
its own employees. Subject to certain contingencies, these
options were to vest one year following the date of grant and
were to remain exercisable for up to 90 days after the
individual PPG employee ceased performing development services
for the Company. However, in connection with the conclusion of
the development program on December 31, 2006, the exercise
periods for these options were extended. In the case of certain
PPG employees who were hired by the
F-20
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Company as full-time employees in April 2006, the exercise
period was extended to run for so long as they remain employees
of the Company, plus an additional period of up to one year
thereafter, just as other Company employees are treated under
the Companys Equity Compensation Plan. For those PPG
employees not hired by the Company, the exercise period was
extended for three years through December 31, 2009.
On December 30, 2005, January 18, 2005, April 20,
2004 and December 23, 2003, the Company granted to PPG
employees performing development services under the Development
Agreement options to purchase 31,500, 30,500, 4,000 and
21,000 shares, respectively, of the Companys common
stock at exercise prices of $10.51, $8.14, $13.28 and $13.92,
respectively. As a result of the Company hiring certain of the
PPG employees in April 2006, the Company accelerated the vesting
of 18,500 of the options granted on December 30, 2005.
Accordingly, the Company recorded $225,882 in research and
development costs related to these options in the third quarter
of 2006. The Company also recorded $100,838 in research and
development costs for the remaining 13,000 options during 2006.
During 2005 and 2004, the Company recorded $275,922 and
$187,911, in research and development costs related to these
options granted.
The Company determined the fair value of the options earned
during 2006, 2005 and 2004 using the Black-Scholes
option-pricing model with the following assumptions:
(1) risk free interest rate of 4.3-4.6%, 4.2% and 4.3-4.4%,
respectively, (2) no expected dividend yield,
(3) contractual life of 3.25 and 10 years,
respectively and (4) expected volatility of
51-78%,
78-80% and
94%, respectively.
In further consideration of the services performed by PPG under
the Development Agreement in 2004, the Company issued warrants
to PPG to acquire 184,885 additional shares of the
Companys common stock. The number of warrants earned and
issued was based on the total number of shares of common stock
that the Company issued to PPG for services provided during
2004. The Company recorded $1,296,748 of research and
development expenses during 2004. The warrants were issued until
February 15, 2005. The Company was not required to issue
any warrants to PPG for services performed in 2006 or 2005.
On January 9, 2007, the Company issued 1,500 shares of
its common stock as a bonus to the remaining PPG research and
development team members. The Company recorded $21,915 in
research and development costs relating to the issuance.
|
|
8.
|
SERIES A
NONCONVERTIBLE PREFERRED STOCK AND SERIES B CONVERTIBLE AND
PREFERRED STOCK:
|
Series A
Nonconvertible Preferred Stock
In 1995, the Company issued 200,000 shares of Series A
Nonconvertible Preferred Stock (Series A) to
American Biomimetics Corporation (ABC) pursuant to a
certain Technology Transfer Agreement between the Company and
ABC. The Series A shares have a liquidation value of
$7.50 per share. Series A shareholders, as a single
class, have the right to elect two members of the Companys
Board of Directors. This right has never been exercised. Holders
of the Series A shares are entitled to one vote per share
on matters which shareholders are generally entitled to vote.
The Series A shareholders are not entitled to any
dividends. The Series A shares were valued at
$1.75 per share, which was based upon an independent
appraisal.
Series B
Convertible Preferred Stock
In 2000, the Company issued 300,000 shares of Series B
Convertible Preferred Stock (Series B) to
Motorola (Note 5). On October 6, 2004, all
300,000 shares of the Series B were automatically
converted into 418,916 shares of the Companys common
stock. There are no Series B shares currently outstanding.
Each share of the Series B shares was convertible, at the
option of the holder, into such number of fully paid and
nonassessable shares of common stock as was determined by
dividing the original purchase price by the conversion price
applicable to such share determined on the date the certificate
is surrendered for conversion. Of the 300,000 shares of the
Series B issued to Motorola, 75,000 shares become
convertible on each of September 29, 2001, 2002, 2003 and
2004, with all
F-21
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
outstanding shares of the Series B being convertible into
shares of the Companys common stock on September 29,
2004. The conversion price for the Series B shares was
initially the original issuance price per share of the common
stock, but was subject to change if the average price of the
common stock fell below $12.00 for the 30 trading days ending
two business days prior to the relevant vesting date, regardless
of prior changes to the conversion price. The Company had the
option to pay Series B shareholders an amount of cash equal
to the difference between $12.00 and the average price of the
common stock, multiplied by the number of shares of common stock
into which the Series B shares would be convertible.
The incremental shares issuable upon conversion were accounted
for as a contingent beneficial conversion feature
(CBCF) in accordance with EITF
No. 00-27.
The CBCF was measured by multiplying the incremental shares by
the fair value of the Companys common stock on the
commitment date of September 29, 2000, which was $22.06.
Accordingly, the Company recorded a CBCF of $487,680 and
$1,953,479 in 2003 and 2002, respectively. The CBCF was treated
as a deemed dividend to the Series B shareholders. In 2004,
the Company made a cash payment of $83,448 in lieu of reducing
the conversion price of the Series B. The cash payment was
treated and recorded as a deemed dividend.
In March 2004, the Company sold 2,500,000 shares of its
common stock at $12.00 per share in a registered
underwritten public offering. The offering resulted in proceeds
to the Company of $28,036,218, net of $1,963,782 in associated
costs. In April 2004, the Company sold an additional
50,000 shares of its common stock at $12.00 per share
to cover over-allotments in connection with this public
offering. The sale of these additional shares resulted in
proceeds of $486,031, net of $113,968 in associated costs.
In February 2004, the Company issued to PPG a warrant to
purchase 315,461 shares of the Companys common stock.
This transaction and the March 2004 public offering of
2,500,000 shares of common stock were deemed dilutive under
the terms of a warrant the Company had previously issued and
resulted in the reduction of the exercise price of that warrant
and an increase in the number of shares issuable under that
warrant. The Company treated this occurrence as a deemed
dividend of $46,176.
In September 2004, in accordance with the terms of the
Series B, the Company made a cash payment to Motorola in
the amount of $83,448 to take into account a conversion
adjustment for 75,000 shares of the Series B that
became convertible into the Companys common stock. The
Company made the payment in lieu of reducing the conversion
price of the Series B. The cash payment was treated and
recorded as a deemed dividend.
In December 2006, the Company issued a total of 20,000 shares of
fully vested common stock with a fair value of $249,600 to
members of its Board of Directors for services performed in 2006.
There are 3,069,009 warrants to purchase common stock
outstanding at December 31, 2006. These warrants are
exercisable at a weighted average price of $13.11 and expire in
2007 through 2012.
On January 9, 2007, the Company issued a total of
84,138 shares of fully vested common stock to employees and
members of the Scientific Advisory Board for services performed
in 2006. The fair value of the shares issued of $1,559,283 for
employees and $260,000 for members of the Scientific Advisory
Board was accrued at December 31, 2006 and recorded as a
compensation charge in general and administrative expense
($1,135,933) and research and development expense ($683,350) for
the year ended.
In addition, the Company granted a total of 105,903 shares of
restricted common stock to employees and members of the
Scientific Advisory Board for services to be rendered. The
restricted stock had a value of $1,547,250 on the date of grant
and vest over three years from the date of grant.
F-22
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
10.
|
STOCK-BASED
COMPENSATION:
|
Equity
Compensation Plan
In 1995, the Board of Directors of the Company adopted a Stock
Option Plan (the 1995 Plan), under which options to
purchase a maximum of 500,000 shares of the Companys
common stock were authorized to be granted at prices not less
than the fair market value of the common stock on the date of
the grant, as determined by the Compensation Committee of the
Board of Directors. Through December 31, 2006, the
Companys shareholders have approved increases in the
number of shares reserved for issuance under the 1995 Plan to
7,000,000, and have extended the term of the 1995 Plan through
2015. The 1995 Plan was also amended and restated in 2003, and
is now called the Equity Compensation Plan. The Equity
Compensation Plan provides for the granting of incentive and
nonqualified stock options, stock, stock appreciation rights and
performance units to employees, directors and consultants of the
Company. Stock options are exercisable over periods determined
by the Compensation Committee, but for no longer than
10 years from the grant date. At December 31, 2006,
there are 1,655,248 shares that remain available to be
granted under the 1995 Plan.
The following table summarizes the stock option activity during
the year ended December 31, 2006 for all grants under the
Equity Compensation Plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
|
Exercise
|
|
|
|
Options
|
|
|
Price
|
|
|
Outstanding at January 1, 2006
|
|
|
4,046,074
|
|
|
$
|
9.26
|
|
Granted
|
|
|
105,750
|
|
|
|
13.28
|
|
Exercised
|
|
|
(351,032
|
)
|
|
|
7.30
|
|
Forfeited
|
|
|
(57,200
|
)
|
|
|
12.32
|
|
Cancelled
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31,
2006
|
|
|
3,743,592
|
|
|
|
9.51
|
|
Vested and expected to vest
|
|
|
3,734,898
|
|
|
|
9.50
|
|
Exercisable at December 31,
2006
|
|
|
3,608,592
|
|
|
|
9.39
|
|
|
|
|
|
|
|
|
|
|
The weighted average grant date fair value of options granted in
2006, 2005, and 2004 was $10.66, $7.21, and $12.62,
respectively. The fair value of the options granted was
estimated using the Black-Scholes option-pricing model. The
Black-Scholes option-pricing model considers assumptions related
to volatility, risk-free interest rate and dividend yield.
Expected volatility was based on the Companys historical
daily stock price volatility. The risk-free rate was based on
the average U.S. Treasury security yields in the quarter of
the grant. The dividend yield was based on historical
information. The expected life was determined from historical
information and managements estimate. The following table
provides the assumptions used in determining the fair value of
the stock options for the years ended December 31, 2006,
2005, and 2004 respectively:
|
|
|
|
|
|
|
|
|
2006
|
|
2005
|
|
2004
|
|
Dividend yield rate
|
|
0%
|
|
0%
|
|
0%
|
Expected volatility
|
|
73.4-79.9%
|
|
80.0-86.3%
|
|
86.3-94.0%
|
Risk-free interest rates
|
|
4.6-5.0%
|
|
3.8-4.5%
|
|
3.8-4.3%
|
Expected life
|
|
7 Years
|
|
7 Years
|
|
7 Years
|
F-23
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following table summarizes the status of unvested options at
December 31, 2006 and the changes during the year ended
December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
|
Grant Date
|
|
|
|
Options
|
|
|
Fair Value
|
|
|
Unvested options at
January 1, 2006
|
|
|
176,500
|
|
|
$
|
8.78
|
|
Granted
|
|
|
105,750
|
|
|
|
10.66
|
|
Vested
|
|
|
(117,750
|
)
|
|
|
9.42
|
|
Forfeited
|
|
|
(29,500
|
)
|
|
|
10.79
|
|
|
|
|
|
|
|
|
|
|
Unvested options at
December 31, 2006
|
|
|
135,000
|
|
|
|
9.73
|
|
|
|
|
|
|
|
|
|
|
A summary of options outstanding and exercisable by price range
at December 31, 2006, is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding
|
|
|
Exercisable
|
|
|
|
|
|
|
|
Weighted-
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Weighted-
|
|
|
|
|
|
|
|
|
|
|
Number of Options
|
|
|
Average
|
|
|
Weighted-
|
|
|
|
|
|
Options
|
|
|
Average
|
|
|
Weighted-
|
|
|
|
|
|
|
|
Outstanding
|
|
|
Remaining
|
|
|
Average
|
|
|
Aggregate
|
|
|
Outstanding
|
|
|
Remaining
|
|
|
Average
|
|
|
Aggregate
|
|
|
|
|
at December 31,
|
|
|
Contractual
|
|
|
Exercise
|
|
|
Intrinsic
|
|
|
at December 31,
|
|
|
Contractual
|
|
|
Exercise
|
|
|
Intrinsic
|
|
Exercise Price
|
|
|
2006
|
|
|
Life (Years)
|
|
|
Price
|
|
|
Value (A)
|
|
|
2006
|
|
|
Life (Years)
|
|
|
Price
|
|
|
Value (A)
|
|
|
$
|
3.75-5.45
|
|
|
|
958,573
|
|
|
|
3.59
|
|
|
$
|
4.79
|
|
|
$
|
9,797,599
|
|
|
|
958,573
|
|
|
|
3.60
|
|
|
$
|
4.79
|
|
|
$
|
9,797,599
|
|
|
5.88-8.56
|
|
|
|
955,633
|
|
|
|
6.32
|
|
|
|
8.26
|
|
|
|
6,448,666
|
|
|
|
939,633
|
|
|
|
6.32
|
|
|
|
8.26
|
|
|
|
6,340,286
|
|
|
9.04-10.51
|
|
|
|
1,056,928
|
|
|
|
6.57
|
|
|
|
10.12
|
|
|
|
5,163,964
|
|
|
|
1,032,928
|
|
|
|
6.54
|
|
|
|
10.14
|
|
|
|
5,035,944
|
|
|
10.62-16.94
|
|
|
|
624,208
|
|
|
|
7.12
|
|
|
|
14.98
|
|
|
|
507,089
|
|
|
|
539,208
|
|
|
|
6.88
|
|
|
|
15.15
|
|
|
|
412,729
|
|
|
17.26-18.13
|
|
|
|
83,750
|
|
|
|
4.47
|
|
|
|
17.86
|
|
|
|
|
|
|
|
73,750
|
|
|
|
4.12
|
|
|
|
17.95
|
|
|
|
|
|
|
24.38
|
|
|
|
64,500
|
|
|
|
3.47
|
|
|
|
24.38
|
|
|
|
|
|
|
|
64,500
|
|
|
|
3.48
|
|
|
|
24.38
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3.75-24.38
|
|
|
|
3,743,592
|
|
|
|
5.74
|
|
|
$
|
9.51
|
|
|
$
|
21,917,318
|
|
|
|
3,608,592
|
|
|
|
5.64
|
|
|
$
|
9.39
|
|
|
$
|
21,586,558
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(A) |
|
The difference between the stock options exercise price
and the closing price of the common stock at December 31,
2006. |
The total intrinsic value of stock awards exercised during the
years ended December 31, 2006 and 2005 were $2,403,556 and
$1,776,948, respectively. At December 31, 2006, there was
$956,199 of total unrecognized compensation cost from
stock-based compensation arrangements granted under the Equity
Compensation Plan, which is related to non-vested options. The
compensation expense is expected to be recognized over a
weighted-average period of approximately 1.32 years.
In 2006 the Company issued 15,000 shares of restricted
stock to employees. The fair value of the restricted stock of
$191,565 is equal to the market price of the Companys
common stock on the date of grant. The restricted stock vests
over a three-year period. The Company recorded compensation of
$32,314 in the consolidated statement of operations for 2006 in
connection with the issuance of the restricted shares.
F-24
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
11. RESEARCH
CONTRACTS:
Contract research revenue consists of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
U.S. Army
|
|
$
|
1,796,338
|
|
|
$
|
897,887
|
|
|
$
|
776,284
|
|
Army Research Laboratory (ARL)
|
|
|
239,357
|
|
|
|
865,445
|
|
|
|
759,767
|
|
Department of Energy (DoE)
|
|
|
1,786,208
|
|
|
|
2,409,442
|
|
|
|
725,793
|
|
Air Force Research Laboratory
(AFRL)
|
|
|
|
|
|
|
481,207
|
|
|
|
343,793
|
|
Department of Defense Advanced
Research Projects Agency (DARPA)
|
|
|
|
|
|
|
|
|
|
|
15,999
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,821,903
|
|
|
$
|
4,653,981
|
|
|
$
|
2,621,636
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12.
|
COMMITMENTS
AND CONTINGENCIES:
|
Lease
Commitments
The Company has an operating lease arrangement for
850 square feet of office space in Coeur dAlene,
Idaho. Total rent expense was $10,275, $78,411 and $371,259 for
the years ended December 31, 2006, 2005 and 2004,
respectively. Minimum future rental payments for this lease as
of December 31, 2006 are $4,000 for 2007.
Other
Commitments
Under the terms of the Companys License Agreement with
Motorola (Note 5), the Company agreed to make minimum
royalty payments to Motorola. To the extent that the royalties
otherwise payable to Motorola under this agreement are not
sufficient to meet the minimums, the Company is required to pay
the shortfall, at its discretion, in all cash or in 50% cash and
50% common stock within 90 days after the end of each
two-year period specified below in which the shortfall occurs.
For the two-year period ended December 31, 2004, the
Company issued to Motorola 35,516 shares of the
Companys common stock, valued at $249,997, and paid
Motorola $250,003 in cash to satisfy the minimum royalty
obligation of $500,000. A minimum royalty payment of $1,000,000
is required to be made within 90 days following the
two-year period ended December 31, 2006. The minimum
royalty has been accrued at December 31, 2006. Thereafter,
no minimum royalty payments are required. In March 2007, the
Company issued to Motorola 37,075 shares of the
Companys common stock, valued at $499,993, and paid
Motorola $500,007 in cash to satisfy the minimum royalty
obligation of $1,000,000.
Under the terms of the 1997 Amended License Agreement with
Princeton University (Note 3), the Company is required to
pay Princeton University minimum royalty payments of
$100,000 per year. To the extent that the royalties
otherwise payable to Princeton University under this agreement
are not sufficient to meet the minimums for the relevant
calendar year, the Company is required to pay Princeton
University the difference between the royalties paid and the
minimum royalty.
The Company has agreements with four executive officers which
provide for certain cash and other benefits upon termination of
employment of the officer in connection with a change in control
of the Company. The executive is entitled to a lump-sum cash
payment equal to two times the sum of the average annual base
salary and bonus of the officer and immediate vesting of all
stock options and other equity awards that may be outstanding at
the date of the change in control, among other items.
Patent
Interference with Semiconductor Energy Laboratory Co.,
Ltd.
In June 2006, Patent Interference No. 104,461 was declared
by the United States Patent and Trademark Office (the
USPTO) between Semiconductor Energy Laboratory Co.,
Ltd. (SEL), and Princeton University and the
F-25
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
University of Southern California (the
Universities). The dispute concerns a
U.S. patent issued to SEL that Company management believes
claims aspects of the Companys phosphorescent OLED
technology covered under several U.S. patents and patent
applications which are exclusively licensed from the
Universities. The Universities are seeking a ruling by the USPTO
that they should be granted a patent to the claimed invention
and that the SEL patent is invalid because the
Universities invention was prior to that of SEL.
Company management believes that the substantial and uncontested
factual evidence of record in this patent interference strongly
supports the Universities position of priority to the
invention in question, and thus that the Universities should
prevail in this action. However, Company management cannot
predict a favorable outcome with certainty, and an adverse
ruling by the USPTO against the Universities might be referenced
in separate proceedings to challenge related U.S. patents
and patent applications that the Company exclusively licenses
from them. Even if this were to occur, however, the Company
exclusively licenses other patent rights from the Universities
that substantially cover the Companys phosphorescent OLED
technology in the form(s) that Company management believes will
have commercial value for the foreseeable future.
Various cross-motions have been filed and briefed in this
proceeding, and they are currently under consideration by the
USPTO. Under the Companys agreement with the Universities,
the Company is required to pay all legal costs and fees
associated with the proceeding.
Patent
Opposition Initiated by Cambridge Display Technology,
Ltd.
On December 8, 2006, Cambridge Display Technology, Ltd.
(CDT) filed a Notice of Opposition to European
Patent No. 0946958 (the EP 958 patent).
The EP 958 patent, which was issued on March 8, 2006,
is the European counterpart patent to U.S. patents 5,844,363,
6,602,540 and 6,888,306, and to pending U.S. patent application
10/966,417, filed on October 15, 2004. These patents and
patent applications relate to our flexible OLED, or FOLED,
technology. They are exclusively licensed to the Company by
Princeton University, and under the license agreement the
Company is required to pay all legal costs and fees associated
with this proceeding.
Company management is in the process of reviewing the Notice of
Opposition and preparing our response. Company management
believes that the Princeton University patent being challenged
by CDT is valid, and thus that Princeton University should
prevail in this action. However, Company management cannot
predict a favorable outcome with certainty.
|
|
13.
|
CONCENTRATION
OF RISK
|
Two non-government customers accounted for 38% and 24% of
consolidated revenue for the years ended December 31, 2006
and 2005, respectively. Accounts receivable from these customers
were $722,000 at December 31, 2006. Revenues from one of
these customers were associated with the purchase of commercial
materials from us. This customer has informed us that it does
not intend to purchase any additional commercial materials at
this time. This customer accounted for 24% of consolidated
revenue for the year ended December 31, 2006.
Revenues from outside of North America represented 65% and 54%
of the consolidated revenue year ended December 31, 2006
and 2005, respectively.
F-26
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The components of income taxes are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Current
|
|
$
|
(544,567
|
)
|
|
$
|
(424,207
|
)
|
|
$
|
(612,966
|
)
|
Deferred
|
|
|
(8,092,992
|
)
|
|
|
(6,601,124
|
)
|
|
|
(6,082,570
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8,637,559
|
)
|
|
|
(7,025,331
|
)
|
|
|
(6,695,536
|
)
|
Increase in valuation allowance
|
|
|
8,092,992
|
|
|
|
6,601,124
|
|
|
|
6,082,570
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(544,567
|
)
|
|
$
|
(424,207
|
)
|
|
$
|
(612,966
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The difference between the Companys federal statutory
income tax rate and its effective income tax rate is due to
state income tax benefits, non-deductible expenses, general
business credits and the increase in the valuation allowance.
As of December 31, 2006, the Company had a number of tax
loss and credit carry forwards. The Companys net operating
loss carry forwards differ from the accumulated deficit
principally due to the timing of the recognition of certain
expenses. A portion of the Companys net operating loss
carryforwards relate to tax deductions from stock-based
compensation that would be accounted for as an increase to
additional-paid-in-capital
for financial reporting purposes to the extent such future
deductions could be utilized by the Company. In accordance with
the Tax Reform Act of 1986, utilization of the Companys
net operating loss and general business credit carry forwards
could be subject to limitations because of certain ownership
changes. The following table summarizes Company tax loss and tax
credit carry forwards at December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Related Tax
|
|
|
Deferred Tax
|
|
|
Expiration
|
|
|
|
Deduction
|
|
|
Asset
|
|
|
Date
|
|
|
Loss carry forwards:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal net operating loss
|
|
$
|
94,680,000
|
|
|
$
|
32,191,000
|
|
|
|
2011 to 2026
|
|
State net operating loss
|
|
|
71,713,000
|
|
|
|
4,268,000
|
|
|
|
2007 to 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total loss carryforwards
|
|
$
|
166,393,000
|
|
|
$
|
36,459,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax credit carryforwards:
|
|
|
|
|
|
|
|
|
|
|
|
|
Research tax credit
|
|
|
n/a
|
|
|
|
2,389,000
|
|
|
|
2018 to 2026
|
|
State tax credits
|
|
|
n/a
|
|
|
|
891,000
|
|
|
|
2013 to 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total credit carry forwards
|
|
|
n/a
|
|
|
$
|
3,280,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-27
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Significant components of the Companys deferred tax assets
and liabilities are as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
Gross deferred tax assets:
|
|
|
|
|
|
|
|
|
Net operating loss carryforwards
|
|
$
|
36,459,000
|
|
|
$
|
27,116,250
|
|
Capitalized
start-up
costs
|
|
|
3,923,000
|
|
|
|
5,884,080
|
|
Capitalized technology license
|
|
|
3,092,000
|
|
|
|
2,866,119
|
|
Stock options and warrants
|
|
|
2,603,000
|
|
|
|
2,892,207
|
|
Accruals and reserves
|
|
|
286,000
|
|
|
|
248,076
|
|
Deferred revenue
|
|
|
4,351,000
|
|
|
|
3,908,191
|
|
Other
|
|
|
430,000
|
|
|
|
1,040,836
|
|
Tax credit carryforward
|
|
|
3,280,000
|
|
|
|
2,375,576
|
|
|
|
|
|
|
|
|
|
|
|
|
|
54,424,000
|
|
|
|
46,331,335
|
|
Valuation allowance
|
|
|
(54,424,000
|
)
|
|
|
(46,331,335
|
)
|
|
|
|
|
|
|
|
|
|
Net deferred tax asset
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
During the years ended December 31, 2006, 2005, and 2004,
the Company sold approximately $7 million, $5 million,
and $8 million, respectively, of its net state operating
losses (NOLs) to New Jersey under the Technology Tax Certificate
Transfer Program, and received $544,567, $424,207, and $612,966,
respectively, for the sale of the NOLs during these years. The
Company recorded the proceeds as an income tax benefit.
A valuation allowance was established for all of the deferred
tax assets because the Company has incurred substantial
operating losses since inception and expects to incur additional
losses in 2007. At this time, the Companys management has
concluded that these deferred tax assets will more likely than
not be realized.
|
|
14.
|
DEFINED
CONTRIBUTION PLAN:
|
The Company maintains the Universal Display Corporation 401(k)
Plan (the Plan) in accordance with the provisions of
Section 401(k) of the Internal Revenue Code (the
Code). The Plan covers substantially all full-time
employees of the Company. Participants may contribute up to 15%
of their total compensation to the Plan, not to exceed the limit
as defined in the Code, with the Company matching 50% of the
participants contribution, limited to 6% of the
participants total compensation. For the years ended
December 31, 2006, 2005 and 2004, the Company contributed
$164,050, $149,630 and $133,780 to the Plan, respectively.
|
|
15.
|
QUARTERLY
SUPPLEMENTAL FINANCIAL DATA (UNAUDITED):
|
The following tables present certain unaudited consolidated
quarterly financial information for each of the eight quarters
in the two-year period ended December 31, 2006. In the
opinion of Company management, this quarterly information has
been prepared on the same basis as the consolidated financial
statements and includes all adjustments (consisting of only
normal recurring adjustments) necessary to present fairly the
information for the
F-28
UNIVERSAL
DISPLAY CORPORATION AND SUBSIDIARY
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
periods presented. The results of operations for any quarter are
not necessarily indicative of the results for the full year or
for any future period.
Year ended December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31
|
|
|
June 30
|
|
|
September 30
|
|
|
December 31
|
|
|
Total
|
|
|
Revenue
|
|
$
|
3,271,406
|
|
|
$
|
3,009,316
|
|
|
$
|
3,096,288
|
|
|
$
|
2,544,282
|
|
|
$
|
11,921,292
|
|
Net loss
|
|
|
(3,522,040
|
)
|
|
|
(4,312,651
|
)
|
|
|
(2,943,287
|
)
|
|
|
(4,408,826
|
)
|
|
|
(15,186,804
|
)
|
Net loss attributable to Common
shareholders
|
|
|
(3,522,040
|
)
|
|
|
(4,312,651
|
)
|
|
|
(2,943,287
|
)
|
|
|
(4,408,826
|
)
|
|
|
(15,186,804
|
)
|
Basic and diluted loss per share
|
|
|
(0.12
|
)
|
|
|
(0.14
|
)
|
|
|
(0.09
|
)
|
|
|
(0.14
|
)
|
|
|
(0.49
|
)
|
Year ended December 31, 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31
|
|
|
June 30
|
|
|
September 30
|
|
|
December 31
|
|
|
Total
|
|
|
Revenue
|
|
$
|
1,467,068
|
|
|
$
|
3,011,995
|
|
|
$
|
3,372,870
|
|
|
$
|
2,296,062
|
|
|
$
|
10,147,995
|
|
Net loss
|
|
|
(4,990,901
|
)
|
|
|
(3,189,980
|
)
|
|
|
(2,979,140
|
)
|
|
|
(4,641,591
|
)
|
|
|
(15,801,612
|
)
|
Net loss attributable to Common
shareholders
|
|
|
(4,990,901
|
)
|
|
|
(3,189,980
|
)
|
|
|
(2,979,140
|
)
|
|
|
(4,641,591
|
)
|
|
|
(15,801,612
|
)
|
Basic and diluted loss per share
|
|
|
(0.18
|
)
|
|
|
(0.11
|
)
|
|
|
(0.10
|
)
|
|
|
(0.17
|
)
|
|
|
(0.56
|
)
|
F-29